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ABSTRACT 
  
 The Herpes Simplex Virus life cycle contains a number of membrane fusion 
events that must function properly to ensure a productive infection, including:  virus 
attachment and entry into susceptible cells, de-envelopment at the outer nuclear lamellae, 
and virus-induced cell-to-cell fusion.  A virus-free cell fusion assay was recently 
developed in order to attempt to understand the underlying mechanisms that are 
responsible for viral fusion events and was utilized in order to investigate the effect of 
mutations targeted to the carboxyl terminus of gB.  We showed that the predicted 
α−helical domain H17b within the carboxyl-terminus of gB is involved in both virus-
induced and virus-free fusion systems, and heparin was shown to be a specific inhibitor 
of gB-mediated fusion in both systems, while resistance to heparin inhibition of gB-
mediated cell fusion was associated with the predicted α−helical structure H17b.   An 
important difference between virus-free and virus-induced membrane fusion is that virus-
expressed gB mediates an insignificant amount of cell-to-cell fusion, while transiently 
expressed gB causes extensive cell-to-cell fusion.  gK was recently shown to inhibit cell 
fusion resulting from transiently expressed gB, gD, gH and gL and hypothesized to 
function as a negative regulator of membrane fusion.  However, we show that gK can not 
solely act as a negative regulator of gB-mediated membrane fusion, since gK is 
demonstrated to be absolutely required for virus-induced cell fusion to occur, suggesting 
a more complicated relationship between gK and gB.  A recent publication from our 
laboratory showed that syncytial mutations in either gB or gK failed to cause fusion in 
the absence of the UL20 gene, suggesting that the UL20 protein was essential for virus-
xviii 
induced cell fusion.  Absence of the UL20 gene also caused accumulation of unenveloped 
capsids into the cytoplasm, indicating that UL20p functioned in cytoplasmic stages of 
virion envelopment.  We delineated via site-directed mutagenesis the functional domains 
of UL20p involved in infectious virus production and virus-induced cell fusion, revealing 
that the role of UL20p in virus-induced cell fusion can be functionally separated from its 
role in cytoplasmic virion morphogenesis.   
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CHAPTER I 
INTRODUCTION  
 
STATEMENT OF PROBLEM AND HYPOTHESIS 
 Herpes Simplex Viruses are known to be the etiologic agents responsible for 
many human diseases including mucocutaneous oral and genital lesions, 
keratoconjunctivitis, and viral encephalitis.  During the herpesvirus life cycle there are a 
number of membrane fusion events that are required for productive infection, including 
those occurring during virus entry and egress from infected cells.  In addition, certain 
viral mutants exhibit the ability to cause extensive cell-to-cell fusion.  The virus-induced 
cell-to-cell fusion phenomenon has the potential to provide insight into the mechanisms 
involved in all herpesvirus membrane fusion events.  While the components involved in 
virus entry are relatively well understood, the mechanisms involved in regulating 
membrane fusion during virion egress and virus-induced cell-to-cell fusion are not well 
defined.  
 During virion egress, there are multiple steps where the capsid must traverse or 
acquire cellular membranes.  HSV-1 is thought to acquire an initial envelope when 
mature capsids formed in the nucleus of cells bud into the perinuclear space. 
Subsequently, a putative fusion event between viral envelopes and the outer nuclear 
membrane, termed de-envelopment, results in capsid release into the cytoplasm.  Final 
envelopment is thought to occur when capsids bud into cytoplasmic vesicles derived from 
the TGN or endosomes, which facilitate egress of enveloped virions to extracellular 
spaces (Mettenleiter, 2002b). Currently, it is not known whether viral glycoproteins 
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involved in virus entry or virus-induced cell fusion also function in the de-envelopment 
step at the outer nuclear membrane.  In addition, the mechanisms involved in final 
envelopment are unclear. 
 Syncytia formation resulting from virus-induced cell-to-cell fusion can be viewed 
as an aberrant manifestation of the interactions of altered membranes in herpesvirus 
infected cells with the unaltered membranes of neighboring cells.  Genetic analysis has 
shown that mutations that cause extensive virus-induced cell-to-cell fusion map to at least 
four and possible more loci within the viral genome: the UL20 gene (Baines et al., 1991; 
MacLean et al., 1991; Melancon, Foster, and Kousoulas, 2004), the UL24 gene (Jacobson 
et al., 1998; Sanders, Wilkie, and Davison, 1982), the UL27 gene encoding glycoprotein 
B (gB) (Bzik et al., 1984; Pellett et al., 1985), and the UL53 gene coding for glycoprotein 
K (gK) (Bond and Person, 1984; Debroy, Pederson, and Person, 1985; Hutchinson et al., 
1992b; Pogue-Geile et al., 1984; Pogue-Geile and Spear, 1987; Ruyechan et al., 1979), 
with the great majority of syncytial mutations arising in either UL27 (gB) or UL53 (gK). 
 Virus-induced cell-to-cell fusion has been extensively studied for several reasons:  
as a probe of the structure and function of cellular membranes during infection reflected 
in their behavior, as a tool for analysis of the functions of viral membrane proteins, and as 
a model of the initial interaction between HSV and susceptible cells that results in fusion 
of the viral envelope with the cellular plasma membrane (Campadelli-Fiume and 
Serafini-Cessi, 1985; Roizman, 1962; Spear, 1985b; Spear, 1993).  Recently, it was 
shown that transiently expressed gB, gD, gH, and gL are necessary and sufficient to 
induce membrane fusion in a virus-free membrane fusion system, reflecting the core 
requirements to activate the herpesvirus fusion machinery (Turner et al., 1998). 
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STATEMENT OF RESEARCH OBJECTIVES 
 The goal of this research was to investigate the structure and functions of the 
Herpes Simplex Virus Type 1 UL20 protein (UL20p), glycoprotein B (gB), and 
glycoprotein K (gK) in virion morphogenesis and egress, and virus-induced cell fusion 
The specific aims of this research were: 
I. To analyze the features in the carboxyl terminus of gB required for the regulation 
of syncytia formation in a virus-free fusion assay: 
1. To delineate gB carboxyl terminal domains involved in cell-to-cell fusion 
by generating a panel of site specific and truncation mutations in the 
carboxyl-terminus of gB and determine their effect on cell-to-fusion 
resulting from transiently expressed gB, gD, and the gH/gL heterodimer. 
2. To determine whether soluble heparin, a specific inhibitor of gB-mediated 
virus-induced cell fusion, can inhibit gB-mediated cell fusion in the 
transient co-expression system (virus-free) in the presence or absence of 
gB-carboxyl terminal mutations that alter gB’s fusogenic properties.  
3. To facilitate a determination of the relevance of the results obtained in the 
virus-free fusion system by comparison to the effects of similar gB 
mutations in virus-induced cell-to-cell fusion. 
II. To analyze whether gB, gK, and UL20p function redundantly in virion de-
envelopment from the perinuclear space during virion morphogenesis and egress: 
1. To generate UL20-null, gB-null, gK-null, UL20/gB double-null, and 
gK/gB double-null viruses through the use of a bacterial artificial 
chromosome (BAC) containing the entire HSV-1 genome. 
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2. To characterize the ultrastructural phenotypes of the UL20/gB double-null 
and gK/gB double-null viruses.  
III. To investigate the requirement of gK or UL20p in virus-induced cell fusion 
caused by syncytial mutations and truncations in the carboxyl terminus of gB:  
1. To introduce a gBsyn3 and gBamb1511 mutation into the previously 
constructed UL20/gB double-null and gK/gB double-null viruses. 
2. To characterize the syncytial phenotypes of the resulting UL20-null and 
gK-null viruses containing syncytial gB mutations. 
IV. To delineate the functional domains of UL20p involved in cytoplasmic virion 
envelopment and virus-induced cell fusion: 
1. To generate a panel of single and multiple (cluster) alanine substitutions as 
well as carboxyl-terminal truncations targeting specific areas of interest 
and conserved regions of the UL20 protein. 
2. To analyze the ability of each mutant UL20p gene to complement the 
UL20-null defect for infectious virion production and virus-induced cell 
fusion caused by gB and gK syncytial mutations. 
3. To compare complementation for virus replication results with the 
phenotypes of recombinant viruses containing mutants of interest. 
4. To investigate the ultrastructural phenotypes of viruses specifying mutant 
UL20 genes exhibiting defects in virion egress and spread. 
 Overall, the results obtained from this research indicate that:  the carboxyl 
terminus of gB contains specific domains that regulate gB-mediated membrane fusion 
phenomena; UL20p, gB, and gK are interdependent for virus-induced cell-to-cell fusion; 
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and specific domains of UL20p function in cell fusion and virion egress.  The work is 
presented in individual chapters in a manuscript format having a specific title for the 
central theme of each chapter: 
Chapter II: An alpha-helical domain within the carboxyl terminus of herpes simplex 
virus type 1 (HSV-1) glycoprotein B (gB) is associated with cell fusion 
and resistance to heparin inhibition of cell fusion.  
Chapter III: Herpes Simplex Virus Type 1 (HSV-1) Glycoprotein K (gK) is Required 
for Glycoprotein B (gB)-mediated Virus-Induced Cell Fusion, while 
neither gB and gK nor gB and UL20p Function Redundantly in Virion De-
Envelopment 
Chapter IV: Genetic analysis of the herpes simplex virus type 1 UL20 protein domains 
involved in cytoplasmic virion envelopment and virus-induced cell fusion. 
LITERATURE REVIEW 
Historical Perspective of Herpesviruses 
 The first description of Herpes Simplex Virus (HSV) can be traced back to the 
ancient Greeks.  Hippocrates used the term “herpes” to describe lesions that appeared to 
creep or crawl along the skin (Wildy, 1973).  Descriptions of lesions resembling HSV 
were also found on a Sumerian Tablet dated to the 3rd Millenium BC and the Ebers 
Papyrus, circa 1500 BC (Whitley, 2001).  Herodotus is noted as the first to describe an 
association between the cutaneous lesions and fever caused by HSV, and Galen 
recognized that recurrent HSV lesions develop at the same anatomical location (Whitley, 
2001).  During the 18th century, Bateman accurately described the nature of HSV 
infection as a “restricted group of localized vesicles with a short, self-limiting course” 
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(Bateman, 1814).  The first description of the link between HSV and the genital organs 
did not appear until De Morbis Venereis was published by John Astruc, physician for 
King Louis XIV, in 1736, after studying the afflictions of French prostitutes (Astruc, 
1736).   
 During the late 19th and early 20th century, human volunteers were often used to 
test the transmission of infectious agents, and Vidal showed that HSV was infectious by 
passing it from human to another (Vidal, 1873).  Gruter, in a switch from human to 
animal studies, demonstrated that HSV could be transmitted from rabbit to rabbit, and he 
is widely credited with the isolation of HSV by the virology community (Gruter, 1924). 
In 1939, Burnett and Williams published an article describing the nature of latency, 
noting that HSV seems to persist for life and can be reactivated under stressful conditions 
to produce visible lesions (Burnet and Williams, 1939).   
 The development of tissue culture technology was critical in the isolation of other 
members of the human herpesvirus family.  Between 1952 and 1956, varicella zoster 
virus (VZV), the causative agent of chicken pox, and cytomegalovirus (CMV) were 
isolated (Craig et al., 1957; Rowe et al., 1956; Smith, 1956; Weller and Stoddard, 1952).  
The eventual cultivation of lymphoblastoid tumor cells and B lymphocytes led to the 
isolation and study of Epstein-Barr virus (EBV) (Epstein, Achong, and Barr, 1964).  In 
the 1990s, cultivation of T lymphocytes led to the isolation of human herpesviruses 6A, 
6B, and 7 (Frenkel et al., 1990; Lopez et al., 1988; Salahuddin et al., 1986).  More 
recently, Representational Differential Analysis (RDA) led to the discovery of human 
herpesvirus 8 (Chang et al., 1994). 
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Taxonomy of Herpesviridae 
 Identification of the new and apparently related viruses led to a scientific desire 
for classification.  However, it was not until 1981 that the current herpesvirus 
classification came into being.  All herpesviruses examined to date are capable of 
establishing a latent infection in their natural hosts in a specific set of cells, which varies 
from one virus to another.  Other biological properties vary, such as the length of the 
reproductive cycle, and these were used as the basis of classification, before DNA 
sequences of the viruses were known.  Members of the family Herpesviridae were 
initially classified by the Herpesvirus Study Group into three subfamilies: the 
Alphaherpesvirinae, the Betaherpesvirinae, and the Gammaherpesvirinae (Roizman, 
Bartha, and Biggs, 1973; Roizman et al., 1992; Van Regenmortel et al., 2000).  DNA 
sequence data has since supported and expanded the platform on which the classification 
system rests.  Table 1.1 shows the classification of the nine known human herpesviruses 
(bold type) as well as other commonly studied herpesviruses (Roizman et al., 1992; Van 
Regenmortel et al., 2000). 
 Alphaherpesvirinae were classified based on their variable host range, short 
reproductive cycle, rapid spread in tissue culture, efficient destruction of infected cells, 
and the ability to establish latent infections primarily in sensory ganglia.  The subfamily 
consists of the genera Simplexvirus, Varicellovirus, Marek’s disease-like virus, and 
Infectious laryngotracheitis-like virus (Van Regenmortel et al., 2000).  
 Betaherpesvirinae were characterized by a limited host range, long reproductive 
cycle, and slow infection progression in tissue culture.  Cells that are infected often 
become enlarged (cytomegalia), and the viruses can maintain latency in secretory 
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Table 1.1: Members of the family herpesviridae 
 
 
Subfamily Designation Vernacular Name
Alphaherpesvirinae Human herpesvirus 1 (HHV-1) Herpes simplex virus type 1 (HSV-1)
Human herpesvirus 2 (HHV-2) Herpes simplex virus type 2 (HSV-2)
Human herpesvirus 3 (HHV-3) Varicella-zoster virus (VZV)
Cercopithecine herpesvirus 1 (CeHV-1) Herpesvirus B, Simian Herpesvirus
Gallid herpesvirus 1 (GaHV-1) Infectious laryngotracheitis virus
Gallid herpesvirus 2 (GaHV-2) Marek's disease herpesvirus 2
Suid herpesvirus 1 (SuHV-1) Pseudorabies virus, Aujesky's disease
Felid herpesvirus 1 (FeHV-1) Feline herpesvirus 1, Feline rhinotracheitis 
herpesvirus
Ictalurid herpesvirus 1 (IcHV-1) Channel catfish herpesvirus
Betaherpesvirinae Human herpesvirus 5 (HHV-5) Cytomegalovirus (CMV)
Cercopithecine herpesvirus 8 (CeHV-8) Rhesus monkey cytomegalovirus
Murid herpesvirus 1 (MuHV-1) Mouse cytomegalovirus
Murid herpesvirus 2 (MuHV-2) Rat cytomegalovirus
Suid herpesvirus 2 (SuHV-1) Pig cytomegalovirus
Felid herpesvirus 2 (FeHV-1) Cat cytomegalovirus
Human herpesvirus 6A (HHV-6A)
Human herpesvirus 6B (HHV-6B) Roseolovirus
Human herpesvirus 7 (HHV-7)
Gammaherpesvirinae Human herpesvirus 4 (HHV-4) Epstein-Barr virus (EBV)
Human herpesvirus 8 (HHV-8) Karposi's sarcoma-associated 
herpesvirus (KSHV)
  
 
glands, lymphoreticular cells, kidneys, and other tissues.  The subfamily consists of the 
genera Cytomegalovirus, Muromegalovirus, and Roseolovirus (Van Regenmortel et al., 
2000).   
 Gammaherpesvirinae were classified by a limited host range and ability to 
replicate in lymphoblastoid cells, with some viruses also causing lytic infection in some 
types of epithelial and fibroblastic cells.  Viruses are usually specific for either B or T 
lymphocytes, and latent virus is frequently demonstrated in lymphoid tissue.  The 
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Gammaherpesvirinae subfamily consists of the genera Lymphocryptovirus (EBV), and 
Rhadinovirus (Van Regenmortel et al., 2000). 
Clinical Significance of Herpes Simplex Viruses 
Epidemiology 
 Infections caused by HSV occur worldwide in both developed countries and 
underdeveloped countries (Black, 1975).  There are no known animal carriers for HSV; 
therefore, humans remain solely responsible for transmitting virus to other humans. Virus 
transmission from an infected to a susceptible individual occurs during close personal 
contact.  The frequency of person to person contact appears to be the major mediator of 
infections (Whitley, 2001).  Due to HSV infection rarely resulting in fatality and the 
nature of latency, more than half of the world’s population probably have recurrent HSV 
infections, enabling the transmission of HSV.  Initial HSV infection usually occurs in 
children less than 5 years old and is most often asymptomatic.  The mouth area is the 
most common location of infection (Whitley, 2001).  Primary infection leads to the 
shedding of virus from the mouth and stool for an average of 7 to 10 days (Amir et al., 
1997), and neutralizing antibodies appear between 4 and 7 days after the onset of HSV 
infection and peak at approximately 3 weeks post infection (Buddingh et al., 1953).   
 The primary factors affecting the rate of HSV infection are location, 
socioeconomic status, and age.  In some studies, by the age of 15, over 95% of children 
were found to possess antibodies to HSV (Bader et al., 1978; Black et al., 1974).  HSV-1 
seroprevalence is much more common than its counterpart HSV-2 (Fleming et al., 1997; 
Nahmias, Lee, and Beckman-Nahmias, 1990).  Because HSV-2 is usually acquired 
through sexual contact, antibodies to HSV-2 are rarely found before the onset of sexual 
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activity. While most genital infections are caused by HSV-2, there is an ever-increasing 
proportion attributable to HSV-1 (Corey et al., 1983; Kalinyak, Fleagle, and Docherty, 
1977).  Genital HSV-1 infections are usually both less severe than HSV-2 and less prone 
to recurrence (Corey et al., 1983; Reeves et al., 1981). 
Pathogenesis 
 Initially, virus must come in contact with a mucosal surface or abraded skin for 
HSV infection to be initiated.  After primary infection, viral replication at the infected 
location, usually oral or genital mucosal tissue, results in the infection of sensory nerve 
endings; and virus is then transported to the dorsal root ganglia (Baringer and Swoveland, 
1973; Bastian et al., 1972).  In HSV-1 infection, the trigeminal ganglia becomes 
colonized and harbors latent virus; whereas in HSV-2 infection the sacral ganglia is the 
site of latency (Whitley, 2001).  After the establishment of latency, certain stimuli can 
cause reactivation to occur, and virus becomes evident at mucocutaneous sites as vesicles 
or ulcers.  A more severe primary infection can result in a higher rate of HSV 
reactivation.   
 Cellular changes induced by viral infection include enlargement of infected cells 
and the appearance of condensed chromatin within the nuclei, followed by degradation of 
the nuclei.  Cells lose intact plasma membranes and form multinucleated giant cells.  In 
infected dermal regions, there is an intense inflammatory response, and the intensity 
decreases substantially with recurrent disease (Whitley, 2001). 
 Mucocutaneous Infections 
 Primary HSV-1 infection can be either totally asymptomatic or can result in a 
symptoms including fever, sore throat, vesicular or ulcerative lesions.  However, 
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asymptomatic infection is generally the rule rather than the exception (Whitley, 2001).  
The duration of symptomatic disease in children is generally 2 to 3 weeks, with a fever of 
101°F to 104°F.  The onset of a recurrent HSV-1 infection is generally marked pain, 
burning, tingling, or itching, which generally lasts for less than 6 hours, and is followed 
by vesicle formation within 24 to 48 hours (Spruance and Crumpacker, 1982; Spruance et 
al., 1984; Spruance et al., 1977).  Usually, 3 to 5 vesicles appear at the border of the lip 
and last no longer than 48 hours.  Pain is most severe at the outset of vesicle formation 
and resolves in 4 to 5 days.  The frequency of recurrences varies greatly among 
individuals, and the factors that influence reactivation are poorly defined but may include 
fever, stress, and exposure to UV light (Segal et al., 1974; Ship, Miller, and Ram, 1977). 
 In HSV-2, the most severe clinical symptoms are encountered with primary 
infection, characterized by the appearance of macules and papules followed by vesicles, 
pustules, and ulcers.  The duration of lesions and viral secretion averages about 3 weeks.  
Men and women experience both similar and dissimilar symptoms (Corey, 1982; Corey 
et al., 1983).  Pre-existing immunity to HSV-1 can have a beneficial effect in reducing 
the severity of HSV-2 primary infections (Allen and Rapp, 1982; Corey et al., 1981; 
Kaufman et al., 1973).  Recurrent HSV-2 is milder than initial infection and is 
characterized by the appearance of 3 to 5 vesicles (Adams et al., 1976).  Symptoms 
usually last 7 to 10 days, and virus is shed for an average of 2 to 5 days.  The biggest 
problem involving recurrent genital herpes is the frequency of recurrences, which varies 
by individual.  Recurrences usually occur several times per year; and, whether 
symptomatic or asymptomatic, transmission of the infection to sexual partners can occur 
with intimate contact (Corey et al., 1983). 
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 Fetal and Neonatal Infections 
 Neonatal HSV infections occur at a rate of about 1 in 3000 deliveries per year 
(Nahmias, Keyserling, and Kerrick, 1983; Nahmias, Keyserling, and Lee, 1989), and 
infection occurs far less frequently than genital infections in the adult population.  The 
type of maternal genital infection at the time of delivery is directly tied to the risk of fetal 
infection.  If the mother has a primary infection the risk of transmission is approximately 
30%, while the risk for recurrent infection is 3% or less (Brown et al., 1991).  The most 
common route of infection, 75% to 80%, is intrapartum contact of the fetus with infected 
maternal secretions (Whitley, 2001).  The clinical symptoms of neonatal HSV infection 
are a reflection of the site and extent of viral replication, with infection being almost 
always symptomatic and often lethal. Babies with HSV infection can have disease: 
localized to the skin, eye, and mouth; encephalitis with or without skin involvement; or 
disseminated infection involving multiple organs (Nahmias et al., 1970; Whitley et al., 
1981).  The highest mortality rate occurs in babies with disseminated infection. In 
addition, frequently occurring HSV-2 cutaneous lesions defined a group at risk for 
neurological problems (Whitley et al., 1991). 
 Keratoconjunctivitis 
 There are 300,000 new cases of HSV eye infection annually, ranking second 
behind trauma as the cause of corneal blindness (Binder, 1977).  Primary herpetic 
keratoconjunctivitis can occur in either a single eye or both eyes, and healing of the 
cornea can take as long as one month even with antiviral therapy.  Recurrent HSV eye 
infections occur at a similar rate to HSV-1 mucocutaneous infections and most often 
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involve only a single eye.  Repeated attacks can last for weeks or months and progressive 
disease can result in vision loss (Whitley, 2001). 
 Infection of an Immunocompromised Host 
 Patients who are immunocompromised due to immunotherapy, malnutrition or 
acquired immunodeficiency syndrome are at risk for severe HSV infections, and these 
patients may develop progressive disease involving the respiratory tract, esophagus, or 
the gastrointestinal tract (Korsager et al., 1975; Montgomerie et al., 1969).  Recurrent 
HSV infection can occur in theses patients at multiple sites and healing occurs over an 
average of 6 weeks (Whitley et al., 1984).   The repeated treatment required for these 
patients can lead to viral mutants resistant to antiviral therapy. 
 Central Nervous System (CNS) Infections 
 HSV is the most common cause of sporadic, fatal encephalitis in this country 
(Olson et al., 1967).  Some studies estimate a rate as high as 1250 cases per year in the 
United States (Whitley, 2001).  Encephalitis is caused when the virus spreads past the 
dorsal root ganglia, in which latency is usually established, to the CNS.  The mechanisms 
responsible for this aberrant event in the virus life cycle are unclear.  The manifestations 
of HSV encephalitis include primarily focal encephalitis along with fever, altered 
behavior, and localized neurological findings.  There is usually evidence of a localized 
temporal lobe disease (Whitley et al., 1977; Whitley et al., 1981).  In untreated patients, 
mortality exceeds 70% and only 2.5% of patients return to normal neurological function 
(Whitley, 2001). 
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Prevention and Treatment of HSV Infection 
 The two methods for control of HSV infections are antiviral therapy and 
prevention.  Antivirals such as acyclovir and valaciclovir are effective in limiting the 
extent of HSV infection and therefore helpful in limiting spread to uninfected individuals.  
However, post-exposure antiviral treatment does not prevent lifelong infection of an 
individual.  Prevention of HSV infection is mainly achieved through avoiding contact 
with infectious secretions.  Vaccination would be the ideal method of HSV prevention; 
however, to date no HSV vaccine has been clinically successful.   
Architecture of the Herpes Virion 
      Virions of herpes viruses can vary in size from 120 nm to 300 nm (Roizman 
and Furlong, 1974), and consist of:  an electron-dense core, an icosadeltahedral capsid 
around the core, an amorphous tegument around the capsid, and an outer envelope 
containing glycoprotein spikes (Roizman and Furlong, 1974).  The variability in the size 
of herpes virions is due mainly to variability in the makeup of the tegument and the state 
of the envelope.  A model of the virion architecture is presented below in Figure 1.1.                                       
The Core 
 The core of a mature herpes virion contains the viral DNA in the form of a torus 
that may appear to be suspended by a proteinaceous spindle to the capsid (Falke, Siegert, 
and Vogell, 1959; Furlong, Swift, and Roizman, 1972; Nazerian, 1974).  The toroidal 
structure is 50 nm high, with an inside diameter of 18 nm and an outside diameter of 70 
nm.  The arrangement of the viral DNA in the torus is not known.   
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Figure 1.1:  Herpesvirus virion structure.  Virions of herpes viruses can vary in size 
from 120 nm to 300 nm (Roizman and Furlong, 1974). A virion consists of:  an electron-
dense core containing the viral genome, an icosadeltahedral capsid around the core, an 
amorphous tegument around the capsid, and an envelope derived from cellular 
membranes containing glycoprotein spikes (Roizman and Furlong, 1974).   
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The Capsid 
 The capsid is approximately 125 nm in diameter in the form of an 
icosadeltahedron and features 162 capsomeres, characteristic of all herpesviruses.  
Capsomeres are either pentons or hexons, consisting of 5 or 6 VP5 (major capsid protein) 
monomers, respectively.  In the capsid, the pentons are located on the icosahedral 5-fold 
vertices, and the hexons make up the faces and edges.  Hexons also contain 6 copies of 
VP26, attachedto the upper edge of VP5 and form a continuous ring around each hexon 
(Zhou et al., 1995).  A heterotrimeric complex known as the triplex connects the 
capsomeres; the triplex consists of two copies of VP23 and one copy of VP19C and acts 
as a sort of scaffold for the capsid (Spencer et al., 1998). 
The Tegument 
 The tegument is contained between the capsid and the virion envelope and 
appears fibrous on negative staining (Morgan et al., 1959; Morgan, Rose, and Mednis, 
1968; Wildy and Watson, 1962).  The tegument can be distributed asymmetrically and its 
thickness can vary depending on the location of the virion particle within the infected 
cell.  There is less tegument that is more symmetrically arranged in perinuclear virions 
than in virions in cytoplasmic vesicles that contain more tegument distributed more 
asymmetrically (Falke, Siegert, and Vogell, 1959).  Tegument proteins are important in 
various aspects of the virus life cycle and are believed to have key functions in the early 
events of infection and virion egress.  There is ordered tegument density around the 
pentons, suggesting symmetry where the capsid and tegument interact (Zhou et al., 1999).  
This density may be due to the VP1-3 protein, an extremely large 336 kDa protein, 
thought to be involved in nucleocapsid attachment to the nuclear pore facilitating DNA 
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release into the nucleoplasm (Batterson, Furlong, and Roizman, 1983; Knipe et al., 1981; 
Ojala et al., 2000).  However, VP1-3 null mutants also accumulate newly assembled, 
DNA-filled capsids in the cytoplasm of infected cells, indicating that VP1-3 is involved 
in various stages of the virus life cycle (Desai, 2000). 
The Envelope 
 The outer covering of the herpesvirus, the envelope, has a typical trilaminar 
appearance (Epstein, 1962) and appears to be made up of altered cellular membranes 
(Armstrong, Pereira, and Andrewes, 1961; Falke, Siegert, and Vogell, 1959; Morgan, 
Rose, and Mednis, 1968).  The herpesvirus envelope contains numerous glycoprotein 
extrusions, while the amounts of each glycoprotein vary.  HSV specifies at least 11 
different glycoproteins, and the copy number of each glycoprotein can well exceed 1,000 
per virion.  Envelope glycoproteins gB, gD, gH, and gL have been shown to be required 
for virion entry into susceptible cells. 
Organization of the Viral Genome 
 The viral DNA of herpesviruses is linear and double stranded, but the DNA 
becomes circular immediately after release from capsids into the nucleoplasm of the 
infected cells.  The length of the genome of different herpesviruses varies between 120 to 
250 kbp, with the size of HSV-1 determined to be 152,261 bp (McGeoch et al., 1988). 
This variability is different than polymorphism in the genome length of individual 
viruses, which is due to terminal and internal repeated sequences that can vary in copy 
number, leading to variations in genome length of more than 10 kbp.  The total G+C 
content of herpesviruses varies from 31% to 75%, and this percentage can vary across the 
genome (Roizman and Pellett, 2001).  HSV-1 and HSV-2 contain approximately 68% 
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and 69% G+C content, respectively (Becker, Dym, and Sarov, 1968; Kieff, 
Bachenheimer, and Roizman, 1971). 
 The sequence arrangement of herpesvirus genomes varies on the presence and 
location of reiterated sequences that allow rearrangement to occur.  In Herpes Simplex 
Virus genomes, the sequences from both termini are repeated in an inverted orientation 
and juxtaposed internally. As a result, the genome is divided into two regions, consisting 
of the unique long (UL) and unique short (US) regions flanked by inverted repeats (Figure 
1.2)                                                         
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Both components are able to invert relative to the other to form four isomers; and, as 
predicted, DNA purified from infected cells contains four equivalent populations, which 
differ in the relative orientation of the unique long and unique short regions (Roizman 
and Pellett, 2001). 
 The majority of herpesvirus genes contain:  a promoter region 50 to 200 bp 
upstream of a TATA box, a transcription initiation site 20 to 25 bp downstream of the 
TATA box, a 5’ untranslated leader sequence of 30 to 300 bp, a single major open 
reading frame (ORF) with a translation initiation codon meeting the host requirement for 
Figure 1.2.  Arrangement of the HSV-1 genome.  (A) The top line represents 
the prototypic arrangement of the HSV-1 genome with the unique long (UL) and 
unique short (US) regions flanked by the terminal repeat (TR) and internal repeat 
(IR) regions.  (B) The bottom line shows map units of the HSV-1 genome. 
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efficient initiation, 10 to 30 bp of 3’ untranslated sequence, and a polyadenylation signal 
with standard flanking sequences (Roizman and Pellett, 2001).  Some exceptions include 
genes without a TATA box or genes with a second in-frame initiator methionine (Chou 
and Roizman, 1986; Markovitz, Filatov, and Roizman, 1999).  Most transcriptional gene  
products are not spliced, although every herpesvirus expresses a few spliced genes.  
Herpesviruses also produce noncoding RNAs, such as the HSV-1 latency associated 
transcript (LAT) (Roizman and Pellett, 2001).  The different members of the herpesvirus 
family encode between 70 and 200 genes, estimated using various methods (Roizman and 
Pellett, 2001).  HSV-1 encodes about 90 gene products, with at least 84 of the 
transcriptional units encoding proteins (Roizman and Knipe, 2001). 
The Herpes Simplex Virus Lifecycle 
Virus Attachment and Entry 
 Herpesvirus entry is a multistep process involving multiple viral glycoproteins 
acting as ligands for multiple receptors on the surface of the target cell.  Entry is the most 
critical step in the HSV life cycle and greatly determines the tropism and pathology of 
each member of the herpesvirus family.  The wide host range of HSV and narrow host 
range of EBV can be in part explained by the ability of each virus to utilize a different 
array of cell surface binding and entry receptors.  Entry of HSV occurs is three distinct 
stages:  the first step involves virus binding to the surface of the cell, the second step 
involves an interaction of gD (HSV-1) with an entry receptor, and the third step involves 
fusion of the viral envelope with the plasma membrane of the cell, releasing the capsid-
tegument complex into the cytoplasm of the infected cell (Figure 1.4).
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Figure 1.3: The Herpes Simplex Virus Life Cycle.  The first stage of the herpes virus 
life cycle consists of virus entry, capsid transport to the cell nucleus, deposition of viral 
DNA into the nucleoplasm, coordinate gene expression and viral DNA replication (black 
arrows).  The second stage is virion morphogenesis and egress comprised of primary 
envelopment at the inner nuclear membrane, de-envelopment at the outer nuclear 
membrane, final envelopment into cytoplasmic vesicles and transport to extrancellular 
spaces (red arrows). 
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Figure 1.4:  Herpes Simplex Virus Entry.  The first step of HSV entry is attachment to 
the plasma membrane of infected cells through interaction of  gC (ligand for binding) 
with cell surface heparan sulfate (receptor for binding).  The second step is fusion of the 
viral envelope with the cell plasma membrane and occurs following attachment of gD 
(ligand for fusion) to either HVEM (herpesvirus entry mediator) or a nectin (receptor for 
fusion) on cell surfaces.  Fusion requires the presence of gD and an entry receptor, as 
well as gB and the gH/gL heterodimer. 
 
22 
Binding Receptors 
 Heparan Sulfate (Glycosaminoglycans) 
 Initial contact of herpesviruses with cells usually occurs through binding 
receptors, in which engagement of the virus with receptor is reversible and changes in the 
virion envelope required for fusion and entry do not occur.   Herpes Simplex viruses 
initial attachment to cells involves the interaction of glycoprotein C, and glycoprotein B 
to a lesser extent, with cell surface glycosaminoglycans, usually heparan sulfate (Shieh et 
al., 1992; WuDunn and Spear, 1989).  Heparan sulfate is synthesized as the 
glycosaminoglycan component of heparan sulfate proteoglycans, and it is widely 
distributed on cell surfaces in mammals.  The presence of heparan sulfate is not essential 
for virus entry, but it greatly increases the efficiency of virus entry into cells (Banfield et 
al., 1995).  Similarly, although glycoprotein C confers the greatest efficiency for virus 
attachment to cell surfaces, increasing the efficiency of virus binding by approximately 
10 fold, it is not essential for either virus entry or replication (Heine et al., 1974). 
Entry Receptors 
 Binding of the HSV glycoprotein D to an entry receptor sets in motion an 
irreversible chain of events leading to the fusion of the virion envelope with the plasma 
membrane of the target cell.  There have been three classes of HSV entry receptors 
classified to date, indicated below and shown in Figure 1.5. 
Tumor Necrosis Factor (TNF) Receptor Family   
 HVEM / Herpes Virus Entry Mediator A (HveA) is a member of the TNF 
receptor family and is expressed in a variety of different cell types including 
lymphocytes, other leukocytes, epithelial cells, and fibroblasts.  While HVEM is utilized 
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Figure 1.5:  Herpes Simplex Virus entry receptors.  The three classes of cell surface 
receptors for HSV entry are:  the tumor necrosis factor (TNF) receptor family consisting 
of HVEM, the immunoglobulin superfamily consisting of the nectins, and 3-O-sulfated 
heparin sulfate.  Only viral attachment can occur in the absence of an HSV entry 
receptor. 
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 by herpes simplex viruses as an entry receptor, the natural ligands for HVEM include 
LIGHT and lymphotoxin-alpha (Mauri et al., 1998).  LIGHT can function as a second 
signal for T-cell activation, and the interactions between LIGHT and HVEM are the 
focus of active investigations of the regulation of immune responses (Kwon et al., 2003).  
HVEM serves as an excellent entry mediator for both HSV-1 and HSV-2.  Certain studies 
have shown that HSV-1 entry of activated T-cells is principally mediated by HVEM, 
although in a variety of other cell types HVEM was shown not to be the primary mediator 
of virus entry (Montgomery et al., 1996).   
 Immunoglobulin Superfamily  
 The second family of herpes simplex virus entry receptors is part of the 
immunoglobulin superfamily and includes several isoforms present in both human and 
nonhuman cells encoded by mRNAs that can vary due to alternative splicing.  Members 
of this family have been shown to act as intercellular adhesion molecules localized at 
adhesion junctions, in which the carboxyl-terminal domains bind to L-afadin, a PDZ-
binding protein that anchors the receptors to the cytoskeleton and adherens junctions.  
These receptors have been named “nectins” on account of their cellular function 
(Takahashi et al., 1999).  Nectins are highly conserved among mammalian species in 
respect to structure, function, and the ability to mediate HSV entry (Milne et al., 2001; 
Shukla et al., 2000).  The nectins are expressed in a variety of cell types including 
epithelial cells, fibroblasts, and neurons (Takai and Nakanishi, 2003). In addition, the 
distribution of this class of receptors in human tissues reflects the susceptibility of cells to 
infection and probably accounts for both virus entry and cell-to-cell spread (Roizman and 
Knipe, 2001). 
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 Nectin-1α (Herpes Virus Entry Mediator C, HveC) and nectin-1β (Herpesvirus 
Immunoglobulin-like receptor, HIgR) are two mRNA splicing variants containing a 
common ectodomain. They are expressed on epithelial, fibroblastic, neural and 
hematopoietic cells, in keratinocytes, and in human tissues that are the target of HSV 
infection including skin, brain, and spinal ganglia (Cocchi et al., 1998; Geraghty et al., 
1998).  Nectin-1α and nectin-1β have the ability to mediate entry of all HSV-1 strains, 
HSV-2, Pseudorabies virus (PrV) and bovine herpes virus 1 (BHV-1) (Geraghty et al., 
1998).   
 Nectin-2α (Herpes Virus Entry Mediator B, HveB) and nectin-2δ are also mRNA 
splice variants, and they mediate the entry of HSV-2, PrV, and certain viable mutant 
forms of HSV-1 but not wild-type HSV-1 (Lopez et al., 2000; Warner et al., 1998).  
Nectin-1 and nectin-2 are related to nectin-3 and nectin-4, and the poliovirus receptor 
(Takai and Nakanishi, 2003). 
 Nectin-3 has been shown to be expressed on J cells, which lack HVEM, nectin-1, 
and nectin-2.  An HSV-1 mutant, designated HSV-1 (JMP), was able to enter into J cells 
expressing nectin-3, but wild-type HSV-1 was not (Cocchi et al., 2004).    HSV-1 (JMP) 
contains mutations in glycoprotein K as well as glycoprotein D.  The mutations in both 
gK and gD were shown to be required for HSV-1 (JMP) entry into J cells (Cocchi et al., 
2004). 
 3-O-sulfated Heparan Sulfate (3-OS HS) 
 Modification of heparan sulfate by D-glucosaminyl 3-O-sulfotransferase 
isoforms-3 and/or -5 creates 3-O-sulfated Heparan Sulfate (3-OS HS), generating a gD-
binding site that allows heparan sulfate proteoglycans to function as entry receptors for 
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HSV-1.  3-O-sulfated heparan sulfates are broadly distributed on human cells and tissue 
and mediate HSV-1 but not HSV-2 entry (Shukla et al., 1999).   
 Other Herpesvirus Receptors 
 Only alphaherpesviruses (except VZV) encode members of the gD family.  
Betaherpesvirus and gammaherpesviruses rely on other viral proteins to serve as ligands 
for cellular receptors.  EBV uses gp42, which becomes a member of a gH-gL-gp42 
complex, to serve as a ligand for human leukocyte antigen (HLA) class II molecules on B 
lymphocytes.  Human CMV encodes glycoprotein O (gO), which is unrelated to gp42 but 
also forms a complex with gH-gL (Huber and Compton, 1998).  In addition, HHV-6A 
encodes glycoprotein Q (gQ), which forms a complex with gH-gL (Mori et al., 2003).  
However, it is unclear whether or not gO or gQ are required for entry in CMV or HHV-
6A, respectively. 
Virus-to-Cell Fusion  
 After binding of gD to a HSV-1 virus entry receptor, the last step in virus entry is 
fusion of the virion envelope with the plasma membrane of the target cell (Morgan, Rose, 
and Mednis, 1968).  The current belief is that gD (Ligas and Johnson, 1988), gB 
(Sarmiento, Haffey, and Spear, 1979), and the gH/gL heterodimer (Forrester et al., 1992) 
are required for the virus-to-cell fusion process to occur.  Since gD is required for entry 
receptor binding, it would be logical to hypothesize that receptor binding triggers a 
conformational change in gD that translates to a change in gB and gH/gL, resulting in 
activation of the HSV-1 membrane fusion machinery.  In some cells types, notably CHO 
cells that express an entry receptor such as nectin-1 and HeLa cells, endocytosis and 
acidification of endosomes are required for efficient virus entry.  Interestingly, it was 
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found that endocytic uptake of HSV virions from the cell surface is rapid and 
independent of any known gD receptor.  In addition, efficient entry through endocytosis 
requires cellular PI 3-kinase activity and the viral glycoproteins gB, gD, and gH/gL 
(Nicola, McEvoy, and Straus, 2003; Nicola and Straus, 2004).  While these two entry 
pathways are spatially distinct, they are still functionally similar in that both require the 
same set of viral glycoproteins and a gD entry receptor.   
Host Protein Shutoff 
 HSV shuts off the synthesis of cellular protein products in two stages.  First, the 
virus mediates degredation of the host cell mRNA.  Second, there is inhibition of further 
synthesis and processing of host mRNA.  The virion host shutoff (vhs) function involves 
structural components of the virion and does not require de novo protein synthesis after 
infection (Fenwick and Walker, 1978; Nishioka and Silverstein, 1977; Nishioka and 
Silverstein, 1978a; Nishioka and Silverstein, 1978b).  The isolation of vhs- mutants, 
which failed to shutoff host cell protein synthesis in HSV-1 infected cells, allowed for 
more detailed study of the viral requirements for host shutoff (Read and Frenkel, 1983).  
The UL41 ORF was identified as being responsible for the phenotype in the vhs- mutants 
(Fenwick, Morse, and Roizman, 1979; Kwong, Kruper, and Frenkel, 1988; Oroskar and 
Read, 1987).  The UL41 protein (VHS) is expressed as a γ1 gene  (Frink, Anderson, and 
Wagner, 1981) and is translated to a 58,000 or 59,500 kDa phosphoprotein (Read, Karr, 
and Knight, 1993).  In addition, VHS was conclusively shown to be capable of 
functioning in the absence of any other viral proteins (Zelus, Stewart, and Ross, 1996).  
VHS was shown to function at least in part by inducing endoribonucleolytic cleavage of 
mRNA in vitro (Elgadi and Smiley, 1999), and the 5’ end of mRNA is degraded before 
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the 3’ end (Karr and Read, 1999).  VHS appears to form a complex with the translation 
factor eIF-4H, and the interaction is required for RNase activity possibly through 
targeting to polyribosomes.  The VHS and eIF-4H complex appears to decap cellular 
mRNA from the 5’ end (Roizman and Knipe, 2001).  
 In the context of a vhs- mutant, host protein synthesis is not shut off early in 
infection and α and β gene expression is extended in comparison to a wild-type virus.  
These effects are due to the fact that VHS accelerates the degradation of both cellular and 
viral mRNAs.  As a result, during the context of a HSV-1 infection, cellular mRNA 
levels diminish and as viral mRNA levels accumulate it is preferentially translated.  In 
this way, VHS may facilitate the transition from α to β to γ gene expression through 
shortening the life of the viral mRNAs (Kwong and Frenkel, 1987; Oroskar and Read, 
1987).  As a γ1 gene product, VHS accumulates late in infection, but does not degrade 
viral mRNA as would be expected.  An interaction between VP16 and VHS at late times 
blocks the degradation of RNA by VHS (Lam et al., 1996).  As a result, the accumulation 
of VHS into tegument complexes accomplishes two crucial functions:  it brings VHS into 
the infected cell to shutoff host protein synthesis, and it regulates the activity of VHS late 
in infection when mostly viral mRNA is present. 
Virion Transport to the Nucleus 
 After fusion of the virion envelope with the plasma membrane of the infected cell, 
the capsid with its associated tegument complex is deposited into the cytoplasm.  Some 
tegument proteins disassociate from the complex and remain in the cytoplasm, while 
others, such as VP16 (αTIF) are transported to the nucleus to effect their functions.  The 
remaining capsid-tegument complex is then transported along the cell’s microtubule 
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network to a nuclear pore.  Studies have shown that dynein, the microtubule dependent 
motor, is bound to capsids after entry (Sodeik, Ebersold, and Helenius, 1997), and these 
results prompted the theory that incoming capsids bind to microtubules and utilize the 
cell’s dynein motor to transport them to nuclear pores.  Other experiments have shown 
that microtubules in proximity to the plasma membrane become disrupted after entry, 
suggesting that the presence of the capsid-tegument complex may destroy normal cellular 
microtubule interactions (Ward et al., 1998).   
 After intracytoplasmic transport to the nucleus, capsids accumulate at the nuclear 
envelope and become associated with nuclear pore complexes.  Experiments have shown 
that the VP1/2 gene is required for DNA release at the nuclear pore (Batterson, Furlong, 
and Roizman, 1983; Knipe, Ruyechan, and Roizman, 1979), and antibodies to nuclear 
pore transport components block capsid binding (Ojala et al., 2000).  It is believed that 
binding to the nuclear pore produces a structural change in the HSV capsid, resulting in 
viral DNA release into the nucleus and an empty capsid docked at the nuclear pore. 
Coordinate Gene Expression 
 During the course of an HSV infection, there are more than 80 gene products 
expressed from the viral genome in a highly regulated cascade fashion (Figure 1.6) in a 
number of coordinately expressed groups (Honess and Roizman, 1974).  Transcription of 
viral DNA takes place in the nucleus, and the host RNA polymerase II is responsible for 
the transcription of all viral genes during infection (Alwine, Steinhart, and Hill, 1974; 
Costanzo et al., 1977).  There are several viral genes that play an important role in the 
regulation of gene expression at different times post-infection.   
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 HSV encodes a function responsible for transactivation of α genes immediately 
after infection (Post, Mackem, and Roizman, 1981), and this was termed the α gene 
transactivating factor (α-TIF).  α-TIF was shown to be a component of the tegument 
capable of inducing the α genes, which contain the “TAATGArATT” promoter response 
element, which binds Oct-1.  VP16 was identified as the viral protein responsible for the 
α-TIF function (Campbell, Palfreyman, and Preston, 1984).  After entry, VP16 is 
released from its interaction with VHS and the tegument complex.  VP16 then binds to a 
cellular protein called the host cell factor (HCF) or C1 (Katan et al., 1990; Kristie and 
Sharp, 1990), and HCF carries VP16 into the nucleus, at which time the VP16-HCF 
complex binds to Oct-1 that is bound to viral DNA.  This event forms the activator  
complex that is responsible for transactivation of α genes (La Boissiere, Hughes, and 
O'Hare, 1999).  In addition to the Oct-1 binding sites, the promoters for α genes also 
contain binding sites for other cellular transcriptional activators upstream of a TATA box 
that may contribute to a basal level of α gene expression in rapidly dividing cells in the 
absence of VP16 (Roizman and Knipe, 2001).  The viral requirement for VP16 may be 
different in resting cells, such as neuronal cells, where cellular transcription factors are 
not available. 
 After being deposited into the nucleus of the infected cell, the HSV-1 viral 
genome localizes to nuclear ND10 structures where the transcription of α genes takes 
place (Maul, Ishov, and Everett, 1996). At 2 to 4 hours post infection, the viral α genes 
are expressed at peak levels.  There are six viral α genes:  ICP0, ICP4, ICP22, ICP27, 
ICP47, and US1.5.  Five of the six α genes stimulate viral β gene expression in at least 
some cell types.  In particular, ICP4 is required for all post-α gene expression (Clements, 
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Figure 1.6: Coordinate gene expression in Herpes Simplex Virus.  1) α-TIF, a γ gene 
product present in the tegument, activates initial transcription of the α genes.  
2) Autoregulation of gene expression. 3) Activation of β gene expression. 4) Activation 
of γ gene expression by α and β genes, release of repression of γ genes, and replication of 
the viral genome. 5) γ genes turn off α and β genes late in infection (Roizman and Knipe, 
2001). 
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 Watson, and Wilkie, 1977; Dixon and Schaffer, 1980), and its effect is exerted at the 
transcriptional level (Godowski and Knipe, 1986).  However, the mechanism by which 
ICP4 exerts its transcriptional control over β gene expression is unclear.  ICP4 is also 
responsible for down regulation of α gene products including itself and ICP0, and the 
“pre α” gene products ORF P and ORF O.  In this case, specific consensus binding sites 
appear to be responsible for ICP4 mediated transcriptional regulation (Faber and Wilcox, 
1986; Gelman and Silverstein, 1987; Kristie and Roizman, 1984; Kristie and Roizman, 
1986; Muller, 1987).  In addition, ICP4 has different isoforms dependent on different post 
translational modifications, and it is possible that the different functions may be 
somewhat dependent on the specific isoform present at different times during the course 
of the infection.  ICP0 promotes viral infection and gene expression, especially at a low 
multiplicity of infection (MOI) where its absence leads to a virus yield that is 100 fold 
less than a wild type virus (Sinclair et al., 1994; Stow and Stow, 1986).  ICP0 is a 
nonspecific transactivator that induces the expression of the HSV α, β, and γ genes.  
Because ICP0 does not bind DNA directly, it appears to act indirectly in modulation of 
transcription (Everett, Orr, and Elliott, 1991). 
 The HSV-1 β genes are produced at peak levels between 4 and 8 hours post 
infection.  Expression of the viral β genes requires the presence of functional ICP4, but is 
not dependent on viral DNA synthesis.  β gene products include proteins involved in viral 
DNA replication and nucleotide metabolism.  These viral proteins promote viral DNA 
replication, which results in expression of the γ class of genes.  The β genes can be 
divided into two general groups: β1 genes, which are expressed shortly after the synthesis 
of α proteins; and β2 genes, which are expressed with more of a delay after α gene 
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expression (Roizman and Knipe, 2001).  β1 genes are exemplified by the single-stranded 
DNA binding protein, ICP8, and the large subunit of ribonucleotide reductase, ICP6.  β2 
genes are exemplified by the viral thymidine kinase encoded by UL23.  Some β2 genes 
require ICP27 for expression, and this dependence may correlate with the later expression 
of these genes (Roizman and Knipe, 2001). 
 The HSV-1 γ (late) genes are produced at peak levels only after viral DNA 
replication has started, and require ICP4, ICP27 and ICP8 for efficient levels of 
transcription.  The transition from β to γ gene expression is also marked by a change in 
the nuclear localization of transcription from sites near ND10 domains to replication 
compartments as evidenced by the localization of ICP4, RNA polymerase II, and ICP22 
(Knipe et al., 1987; Leopardi et al., 1997; Rice et al., 1994).  γ gene products include 
structural proteins, glycoproteins, and tegument components required to prepare newly 
infected cells for an efficient infection.  The γ genes have been subdivided into two 
groups based on timing of expression and their dependence on viral DNA replication:  γ1 
(leaky-late) genes, which are expressed relatively early in infection and transcription is 
increased only a few fold after DNA replication has occurred; and γ2 genes, which do not 
accumulate in appreciable amounts until after DNA replication and are not expressed in 
the presence of inhibitors of viral DNA synthesis (Wagner, 1985).  Typical γ1 genes 
include the major capsid protein ICP5, gB, gD, and ICP34.5, whereas typical γ2 genes 
include gC, UL41 (VHS), UL36, UL38, UL20, and gK.   
Viral DNA Replication 
 After the β genes have been expressed and translated, there are several proteins 
that are localized to the nucleus where they assemble on the parental viral DNA in 
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punctuate “prereplicative sites” located near nuclear ND10 structures (Ishov and Maul, 
1996; Uprichard and Knipe, 1996).  Initially, viral DNA replication initiates on the 
circular viral DNA, creating a “theta” structure, which as replication progresses 
transitions to a rolling circle mechanism of replication producing head-to-tail 
concatemers of viral DNA (Jacob, Morse, and Roizman, 1979).  At this point, replication 
takes place in “replication compartments” that consist of accumulating DNA molecules 
and replication complexes (Quinlan, Chen, and Knipe, 1984). 
 There are seven viral proteins absolutely required for viral DNA replication and 
sufficient to replicate a viral origin transfected into cells.  These are the viral DNA 
polymerase (UL30) (Purifoy, Lewis, and Powell, 1977), its accessory protein (UL42) 
(Conley et al., 1981), an origin-binding protein (UL9), the single stranded DNA binding 
protein (ICP8), and the helicase-primase complex that consists of three proteins:  UL5, 
UL8, and UL52 (Challberg, 1986; Wu et al., 1988).  Host cell factors may also be 
involved in DNA synthesis, and host enzymes that include the DNA polymerase α-
primase, DNAligase, and topoisomerase II are almost certainly also required.  There are 
also three origins of replication located on the viral genome:  oriS, a palindromic 
sequence of 45 bp that is located in c sequences bounding the S component and present in 
two copies; and oriL, a palindromic sequence of 144 bp that is located between the 
transcriptional units of ICP8 and the DNA polymerase (UL29 and UL30, respectively) 
(Deb and Doelberg, 1988; Frenkel et al., 1976; Knopf, 1986; Locker, Frenkel, and 
Halliburton, 1982; Lockshon and Galloway, 1986; Mocarski and Roizman, 1982; Stow, 
1982; Vlazny, Kwong, and Frenkel, 1982; Weller et al., 1985).  The reason for the 
presence of three origins of replication is not clear, although it may reflect the 
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evolutionary history of the virus.  Only one origin of replication is needed for replication 
to occur (Igarashi et al., 1993; Polvino-Bodnar, Orberg, and Schaffer, 1987). 
 The basic model for the replication of HSV viral DNA proceeds as follows.  First, 
the parental viral DNA is circularized upon being deposited into the nucleus of the 
infected cell.  After α and β gene expression, UL9 binds to specific elements in either 
oriL or oriS and begins to unwind the viral DNA.  UL9 then recruits the ssDNA binding 
protein ICP8 to the unwound portion of the viral DNA.  At this point, UL9 and ICP8 
recruit the remaining five proteins to the replication forks.  The helicase–primase and 
viral DNA polymerase complexes assemble at each replication fork and initiate theta 
form replication.  Through an unknown mechanism, replication switches from theta form 
to the rolling circle form of replication, and UL9 is not required for rolling circle 
replication because it is not origin dependent.  The rolling circle replication forms long 
head-to-tail concatamers of viral DNA, which become cleaved into individual units 
during packaging of viral DNA into capsids (Roizman and Knipe, 2001).  
Capsid Assembly and Packaging 
 After DNA replication has started, the γ genes are transcribed, including those 
encoding HSV-1 capsid proteins.  First, empty shells containing an internal scaffold are 
assembled, with the internal scaffold lost upon viral DNA packaging into the capsid.  
Then the mature capsid is able to proceed along the viral egress pathway.   At least some 
of the initial stages of capsid assembly occur in the cytoplasm of the infected cell 
(Nicholson et al., 1994; Rixon et al., 1996).  The major capsid protein (VP5), the outer tip 
of hexons (VP26), and a triplex protein (VP23) are not capable of nuclear localization on 
their own; however, VP5 can be carried into the nucleus by VP19C, another capsid 
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triplex protein, or by pre-VP22a, a scaffolding protein.  VP23 localizes to the nucleus 
only in the presence of VP19C, while VP26 localizes to the nucleus only when it is 
expressed with both VP5 and VP19C or pre-VP22a (Nicholson et al., 1994; Rixon et al., 
1996).  Electron microscopic studies have shown that final envelopment occurs in the 
nucleus; and three types of capsids, called A, B, and C capsids have been identified by 
sucrose density gradient ultracentrifugation (Gibson and Roizman, 1972).  All three types 
of capsids are about 120 nm in diameter with an outer shell composed of hexons and 
pentons made up of VP5.  The individual capsomeres are linked by triplex structures 
consisting of VP19C and VP23, the two minor capsid proteins.  Each triplex consists of 
one molecule of VP19C and two molecules of VP23 (Newcomb et al., 1993).  C-capsids 
are mature capsids that contain packaged viral DNA and can proceed to become 
infectious virions by budding through the nuclear membrane into the perinuclear space 
(Perdue et al., 1976).  In contrast, A and B capsids lack viral DNA, but B capsids are 
filled with VP22a and VP21, the cleaved scaffolding proteins, and a viral protease VP24 
(Gibson and Roizman, 1972; Newcomb et al., 1993).  The internal proteins VP22a, 
VP21, and VP24 are removed upon packaging of viral DNA to form C capsids (Davison, 
Rixon, and Davison, 1992; Gibson and Roizman, 1972).  A capsids do not contain viral 
DNA or scaffolding proteins and are believed to be an abortive result of failed attempts at 
DNA packaging. 
 In terms of the order of assembly, once in the nucleus, VP5-pre-VP22a complexes 
come together as a result of self assembly of pre-VP22a.  The triplex proteins VP19C and 
VP23 are then added to form a partial capsid.  As hexons and pentons are added, the 
structure assembles into a round procapsid (Newcomb et al., 1996). At this point, the 
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procapsid undergoes a structural transformation and becomes polyhedral (Church and 
Wilson, 1997; Thomsen et al., 1995; Trus et al., 1996).  It is unknown at this time 
whether the round or polyhedral B capsids are the structure in which viral DNA is 
packaged (Lee, Irmiere, and Gibson, 1988; Perdue et al., 1974; Trus et al., 1996).  
Encapsidation of viral DNA is a process in which unit length monomers of viral DNA are 
cleaved from concatamers and packaged into preformed B capsids, as originally shown 
for pseudorabies virus (Ladin, Blankenship, and Ben-Porat, 1980; Ladin et al., 1982).  
Cleavage of concatamers occurs at specific sites and requires the pac1 and pac2 
packaging signals (Deiss, Chou, and Frenkel, 1986; Smiley, Duncan, and Howes, 1990; 
Varmuza and Smiley, 1985).  The process of encapsidation of viral DNA into capsids is 
complex and requires several gene products, including the UL6, UL15, UL25, UL28, 
UL32, UL33, UL36 and UL37 gene products, but the mechanism of viral DNA 
packaging is not well defined (Roizman and Knipe, 2001). 
Herpesvirus Egress 
 Nuclear Egress: Primary Envelopment 
 After encapsidation of genomic DNA, mature nucleocapsids aquire a primary 
envelope by budding through the inner nuclear membrane into the perinuclear space 
(Vlazny, Kwong, and Frenkel, 1982).  Two conserved herpesvirus proteins, UL31 and 
UL34 have recently been shown to be involved in the budding process.  UL34 is C-
terminally anchored membrane protein present in the inner and outer nuclear membrane 
(Klupp, Granzow, and Mettenleiter, 2000), while UL31 is a nuclear phosphoprotein also 
present in the nuclear membrane of infected cells (Fuchs et al., 2002; Reynolds et al., 
2001).  The UL31 protein requires UL34 for proper nuclear targeting (Fuchs et al., 2002), 
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Figure 1.7:  Representation of HSV-1 virion morphogenesis and egress. (I) Mature 
capsids budding through the inner nuclear membrane into the perinuclear space; (II) De-
envelopment of perinuclear virions at the outer nuclear membrane; (III) Re-envelopment 
of cytoplasmic capsids by budding into cytoplasmic vesicles; (IV) Final egress to the 
extracellular space.  The steps at which UL20 and gK are thought to function in virion 
egress are indicated by red arrows. 
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whereas the UL34 protein appears to possess an intrinsic nuclear targeting signal (Klupp, 
Granzow, and Mettenleiter, 2000).  However, the nuclear targeting of UL34 is increased 
by the presence of UL31 (Fuchs et al., 2002; Reynolds et al., 2001).  Analysis of UL31 
and UL34 deletion mutants has indicated that the absence of either protein results in a 
drastic impairment in primary envelopment with capsids trapped within the nucleus  
(Chang et al., 1997; Fuchs et al., 2002; Klupp, Granzow, and Mettenleiter, 2000; 
Reynolds et al., 2001; Roller et al., 2000).  In addition, partial dismantling of the nuclear 
lamina has been observed after HSV infection and may be required so that intranuclear 
capsids are able to gain access to the inner nuclear membrane (Scott and O'Hare, 2001).  
Multiple lines of evidence indicate that UL31 and UL34 play a role in dismantling the 
nuclear lamina in infected cells.  Overexpression of the UL31 protein in uninfected cells 
was sufficient to relocalize lamin A/C from the nuclear rim into nucleoplasmic 
aggregates, while overexpression of UL34 was sufficient to relocalize some lamin A/C 
into the cytoplasm (Reynolds, Liang, and Baines, 2004). More importantly, both UL31 
and UL34 have been shown to directly bind lamin A/C, suggesting that the UL31 and 
UL34 proteins modify the conformation of the nuclear lamina in infected cells, possibly 
by direct interaction with lamin A/C. Given that the nuclear lamina potentially excludes 
nucleocapsids from envelopment sites at the inner nuclear membrane, the lamina 
alteration may reflect a role of the UL31/UL34 protein complex in perturbing the lamina 
to promote nucleocapsid egress from the nucleus (Baines 2004).  It is unclear whether 
additional primary envelope and tegument proteins exist that are required for primary 
envelopment to take place.  The UL11 protein has been proposed to function in primary 
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envelopment and increases the efficiency of envelopment at this step (Baines and 
Roizman, 1992; MacLean et al., 1992).   
 Egress from the Perinuclear Space: De-Envelopment  
 The subsequent steps in HSV-1 egress following primary envelopment have been 
in dispute for some time.  Two models were proposed to explain virion egress.  The first 
model, sometimes called the “lumenal” pathway, suggests that perinuclear virions retain 
their primary envelope and integrity as they leave the cell through the secretory pathway 
(Campadelli-Fiume et al., 1991; Darlington and Moss, 1968; Johnson and Spear, 1982; 
Johnson et al., 2001).  In this model, virion glycoproteins are modified in transit to the 
plasma membrane and perinuclear virions should contain the entire complement of 
tegument and envelope proteins present on mature extracellular virions.  The alternative 
model proposes that the primary envelope of perinuclear virions fuses with the outer 
nuclear lamellae, resulting in loss of the primary envelope and some tegument 
components and translocation of the capsid into the cytoplasm of the infected cells 
(Figure 1.7, step II) (Enquist et al., 1998; Mettenleiter, 2000).  In this “de-envelopment 
re-envelopment” pathway, final tegumentation and envelopment (re-envelopment) occur 
in cytoplasmic compartments (Figure 1.7, step III).  In addition, in this model perinuclear 
and intracytoplasmic/extracellular virions should differ in composition.   
 There is evidence that supports both the “lumenal” and the alternative “de-
envelopment re-envelopment” pathways.  However, the vast majority of recent evidence 
supports the “de-envelopment re-envelopment” model of HSV-1 virus egress.  The first 
line of evidence supporting the alternative model is that primary envelope and primary 
tegument of perinuclear virions clearly differ in ultrastructural appearance from the final 
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envelope and final tegument of extracellular virions when observed by electron 
microscopy (Gershon et al., 1994; Granzow et al., 2001).  In addition, while UL31 and 
UL34 localize on nuclear membranes and perinuclear virions, the UL31 and UL34 
proteins were not detected in extracellular virions (Reynolds et al., 2002).  In further 
support, the major tegument proteins UL46 and UL49 are present in 
intracytoplasmic/extracellular virions but absent from perinuclear virions (Klupp, 
Granzow, and Mettenleiter, 2000; Mettenleiter, 2002b).  Also, the phospholipid 
composition on the final virion envelope differs substantially from the composition of the 
nuclear membrane, explained only by a two-step envelopment model of HSV virion 
egress (van Genderen et al., 1994).  Electron microscopic analysis has also demonstrated 
the fusion of primary envelopes with the outer nuclear membrane with many 
herpesviruses including HSV-1 (Granzow et al., 2001; Harms et al., 2000).  As a result, 
the two-step “de-envelopment re-envelopment” model of virion egress is congruent with 
both biochemical and morphological data and constitutes a unified model for the 
morphogenesis of herpesviruses (Mettenleiter, 2002b). 
 The mechanism of virion de-envelopment from the perinuclear space is unclear.  
Deletion of the major glycoproteins involved in other membrane fusion events does not 
affect the de-envelopment process as indicated by multiple studies (Cai et al., 1987; 
Granzow et al., 2001; Jayachandra, Baghian, and Kousoulas, 1997; Steven and Spear, 
1997).  It is possible that these glycoproteins function in a redundant manner, and that 
only deletion of multiple genes encoding glycoproteins would have an observable effect 
on virion de-envelopment at the outer nuclear membrane.  This possibility is addressed 
later in Chapter III.   
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 Tegumentation in the Cytoplasm 
 While the complexity of the herpesvirus capsid is not much different than that of 
other icosahedral viral capsids such as the picornavirus capsid, the complexity of the 
herpesvirus tegument is drastically increased.  At least 15 proteins have been identified 
that are part of the HSV-1 tegument.  Even more proteins make up the tegument of other 
herpesviruses such as VZV or CMV (Gibson, 1996; Spengler et al., 2001).  Recent data 
indicate that tegumentation follows an intrincate pattern of protein-protein interactions 
that contains significant levels of redundancy built in, at least as observed in cell culture 
(Mettenleiter, 2002b).  The tegument proteins interact with the capsid on one side and the 
viral envelope proteins on the other side in order to link the structural components to the 
final envelope of the HSV-1 virion and to secure the integrity of the virus particle (Figure 
1.7) (Mettenleiter, 2002b).  For a long time the herpesvirus tegument was considered 
unstructured; however, cryoelectron microscopic analysis has indicated that at least the 
innermost portion of the tegument located adjacent to the capsid exhibits icosahedral 
symmetry, resulting from the interaction of a large tegument protein, presumably UL36, 
with the pentons of the capsid (Zhou et al., 1999).  The UL36 gene product has been 
shown to interact with the major capsid protein VP5, which forms both the pentons and 
hexons (Machtiger et al., 1980; McNabb and Courtney, 1992; Newcomb et al., 1993).  
So, it appears that the first layer of tegument around the capsid is structured and 
composed of UL36.  UL37 has been shown to interact with UL36 in co-
immunoprecipitation and yeast two-hybrid experiments, and capsids that accumulate in 
the absence of UL37 contain UL36 (Klupp et al., 2002). UL36 and UL37 appear to be the 
only tegument proteins conserved in all herpesvirus subfamilies, and the absence of the 
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HSV-1 UL36 and UL37 proteins abolishes virus maturation (Desai et al., 2001; Desai, 
2000; Klupp et al., 2001).  Unfortunately, the subsequent steps in capsid tegumentation 
are still largely undefined.  Virion morphogenesis still proceeds in the absence of several 
other tegument proteins, including UL13, US3 (Purves et al., 1987), UL41, UL46, UL47 
(Rafield and Knipe, 1984; Roizman and Knipe, 2001), and UL49 (Mettenleiter, 2002b).  
So far the most dramatic effect has been seen upon deletion of UL48 (α-TIF), which is 
responsible for transducing α gene promoters and makes up a major part of the virus 
tegument (Batterson and Roizman, 1983; Heine et al., 1974).  The absence of UL48 may 
interfere with a later step in virion assembly, presumably affecting tegumentation and re-
envelopment in the cytoplasm (Mossman et al., 2000).  Interestingly, UL48 has been 
shown to interact with other tegument components, UL49 and UL41 (VHS) (Smibert et 
al., 1994).  Mutant forms of UL41 that do not bind UL48 do not become incorporated 
into the virion (Read, Karr, and Knight, 1993).  Cross-linking studies have indicated that 
UL48 may interact with gB, gD, and gH (Zhu and Courtney, 1994), although these 
interactions have not been confirmed through more stringent methods. 
Final Envelopment at the Trans-Golgi Network/Endosomes and Egress to 
Extracellular Spaces 
 
 Following tegumentation in the cytoplasm, HSV-1 capsids bud into cytoplasmic 
vesicles derived from the trans-Golgi Network (TGN) or endosomes, acquiring their final 
envelope (Figure 1.7, step III). Although the mechanism of secondary envelopment is not 
well defined, the study of mutants that contain deletions of certain glycoproteins has shed 
light on some requirements of the final envelopment event. By far the most dramatic 
effect on secondary envelopment and final egress is caused by the deletion of either 
UL20 or gK, and ultrastructural study of UL20-null and gK-null infected cells reveals a 
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dramatic accumulation of unenveloped and aberrantly enveloped capsids in the cytoplasm 
of infected cells with a marked absence of extracellular virus.  With regard to gK-null and 
UL20-null virus titers, there is also a corresponding lack of infectious virus in the 
supernates of infected cells, with close to wild-type levels of intracellular virus (Foster et 
al., 2004a; Jayachandra, Baghian, and Kousoulas, 1997).  The ultrastructural phenotypes 
of UL20-null and gK-null viruses are covered in detail in Chapter III and Chapter IV. 
 Following the final envelopment step, nascent virions must still egress to 
extracellular spaces.  The current belief is that cellular transport machinery is utilized in 
this step, although the mechanisms are unclear.  It is apparent that the late stages in viral 
egress may differ depending on the cell type that is infected.  For example, deletion of gE 
and gI, which have been shown to interact and form a complex, does not impair 
productive replication of HSV-1 (Enquist et al., 1998).  However, in polarized epithelial 
cells, wild-type HSV-1 virions are sorted predominantly to cell junctions, while gE/gI 
null virions are non-specifically released into supernatants (Dingwell and Johnson, 1998).   
Delivery of virus particles to cell junctions would be expected to enhance virus spread 
and enable viruses to avoid host immune defenses. 
 Deletion of multiple genes encoding envelope glycoproteins has revealed that 
certain aspects of final envelopment and egress may feature redundant mechanisms, each 
of which is sufficient for function, at least in cell culture.  For instance, while neither 
gE/gI or gM is required for productive replication in PrV or HSV-1, simultaneous 
deletion of gE/gI and gM results in drastic inhibition of plaque formation and replication 
in PrV (Brack et al., 1999).  In addition, simultaneous deletion of UL11 and gM resulted 
in similar egress defect in PrV (Kopp et al., 2004).  In contrast, simultaneous deletion of 
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gE/gI and gM does not have a major effect in HSV-1 (Browne, Bell, and Minson, 2004); 
however, a triple mutant lacking gD, gE, and gI had a severe defect in the final 
envelopment step. The authors proposed that HSV gD and the gE/gI heterodimeric 
complex act in a redundant fashion to anchor the virion envelope onto tegument-coated 
capsids (Farnsworth, Goldsmith, and Johnson, 2003).  In contrast, it is also possible that 
deletion of multiple glycoproteins indirectly disrupts the integrity of many different 
protein-protein interactions required for the final envelopment step and that the resulting 
phenotype results from the compounded effects of an abnormal glycoprotein profile.  
More study of the reason for defects in double and triple-null viruses is required before 
conclusions can be drawn regarding mechanisms of final envelopment. 
 Formation of Light (L) Particles 
 The presence of egressing capsids in the cytoplasm is not required for tegument 
assembly and subsequent envelopment to take place.  The formation of extracellular 
herpesvirus light (L) particles that lack capsids, consist of only tegument and envelope, 
and are formed independent of normal virus maturation have been thoroughly studied in 
HSV-1 (McLauchlan and Rixon, 1992; Rixon, Addison, and McLauchlan, 1992).  L 
particles appear to contain the full complement of tegument proteins as well as an 
authentic envelope containing all appropriate glycoproteins.  Studies of PrV have shown 
that L particle formation occurs in the absence of UL36 and UL37, which are tegument 
components that are critical for capsid tegumentation.  It is possible that normal 
tegumentation may be centered on UL36 and UL37 interactions with the capsid and that 
UL49 may be required for proper interactions with viral glycoproteins in the final 
budding and envelopment steps.  In the absence of capsids, tegument assembly could 
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proceed anchored on UL49, resulting in the formation of L particles (Mettenleiter, 
2002b). 
HSV-1 Glycoproteins and Their Putative Functions 
Herpes simplex viruses specify at least eleven virally encoded glycoproteins: gB, 
gC, gD, gE, gG, gH, gI, gJ, gK, gL, gM, and potentially gN (UL49.5). HSV also encode 
several non-glycosylated membrane associated proteins: UL20, US9, UL24, UL43, and 
UL34. Herpesvirus membrane proteins function in several important roles including virus 
entry via fusion of the viral envelope with cellular membranes, intracellular virion 
morphogenesis and egress, cell-to-cell spread, and virus-induced cell fusion 
(Mettenleiter, 2002a; Mettenleiter, 2002b; Roizman and Knipe, 2001; Spear, 2004; Spear 
and Longnecker, 2003).  At least 11 membrane proteins are present on the surface of the 
virion envelope (Roizman and Knipe, 2001).    
Glycoprotein B 
 The HSV-1 UL27 gene encodes the 904 aa glycoprotein B (gB). gB is highly 
conserved across all subfamilies of herpesviruses.  HSV-1 gB is homotrimeric (aa) type I 
membrane glycoprotein composed of a 696-aa ectodomain that is N-glycosylated at 
multiple sites (Claesson-Welsh and Spear, 1986; Claesson-Welsh and Spear, 1987; 
Highlander et al., 1991; Laquerre, Person, and Glorioso, 1996; Spear, 1993; Whitley, 
2001), a 69-aa transmembrane domain, and a 109-aa carboxy-terminal domain. The 
cytoplasmic domain of gB is the longest among HSV-1 glycoproteins, implying a crucial 
role for this domain in gB-mediated functions.  A variety of evidence indicates that gB 
plays important roles in membrane fusion phenomena during virus entry and virus-
induced cell fusion: HSV-1 mutant viruses lacking gB are not able to enter into cells (Cai 
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et al., 1987) due to a post-attachment defect that can be resolved by polyethelene glycol 
mediated fusion of viral envelopes with cellular membranes (Cai, Gu, and Person, 1988); 
Single amino acid substitutions and truncations of the carboxyl terminus of gB cause 
extensive virus-induced cell fusion (Baghian et al., 1993; Bzik et al., 1984; Cai et al., 
1988; Gage, Levine, and Glorioso, 1993). Transient co-expression of gB with gD, gH and 
gL causes cell-to-cell fusion, which is substantially increased by carboxyl terminal 
truncations of gB (Foster, Melancon, and Kousoulas, 2001; Haan, Lee, and Longnecker, 
2001; Klupp, Nixdorf, and Mettenleiter, 2000; Pertel, 2002). These results suggest a 
direct role for gB in membrane fusion and suggest that perturbations of the carboxyl 
terminal domains of gB facilitate gB-mediated cell-to-cell fusion.  gB is viewed as the 
primary component of herpesvirus membrane fusion machinery. 
Glycoprotein C 
 The 1,536 bp HSV-1 UL44 gene encodes for the 511 aa long precursor of 
glycoprotein C (gC) (Frink et al., 1983).  gC contains a 25 aa signal sequence at the N-
terminus, a long 453 aa extracellular domain, a 23 aa transmembrane anchoring domain, 
and a short 10 aa C-terminal cytoplasmic tail (Homa et al., 1986).  The first contact of 
virions with the surface of susceptible cells is through glycosaminoglycans (GAGs).  gC 
can mediate the initial binding of HSV-1 virus to a cell surface GAG, heparan sulfate 
(HS). The heparan sulfate binding site of gC has been localized to the N-terminal 120 aa 
(Tal-Singer et al., 1995).  The aminoglycoside neomycin interferes with the binding of 
virus to HS mediated by gC (Herold et al., 1994).  Although gC is dispensable for the 
infection of cultured cells, its presence can increase the efficiency of virus binding almost 
10-fold, at least for HSV-1.  The main function of gC binding to GAGs seems to be 
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concentration of the virus on cell surfaces, enabling the more stable interaction of gD 
with an entry receptor. 
Another important function of gC is its ability to inactivate complement to 
facilitate immune evasion by HSV-1.  The gC of many herpesviruses has the ability to 
bind C3b (Eisenberg et al., 1987; Friedman et al., 1984; Huemer et al., 1993; Huemer et 
al., 1995).  The presence of gC protects the virus and infected cell from antibody (Ab)-
independent complement neutralization and cell lysis (Lubinski et al., 1999; Lubinski et 
al., 1998), and gC is an important virulence factor in vivo (Isaacs, Kotwal, and Moss, 
1992; Kotwal et al., 1990; Sahu et al., 1998).  HSV-1 mutant viruses lacking gC are 
rapidly inactivated by human complement, resulting in up to a 5000 fold loss of titer 
(Friedman et al., 1996).  While Ab is not required for neutralization of a gC null virus, 
the presence of Ab enhances neutralization (Friedman et al., 1996; Harris et al., 1990). 
An unresolved issue regarding gC function is the relationship of gC to virus-
induced syncytia formation.  Several spontaneously arising syncytial virus strains were 
found to be gC-deficient.  In particular the MP strain variant MP10311 contains a 
syncytial mutation in gK and is gC-deficient (Bartoletti et al., 1985).  In general, the 
syncytial phenotype of these strains was found to be more effectively expressed in the 
absence of gC, especially in Hep-2 cells (Bond, Person, and Warner, 1982; Goodman and 
Engel, 1991; Manservigi, Spear, and Buchan, 1977; Pertel and Spear, 1996; Tognon et 
al., 1984).  One possible explanation of the enhancement of the syncytial phenotype is 
that in the absence of gC, because extracellular virus does not bind to cell surfaces as 
rapidly, virus-induced cell fusion acts as the preferential method of cell-to-cell spread of 
HSV-1.   
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Glycoprotein D 
 The 1182 bp long US6 gene specifies a 394 aa precursor to glycoprotein D (gD).  
gD consists of a 25 aa signal peptide, a long 315 aa ectodoamin containing three 
glycosylation sites (McGeoch et al., 1985; Watson et al., 1982), a 22 aa transmembrane 
domain, and a 32 aa C-terminal cytoplasmic domain (Minson et al., 1986).  The 
ectodomain of gD has 6 cysteine residues at positions 66, 106, 118, 127, 189, 202 
forming disulfide bonds (Long et al., 1992). Importantly, gD has been shown to act as the 
viral ligand for all known HSV-1 entry receptors (Spear, Eisenberg, and Cohen, 2000).  
As a result, gD is absolutely required for virus entry and virus-induced cell-to-cell fusion 
to occur. As discussed earlier, HSV-1 gD has the ability to bind HVEM, nectin-1, nectin-
2, and other cell surface receptors to mediate virus entry.  In addition, cells that express 
gD are resistant to HSV infection in a dose-dependent manner due to a saturation of the 
corresponding entry receptors (Campadelli-Fiume et al., 1988; Johnson, Burke, and 
Gregory, 1990).  X-ray structures of HSV-1 gD alone and in complex with HVEM 
revealed that a portion of gD assumes an Ig-like fold with unconventional disulfide-
bonding patterns (Carfi et al., 2001). There is an N-terminal extension from the Ig-like 
fold that forms a hairpin loop in the complex with HVEM, but is disordered in the 
crystals of gD alone. The contacts in gD for HVEM have been localized to amino acids 7 
to 15 and 24 to 32 within the N-terminal hairpin (Spear and Longnecker, 2003). 
Mutagenic analysis of HSV-1 gD revealed that the first 32 amino acids of the N-terminal 
extension have a critical role in functional interactions of gD with all the HSV entry-
fusion receptors, except for nectin-1, and that the amino acid sequence within this region 
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governs whether nectin-2 can be recognized as an entry and fusion receptor (Yoon et al., 
2003; Zago and Spear, 2003).   
Glycoproteins E and I 
 The 1652 bp long US8 gene encodes the 550 aa glycoprotein E (gE) (Lee, Para, 
and Spear, 1982), while the 1172 bp long US7 gene encodes 390 aa glycoprotein I (gI) 
(Longnecker et al., 1987).  HSV, VZV, and PrV express a heterodimer of gE and gI that 
functions to mediate cell-to-cell spread of virus in epithelial and neuronal tissues (Balan 
et al., 1994; Card et al., 1992; Cohen and Nguyen, 1997; Dingwell et al., 1994; Dingwell 
and Johnson, 1998; Jacobs et al., 1993; Johnson and Feenstra, 1987; Johnson et al., 1988; 
Kimura et al., 1998; Kritas, Pensaert, and Mettenleiter, 1994; Kudelova et al., 1991; 
Mettenleiter et al., 1987b; Mulder et al., 1994; Neidhardt, Schroder, and Kaerner, 1987; 
Tirabassi and Enquist, 1998; Tirabassi et al., 1997; Whealy et al., 1993). HSV and PRV 
gE/gI complexes are required for efficient spread of viruses between certain cultured 
epithelial cells, neurons, and other polarized cells with extensive cell junctions, but are 
not needed for spread between highly transformed, nonpolarized cells, such as Vero or 
HeLa cells, which do not form cell junctions (Dingwell et al., 1994; Dingwell, Doering, 
and Johnson, 1995; Mettenleiter et al., 1987a; Tirabassi et al., 1997; Wisner et al., 2000; 
Zsak et al., 1992). For example, plaques formed by a gE-negative HSV mutant on 
monolayers of a keratinocyte cell line included eightfold fewer cells than plaques 
produced by wild-type HSV-1, yet there was no difference in cell-to-cell spread in 
monolayers of HeLa cells (Wisner et al., 2000). Moreover, PRV and HSV gE/gI 
complexes are required for spread within synaptically connected neuronal circuitry in the 
peripheral and central nervous systems (Babic et al., 1996; Dingwell, Doering, and 
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Johnson, 1995; Mulder et al., 1994; Tirabassi and Enquist, 1998; Tirabassi et al., 1997; 
Whealy et al., 1993).  
 gE and gI are extensively complexed in virus-infected cells (Johnson and 
Feenstra, 1987; Johnson et al., 1988), and it is the gE/gI complex that functions in cell-to-
cell spread (Dingwell et al., 1994; Dingwell, Doering, and Johnson, 1995; Johnson and 
Feenstra, 1987; Johnson et al., 1988; Olson and Grose, 1998; Tirabassi et al., 1997; 
Zuckermann et al., 1988). In contrast to their effects on cell-to-cell spread, HSV and PRV 
gE/gI complexes do not appear to be required for entry of cell-free virus, i.e., virus 
particles applied to the apical surfaces of cells (Dingwell et al., 1994; Mettenleiter et al., 
1987a).  HSV-1 gE/gI localizes specifically to the TGN during early phases of infection 
but moves out to cell junctions at intermediate to late times.  One mechanism by which 
gE/gI facilitates cell-to-cell spread of HSV-1 involves the sorting of newly assembled 
virions to lateral cell surfaces and cell junctions.  Mutant HSV-1 lacking gE accumulated 
more extensively in the cytoplasm, at apical cell surfaces, and in cell culture supernatants 
than did wild-type HSV-1 particles, which were found predominantly at cell junctions 
(Alconada et al., 1999; Kimura et al., 1998).  
 The gE/gI complex is also known as the HSV Fc Receptor (FcR) because of its 
high affinity for the Fc portion of IgG.  Through binding of the Fc portion of IgG, the 
gE/gI complex contributes to the immune evasion capabilities of HSV-1, reducing the 
effectiveness of antibody-dependent cellular cytotoxicity (ADCC) targeting the virus and 
infected cells (Eberle et al., 1995). 
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Glycoprotein G 
 The 716 bp long US4 gene encodes the 238 aa glycoprotein G (gG).  During 
infection, gG is incorporated into nuclear and cytoplasmic membranes in the cell (Frame, 
Marsden, and McGeoch, 1986; Sullivan and Smith, 1987).  The relevant function of gG 
in the herpesvirus life cycle has been difficult to identify. Mutant HSV-1 lacking US4 
showed no discernible phenotypic abnormalities relative to the wild-type HSV-1 virus in 
non-polarized cells in culture, and the absence of gG resulted in only marginal 
attenuation of the virus in certain in vivo models (Atkinson, Barr, and Timbury, 1978). 
However, at the primary site of infection, HSV-1 is required to infect the apical surfaces 
of mucosal epithelial cells.  Recombinant viruses lacking gG were shown to be defective 
in the gC-dependent infection of the apical surfaces of polarized epithelial cells in culture 
and also in infection of the apical surfaces of corneal epithelial cells in vivo (Tran et al., 
2000).  It is not known whether the gG function in infection is mediated in a cooperative 
manner with gC, whereby gG would assist with gC binding, or in an independent manner, 
whereby gG would be necessary in a second step that renders the gC interaction 
irreversible. 
Glycoproteins H and L 
 The 2517 bp UL22 gene encodes the 838 aa glycoprotein H (gH).  gH is a type I 
membrane glycoprotein containing an 18 aa signal peptide, a long 785 aa ectodomain, a 
single 21 aa transmembrane hydrophobic domain close to the C-terminus, and a 14 aa C-
terminal cytoplasmic tail.  The 675 bp UL1 gene encodes the 224 aa glycoprotein L. gL 
contains a 25 aa signal peptide; however, unlike other herpesvirus glycoproteins, gL does 
not contain a transmembrane domain.  It appears that gL is not an integral membrane 
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protein; rather, its membrane association and incorporation into virus particles is 
dependent on its interaction with gH (Dubin and Jiang, 1995).  Infected cell membranes 
contain a heterodimer of gH and gL (gH/gL).  When gH is expressed in transfected cells 
in the absence of gL, the resulting gH polypeptide is neither folded or processed 
correctly.  The malformed gH remains in the endoplasmic reticulum and undergoes self-
aggregation (Foa-Tomasi et al., 1991; Forrester et al., 1991; Roberts et al., 1991).  
Similarly, cells infected with a gL-null virus do not produce virions containing gH.  
When cells are infected with a gH-null virus, gL is neither correctly processed nor 
incorporated into the plasma membrane or viral envelope (Hutchinson et al., 1992a; 
Roop, Hutchinson, and Johnson, 1993).  Due to the lack of a transmembrane region, the 
gL polypeptide is secreted into the medium (Dubin and Jiang, 1995).  When both UL22 
and UL1 are cotransfected into cells, the antigenic conformation of the gH/gL 
heterodimer is identical to that of virus infected cells, indicating that no other viral 
proteins are necessary for heterodimer formation.  The mutual interaction of both 
glycoproteins is mediated by the N-terminal region of the first 69 aa of gL after cleavage 
of the 25 aa signal peptide (Roop, Hutchinson, and Johnson, 1993), while gH interacts 
through a central region of the its extracellular domain.  A properly formed gH/gL 
heterodimer is required for both virus entry and virus-induced cell-to-cell fusion.  
Although viruses lacking gH/gL are unable to enter cells, they are able to attach to the 
cell surface. Therefore, the role of gH/gL in virus entry is during the virus envelope-
plasma membrane fusion event and is not required for virion attachment or receptor 
binding.  An interesting result concerning the mechanism of gH/gL functions was 
obtained when using anti-gL mAbs directed to the C-terminal portion of gL.  Certain 
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mAbs inhibited virus-induced cell-to-cell fusion resulting from syncytial mutations but 
not virus entry, indicating a fundamentally different mechanism may be at work in the 
two processes (Novotny, Parish, and Spear, 1996). 
Glycoprotein J 
 The 279 bp US5 gene encodes the 92 aa glycoprotein J (gJ) (Ghiasi et al., 1998).  
gJ contains a predicted signal peptide as well as a hydrophobic transmembrane domain.  
The current function of gJ is unknown.  Deletion viruses that lack the US5 ORF show no 
phenotypic deficiencies either in vitro or in vivo (Balan et al., 1994).  More specifically, a 
gJ-null HSV-1 was capable of multiplying from an inoculation site in mice and entering 
and replicating in the peripheral and central nervous system (Balan et al., 1994).  
However, it has been shown that another gene in the unique long (UL) region of the viral 
genome, UL27.5, has amino acid sequences common to US5.  UL27.5 was discovered 
due to the fact that antibodies generated against the 23 kDa gJ cross reacted with an 
unknown 43 kDa product (Chang et al., 1998).  In contrast to gJ, UL27.5 accumulates in 
the cytoplasm of infected cells; nevertheless, it may be possible that UL27.5 and gJ could 
function redundantly and an observable change in phenotype would not be seen unless 
both US5 and UL27.5 were disrupted. 
Glycoprotein K 
 The 1017 bp UL53 gene encodes the 338 aa precursor of glycoprotein K (gK) 
(Debroy, Pederson, and Person, 1985; Pertel and Spear, 1996).  gK contains a cleavable 
30 aa signal sequence as well as two asparagine residues at positions 48 and 58 that are 
glycosylated by N-linked mannose (Hutchinson et al., 1992b; Ramaswamy and Holland, 
1992).  gK is extremely hydrophobic and was originally proposed to contain four 
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transmembrane domains, with both the N-terminus and C-terminus predicted to lie on the 
lumenal/extracellular side of cellular membranes (Debroy, Pederson, and Person, 1985).  
In contrast, experiments with in vitro translated gK in the presence of microsomal 
membranes predicted gK to contain three transmembrane domains, with the C-terminal 
tail located intracellularly (Debroy, Pederson, and Person, 1985; Mo and Holland, 1997; 
Ramaswamy and Holland, 1992).  However, recent experiments by our laboratory 
utilizing epitope tags inserted into specific regions of gK confirmed the original 
prediction for the membrane topology of gK (Foster, Alvarez, and Kousoulas, 2003).  
 Original attempts to isolate gK-deficient viruses through substitution of UL53 
with the lacZ gene were unsuccessful and it was determined that gK was essential for 
HSV replication in vivo (MacLean et al., 1991).  A subsequent attempt at the isolation of 
a F-strain gK-null virus was successful, resulting in an insertion-deletion mutation in gK 
that expressed a fusion protein containing the N-terminal 112 aa of gK.  The aberrant 
virions were significantly less infectious and did not reach the extracellular space, with a 
high number of naked capsids and aberrant virions in the cytoplasm (Hutchinson and 
Johnson, 1995).  Furthermore, cells infected with the F strain gK-null virus caused cell 
fusion in 143TK- cells.  However, a KOS strain containing a more precise deletion of the 
UL53 gene resulted in a slightly different phenotype (Jayachandra, Baghian, and 
Kousoulas, 1997).  While the egress of virions in the KOS gK-null virus was still 
severely impaired relative to a wild-type virus, the KOS gK-null did not cause cell fusion 
in 143TK- cells.  A KOS virus that was constructed to mirror the F strain insertion-
deletion resulted in syncytia formation in 143TK- cells, so the syncytial phenotype of the 
“gK-null” viruses was attributed to the expression of the N-terminal 112 aa of gK 
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(Jayachandra, Baghian, and Kousoulas, 1997).  Importantly, a precise insertion-deletion 
gK mutation recently constructed in an F-strain BAC was not syncytial and showed a 
similar egress defect, confirming previous results (see Chapter III). 
Studies of gK localization in infected cells had previously shown that gK was 
exclusively localized in the perinuclear spaces and contained unprocessed carbohydrates 
added in the rough endoplasmic reticulum, indicating that gK was not transported to the 
Golgi complex and never reached the cell surface (Hutchinson, Roop-Beauchamp, and 
Johnson, 1995).  Interestingly, while spontaneous mutations leading to syncytia 
formation can arise in UL20 (Baines et al., 1991; MacLean et al., 1991), UL24 (Jacobson, 
Martin, and Coen, 1989; Sanders, Wilkie, and Davison, 1982), UL27 (gB) (Bzik et al., 
1984; Pellett et al., 1985), and UL53 (gK) (Bond and Person, 1984; Debroy, Pederson, 
and Person, 1985; Pogue-Geile et al., 1984; Ruyechan et al., 1979), a large majority of 
syncytial mutations map to the UL53 (gK) gene.  The number of syncytial mutations 
found in gK would seem to be at odds with data indicating that gK never reaches the 
surface of infected cells; however, data obtained in our laboratory utilizing viruses 
engineered to contain epitope tags in the putative extracellular domains of gK indicates 
that gK does indeed reach the surface of infected cells, resolving the paradox of how gK 
could potentially function in virus induced cell-to-cell fusion (Foster, Alvarez, and 
Kousoulas, 2003).  In transiently transfected cells, gK localized in the ER and did not the 
cell surface.  It was originally reported for PrV that gK is not correctly processed in a 
UL20 deletion mutant, and that coexpression of gK and UL20 restored gK processing at 
least partially (Dietz et al., 2000).  In support of these original findings, our laboratory 
showed that coexpression of gK and UL20 in transfected cells restored the transport of 
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gK to cell surfaces (Foster, Alvarez, and Kousoulas, 2003).  Nevertheless, while 
coexpression of UL20 also restored the transport of syncytial gK genes in transfected 
cells, syncytia formation did not result in these experiments, indicating that additional 
viral proteins are needed to activate the membrane fusion potential of gK (Foster, 
Alvarez, and Kousoulas, 2003). 
Glycoprotein M and UL49.5 (gN) 
 The 1422 bp UL10 gene encodes the 473 aa glycoprotein M (gM), which contains 
eight predicted hydrophobic transmembrane regions (Babic et al., 1996; Baines and 
Roizman, 1993). gM is a component of the virion envelope and is present in the 
cytoplasmic membranes of infected cells (MacLean, Robertson, and Jamieson, 1993).  
Viruses deficient in the expression of gM exhibit a 10 to 20 fold reduction in virus titers 
in Vero or BHK cells and form slightly smaller plaques (MacLean et al., 1991; MacLean, 
Robertson, and Jamieson, 1993).  The 276 bp UL49.5 (UL49A) gene encodes a 91 aa 
integral membrane protein (Baines and Roizman, 1993). The UL49.5 polypeptide 
contains a 23 aa cleaved signal peptide and a C-terminal hydrophobic transmembrane 
domain (Barnett et al., 1992).  There are also potential sites for O-glycosylation, leading 
to the naming of UL49.5 as glycoprotein N (gN) in some cases.  In PrV, the UL49.5 
homolog was found to be O-glycosylated and incorporated into virions as a 14kDa 
envelope protein (Jons et al., 1996).  However, the UL49.5 gene product showed no 
evidence of glycosylation in HSV-1 infected cells, and appeared to be abundantly present 
in virions, linked to the tegument by disulfide bonds (Adams et al., 1998).  While initial 
attempts at deletion of UL49.5 were unsuccessful and indicated the possibility that 
UL49.5 was required for virus replication (Barker and Roizman, 1992), a more recent 
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attempt utilizing a more precise deletion resulted in a UL49.5-deficient virus that showed 
no phenotypic differences in plaque yield or morphology and only a marginal two-fold 
difference in virus yield (Adams et al., 1998). 
 Glycoprotein M and UL49.5 (gN) are conserved throughout alpha, beta-, and 
gammaherpesviruses and have been shown to form a complex in a number of 
herpesviruses analyzed to date (Jons, Dijkstra, and Mettenleiter, 1998; Koyano et al., 
2003; Lake, Molesworth, and Hutt-Fletcher, 1998; Mach et al., 2000; Wu, Zhu, and 
Letchworth, 1998).  The PrV gM has been shown to act as an inhibitor of cell fusion 
resulting from cotransfection of either the PrV gB, gD and gH/gL or the F protein of 
bovine respiratory syncytial virus, indicating a general mechanism of fusion inhibition by 
gM (Klupp, Nixdorf, and Mettenleiter, 2000). While no definitive interaction has been 
shown between the HSV-1 gM and UL49.5, an enhancement of function has been 
demonstrated when both are present, inasmuch as cotransfection of the HSV-1 gM and 
UL49.5 significantly inhibited cell fusion caused by the HSV-1 gB, gD and gH/gL or the 
Molony murine leukemia virus envelope protein, while transfection of the HSV-1 gM 
alone did not inhibit membrane fusion (Koyano et al., 2003).  A requirement of both gM 
and gN for inhibition of cell fusion was also shown for HHV-8 (Koyano et al., 2003).  At 
this point in time, the mechanism by which gM and UL49.5 mediate inhibition of cell-to-
cell fusion is unknown. 
Characterization of the UL20 Protein (UL20p) 
The UL20 ORF 
 The UL20 open reading frame is situated between the UL19 gene and the recently 
confirmed UL20.5 gene in the unique long region of the HSV-1 genome.  The UL20 gene 
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is expressed from the complementary strand of the viral DNA.  The 669 bp UL20 gene 
encodes the 222 aa UL20 protein (UL20p).  UL20 is expressed as a γ1 (late) gene that 
does not require viral DNA replication for expression (Ward et al., 1994) and is 
conserved in the alphaherpesviruses. 
Membrane Topology of UL20p 
 Based on its predicted amino acid sequence, the UL20 protein was suggested to 
be an integral membrane protein containing two or three hydrophobic transmembrane 
domains (McGeoch et al., 1988).  However, when the hydrophobic and membrane-
spanning domains of UL20p were calculated by using the TMPred and SOSUI computer 
algorithms (Hirokawa, Boon-Chieng, and Mitaku, 1998; Hofmann and Stoffel, 1993) and 
used to derive a predicted membrane spanning model of UL20p, four hydrophobic 
regions were predicted, with no predicted signal peptide. This putative UL20p model 
features four membrane spanning regions (Fig. 4.1), placing both the 66 aa amino 
terminus and the 14 aa carboxyl terminus of UL20p within the cytoplasm (domains I and 
V). In addition, a third small 10 aa domain is predicted to be located intracellularly 
(domain III), while the two other domains are predicted to be located extracellularly 
(domains II and IV).  Domain II is predicted to contain 7 aa, while domain IV is 
predicted to contain 32 aa.  As the largest extracellular domain, domain IV holds the best 
chance for interactions with the extracellular portions of other membrane proteins.  This 
predicted model of the UL20p membrane topology has been partially confirmed in our 
laboratory with FLAG epitope tags located either on the N-terminus of UL20p, which is 
intracellular, or inside of domain IV, which is present on the extracellular/lumenal side of 
cellular membranes (Foster et al., 2004b). 
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Interdependence with gK for Cell Surface Expression and Internalization to the Trans-
Golgi Network 
 
 Initial reports on the cellular localization of the UL20 protein indicated that it was 
not expressed at the cell surface but was present in virions purified from extracellular 
fluid and from the cytoplasm. The UL20 protein was found to be present in the nuclear 
membranes, in the Golgi apparatus, and dispersed in the cytoplasm but was not detected 
in the plasma membranes of infected cells (Ward et al., 1994).  In contrast, recent 
experiments performed by our laboratory showed that independently expressed gK or 
UL20p failed to be transported from the ER in Vero cells. Similarly, infection of Vero 
cells with either a gK-null or UL20-null virus resulted in ER entrapment of UL20p or gK, 
respectively.  In contrast, transiently coexpressed gK and UL20p predominantly localized 
to the TGN, and TGN-localized gK and UL20p to originated from internalized gK and 
UL20p expressed at cell surfaces.  In all experiments, UL20p and gK colocalized, 
consistent with the hypothesis that gK and UL20p directly interact, and that this 
interaction is important for their TGN localization and function in the virus life cycle 
(Foster et al., 2004b). 
Function of UL20p in the HSV-1 Lifecycle 
 The original description of the role of UL20p in the virus life cycle was 
predicated on the observation that an F-strain UL20-null virus, R7225, had a perinuclear 
block in virus egress, resulting in a large accumulation of virions between the inner and 
outer nuclear membrane as well as an abnormal level of unenveloped capsids in the 
cytoplasm.  In addition, the R7225 virus formed small syncytia on 143TK- cells (Baines 
et al., 1991).  However, at the time it was unknown that the UL20.5 gene was located 
adjacent to UL20, and the R7225 virus contains an aberrantly fused gene consisting of 
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the 5’ half of the UL20.5 ORF and the 3’ half of the UL20 gene.  As such, it was 
unknown whether or not the description of the UL20-null phenotype could be attributed 
to the aberrant gene.   
 To resolve the true phenotype of an HSV-1 virus lacking the UL20 gene, our 
laboratory constructed an insertion-deletion mutation into the HSV-1 KOS-strain UL20 
gene that consisted of removal of the 5’ region of the UL20 ORF, while maintaining the 
integrity of both the UL20.5 gene and the promoter for the major capsid protein, UL19.  
In accordance with the R7225 virus, the KOS strain UL20-null virus exhibited a defect in 
virion egress; however, the block in virion egress consisted solely of an accumulation of 
unenveloped capsids in the cytoplasm, and no accumulation of perinuclear virions was 
observed (Foster et al., 2004a).  Furthermore, the KOS UL20-null virus did not form 
syncytial plaques on 143TK- cells.  The observable phenotypes of the KOS UL20-null 
virus were in agreement with the phenotype described for a PrV virus lacking UL20 
(Fuchs et al., 1997), indicating that the previously described phenotype of the R7225 
virus was in all likelihood due to the presence of the aberrantly fused gene.  In addition, 
we found that the UL20 protein was required for virus-induced cell-to-cell fusion 
resulting from syncytial mutations in either gB or gK, implying that UL20 may serve to 
regulate membrane fusion events in HSV-1 (Foster et al., 2004a).  In Chapter IV, we 
investigate the domains of UL20 that function in gB and/or gK-induced syncytia 
formation as well as in virion egress. 
Virus-Induced Syncytia Formation 
 While wild-type herpesviruses usually cause infected cells to round up and clump 
together, some viral mutants in both HSV-1 and HSV-2 cause cells to fuse into large 
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polykaryocytes containing many nuclei (Ejercito, Kieff, and Roizman, 1968; Hoggan and 
Roizman, 1959; Ruyechan et al., 1979). Virus-induced cell-to-cell fusion has been 
extensively studied for several reasons:  as a probe of the structure and function of 
cellular membranes during infection reflected in their behavior, as a tool for analysis of 
the functions of viral membrane proteins, and as a model of the initial interaction 
between HSV and susceptible cells that results in fusion of the viral envelope with the 
cellular plasma membrane (Campadelli-Fiume and Serafini-Cessi, 1985; Roizman, 1962; 
Spear, 1985a; Spear, 1985b). 
Syncytia formation can be viewed as an aberrant manifestation of the interactions 
of altered membranes in herpesvirus infected cells with the unaltered membranes of 
neighboring cells.  Genetic analysis has shown that mutations that cause extensive virus-
induced cell-to-cell fusion map to at least four and possible more loci within the viral 
genome: the UL20 gene (Baines et al., 1991; MacLean et al., 1991; Melancon, Foster, 
and Kousoulas, 2004), the UL24 gene (Jacobson, Martin, and Coen, 1989; Sanders, 
Wilkie, and Davison, 1982), the UL27 gene encoding glycoprotein B (gB) (Bzik et al., 
1984; Pellett et al., 1985), and the UL53 gene coding for glycoprotein K (gK) (Bond and 
Person, 1984; Debroy, Pederson, and Person, 1985; Hutchinson, Roop-Beauchamp, and 
Johnson, 1995; Pogue-Geile et al., 1984; Pogue-Geile and Spear, 1987; Ruyechan et al., 
1979), with the great majority of syncytial mutations arising in either UL27 (gB) or UL53 
(gK).    
The mechanisms involved in virus-induced cell fusion are unclear, but some 
progess has been made on understanding the components required for cell fusion 
resulting from syncytial mutations in UL27 or UL53.  In one set of experiments, the 
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requirements for syncytia formation caused by a mutation at codon 855 of gB (gBANG) 
were analyzed.  In Vero cells, gC, gG, gJ, and UL43 were shown to be dispensable for 
syncytium formation at both high and low multiplicities of infection, while gD, gH, gL, 
gE, gI, and gM were all required for the fusion of cellular membranes (Davis-Poynter et 
al., 1994). These results confirmed that the requirements for virion entry and cell-to-cell 
fusion are not identical. While gD and gH/gL, like gB, are essential for both virion entry 
and virus-induced cell-to-cell fusion, gE, gI, and gM, on the other hand, are dispensable 
for virus penetration, yet can play a role in cell-to-cell spread (Davis-Poynter et al., 
1994).  In addition, it has been shown that syncytial mutations in gK failed to cause virus-
induced cell fusion in the absence of gB, indicating that gB was essential for gK-
associated cell-to-cell fusion (Cai, Gu, and Person, 1988). Recently, our laboratory 
demonstrated a requirement for UL20 in virus-induced cell fusion caused by syncytial 
mutations in either gB or gK.  However, the role of gK in syncytia formation caused by 
gB syncytial mutations had not been studied, and in Chapter III we investigate this 
possibility. 
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CHAPTER II 
AN α-HELICAL DOMAIN WITHIN THE CARBOXYL TERMINUS 
OF HERPES SIMPLEX VIRUS TYPE 1 (HSV-1) GLYCOPROTEIN B 
(gB) IS ASSOCIATED WITH CELL FUSION AND RESISTANCE TO 
HEPARIN INHIBITION OF CELL FUSION* 
 
 
 
INTRODUCTION 
 Viral glycoproteins are key determinants in membrane fusion events throughout 
the virus life cycle. Herpes simplex viruses specify at least twelve glycoproteins: gB, gC, 
gD, gE, gG, gH, gI, gJ, gK, gL gM, and gN, which are expressed in infected cells.  These 
glycoproteins function in several important roles including pH independent virus entry 
via fusion of the viral envelope with cellular membranes, cell-to-cell spread, virus-
induced cell fusion, and egress of infectious virion particles (reviewed in Mettenleiter, 
2000; Spear, 1993).  Recombinant mutant viruses that lack either gB (UL27), gD (US6), 
gH (UL22) or gL (UL1) attach to cell surfaces through cell surface glycosaminoglycans, 
but fail to penetrate, indicating these glycoproteins are required at least in part for virus-
to-cell fusion (Cai, Gu, and Person, 1988; Forrester et al., 1992; Ligas and Johnson, 
1988; Roop, Hutchinson, and Johnson, 1993). Either of two HSV-1 glycoproteins, gC 
(UL44) or gB, can mediate binding of virus to heparan sulfate proteoglycans on cellular 
surfaces.  Accordingly, attachment is inhibited by soluble heparin, a glycosaminoglycan 
closely related to heparan sulfate (Gruenheid et al., 1993; Herold et al., 1994; Herold et 
al., 1991; Shieh et al., 1992; WuDunn and Spear, 1989). Fusion between the viral 
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envelope and cell membrane requires gB, gD and gH/gL, and possibly the tegument 
protein UL25 (Addison et al., 1984; Cai, Gu, and Person, 1988; Forrester et al., 1992; 
Ligas and Johnson, 1988; Roop, Hutchinson, and Johnson, 1993). Penetration of virus 
requires the interaction of gD with specific cell surface receptors (Cocchi et al., 1998; 
Geraghty et al., 1998; Montgomery et al., 1996; Warner et al., 1998). 
 Spread of infectious virus occurs either by release of virions to extracellular 
spaces or through virus-induced cell-to-cell fusion. Mutations that cause extensive virus 
induced cell-to-cell fusion can arise in at least four genes of the HSV genome: the UL53-
gK gene, the gB gene, the UL20 gene, and the UL24 gene (Baines et al., 1991; Bond and 
Person, 1984; Bzik et al., 1984b; Cai, Gu, and Person, 1988; Debroy, Pederson, and 
Person, 1985; DeLuca et al., 1982; Dolter, Ramaswamy, and Holland, 1994; Engel, 
Boyer, and Goodman, 1993; Gage, Levine, and Glorioso, 1993; Hutchinson et al., 1992; 
Jacobson, Martin, and Coen, 1989; Pogue-Geile and Spear, 1987; Ruyechan et al., 1979; 
Sanders, Wilkie, and Davison, 1982; Weise et al., 1987).  However, like virus-to-cell 
fusion, gB, gD, gH, and gL have been shown to be necessary and sufficient to cause 
virus-induced cell fusion. The evidence is twofold. First, mutant viruses that do not 
express any one of these four glycoproteins fail to produce syncytia (Cai, Gu, and Person, 
1988; Davis-Poynter et al., 1994; Ligas and Johnson, 1988; Roop, Hutchinson, and 
Johnson, 1993). Similarly, transient expression of HSV-1 or HSV-2 gB, gD, gH and gL 
causes polykaryocyte formation in transfected Cos cells (Muggeridge, 2000; Turner et 
al., 1998). Glycoproteins gE (US8), gI(US7), and gM (UL10), as well as the UL45 
protein, may be able to enhance virus-induced cell fusion, since deletions of these genes 
cause inhibition of cell fusion (Davis-Poynter et al., 1994; Haanes et al., 1994; Visalli 
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and Brandt, 1991). Similarly, gC may be able to inhibit virus-induced cell fusion of at 
least some cell types, which may explain the lack of gC expression in many syncytial 
mutants (Manservigi, Spear, and Buchan, 1977; Novotny, Parish, and Spear, 1996; Pertel 
and Spear, 1996). It is apparent there are similarities as well as significant differences 
between the virus-induced cell fusion and fusion of cells by transient co-expression of 
gB, gD, gH/gL. Both systems require the expression of gD receptors for fusion to occur 
(Pertel et al., 2001; Terry-Allison et al., 1998); however, the transient expression system, 
in contrast to the virus induced cell fusion, does not require the presence of heparan 
sulfate (Pertel et al., 2001; Shieh and Spear, 1994). Additionally, viral proteins that 
exhibit the ability to influence virus-induced cell fusion do not produce similar effects in 
the transient fusion assay system (Klupp, Nixdorf and Mettenleiter, 2000; Turner et al., 
1998).  
 Glycoprotein B is highly conserved across all subfamilies of herpesviruses. It 
exists within cells as a homodimeric type I integral membrane protein that is N-
glycosylated at multiple sites within the polypeptide.  Each 904 amino acid (aa) monomer 
includes a cleavable signal sequence, an extracellular domain of 696 aa, a 69 aa triple 
pass transmembrane region, and a 109 aa carboxyl terminal domain.  Single amino acid 
substitutions within two regions of the intracellular cytoplasmic domain of gB were 
shown to cause syncytium formation and were designated Region I (aa positions 816 and 
817) and Region II (aa positions 853, 854, and 857) (Bzik et al., 1984a; Cai et al., 1988; 
Gage, Levine, and Glorioso, 1993; Walev et al., 1994). Deletion of the carboxyl terminal 
41 amino acids of gB did not adversely affect viral infectivity and replication; whereas, 
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deletion of the carboxyl terminal 28 amino acids caused extensive virus-induced cell 
fusion (Baghian et al., 1993; Huff et al., 1988).  
 We extended our previous findings by examining the role of specific carboxyl 
terminal domains of gB in cell fusion in the context of viral infection as well as in a 
transfection-fusion system. We show that an α-helical domain within the gB carboxyl 
terminus appears to regulate cell fusion. Moreover, we provide evidence that heparin 
inhibition of gB-mediated cell fusion is also regulated by the carboxyl terminus of gB for 
both virus-induced cell fusion as well as fusion by co-expression of gB, gD, and gH/gL. 
In this regard, gB-mediated fusion functions similarly for both fusion systems. 
MATERIALS AND METHODS 
Cells and Viruses 
 Vero and COS7 cells were obtained from ATCC (Rockville, MD) and grown in 
Dulbecco’s modified Eagle’s Medium (DMEM) supplemented with 10% fetal calf serum 
(FCS).  KOS/EGFP specifies the enhanced green fluorescence protein (EGFP) from a 
CMV-EGFP gene cassette inserted within the intergenic region between the UL53 and 
UL54 open reading frames (ORFs)  (Foster, Chouljenko, and Kousoulas, 1999).  In order 
to facilitate visualization of syncytia formation, recombinant viruses amb1511/EGFP, 
MP/EGFP, and tsB5/EGFP were constructed by insertion of a CMV-EGFP gene cassette 
as described in detail previously for the KOS/EGFP virus  (Foster, Chouljenko, and 
Kousoulas, 1999). All viruses were propagated on Vero cells.  
Construction of Expression Plasmids 
 Plasmid p9-2080 specifies a wild type (wt) copy of gB; whereas, plasmids p9-
1511, p9-1513, p9-1528, p9-1537 specify carboxyl-terminally truncated gB driven by the 
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Adenovirus Major Late Promoter (Ad MLP) and were as described previously  (Baghian 
et al ., 1993). The entire open reading frames (ORFs) for gB and gD were amplified by 
PCR with specific primers that removed the 3´ stop codon such that the genes were 
inserted in frame with a V5 epitope tag when ligated to pcDNA3.1 TA TOPO to generate 
plasmids pCMV-gB and pCMV-gD.  Truncations in gB were generated by PCR.  
Plasmids gB(∆36), gB(∆28), gB(∆16),  express C-terminally truncated derivates of gB of 
36, 28, and 16 amino acids (aa) respectively.  A gB gene specifying a single codon 
change from alanine to proline at amino acid 874 was produced by splice-overlap 
extension (SOE) PCR utilizing synthetic oligonucleotides containing the point mutation.  
The PCR derived gB(A874P) was ligated into pcDNA3.1 TA TOPO to generate plasmid 
pCMV-gB(A874P). All plasmid inserts were sequenced by Sanger dideoxy-chain 
termination methodology using an automated DNA sequencer (PE Biosystems, 377 
Sequencer). Plasmid pcDNA3 gHgL were kindly provided by A. Minson.   
Cell Fusion Assay 
 In vitro cell fusion assays were performed essentially as described previously  
(Klupp, Nixdorf, and Mettenleiter, 2000; Muggeridge, 2000; Turner et al., 1998). Briefly, 
the day prior to transfection, 35 mm 6 well plates were seeded with 8 x 104 COS7 cells.  
A total of 6 µg of plasmid DNA encoding the indicated glycoproteins was transfected 
with Superfect (Qiagen, Valencia CA) according to the manufacturer’s directions.  Three 
hours post-transfection, media was aspirated and cells were overlaid with DMEM 5% 
FCS.  Where indicated, heparin (10mg/ml) was included in the overlay media.  Twenty-
four hours post transfection, cells were overlaid with 4 x105 freshly trypsinized COS7 
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cells per well with or without the inclusion of heparin.  Cells were subsequently 
incubated at 37°C for an additional 12 hours before levels of fusion were determined. 
Immunofluorescence Assay and Quantitation of Fusion 
 Cells were fixed with 100% methanol for 10 minutes, washed twice with TBS, 
and incubated at room temperature for 1 hour with the primary antibody anti-V5 
(Invitrogen, Carlsbad, CA) diluted 1:200 in TBS-10% goat serum.   Cells were then 
washed three times with TBS and incubated for one hour at room temperature with FITC 
conjugated goat anti-mouse IgG (Sigma, St. Louis, MO) diluted 1:100 in TBS-10%goat 
serum.  After incubation, excess antibody was removed by washing three times with 
TBS.  Propidium iodide nuclear counterstain (Molecular Probes, Eugene, OR) was 
applied in order to facilitate quantitation of fusion.  Fusion was examined on a Nikon 
Diaphot inverted fluorescent microscope.  The number of nuclei in 100 transfected cells 
or polykaryocytes per well was determined by two independent observers. Transfected 
cells were defined as those cells that were IFA positive.  Average values and standard 
deviations were then calculated from the combined data obtained by the two observers.  
Percent change in levels of fusion over wild-type (wt) gB was calculated by the formula 
[(average nuclei mutated gB)-(average nuclei wt gB)]/ (average nuclei wt gB) x 100%. 
Percent inhibition of fusion by heparin was defined as {[(average nuclei of untreated 
assay)-1]-[(average nuclei of heparin treated assay)-1]}/ [(average nuclei of untreated 
assay)-1] x 100%.   
Heparin Inhibition of Viral Polykaryocyte Formation 
 Subconfluent Vero cells were infected at an MOI of 0.1 for 1 hour and 
subsequently overlaid with DMEM-2% FCS, 1% methylcellulose either lacking or 
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containing heparin (10mg/ml). The amount of heparin used in the virus-free fusion 
inhibition experiments was chosen on the basis of being the amount required to inhibit 
virus-induced cell fusion. Lower amounts of heparin (1 mg/ml instead of 10 mg/ml), 
effectively inhibited virus-free fusion caused by wild type gB. Viral plaques were 
visualized by phase-contrast and fluorescent microscopy at 24 hours post infection. 
RESULTS 
The Effect of gB Truncations on Virus-Independent Cell Fusion 
 Previously, we investigated the effect of several gB truncations on virus-induced 
cell fusion. We found that a recombinant virus expressing a 28 amino acid truncated gB 
resulted in extensive virus-induced cell fusion (Baghian et al., 1993). A schematic of the 
predicted structure of the carboxyl terminus of gB showing the location of relevant 
truncations and mutations is shown in figure 2.1. The 28 amino acid deletion of gB 
disrupts the predicted α-helical structure H17b composed of 16 amino acids. To assess 
whether these gB truncations caused similar effects in a virus-independent cell fusion 
assay, we transfected COS7 cells with plasmids constitutively expressing glycoproteins 
gD, gH and gL in the presence of different mutated gB (Fig. 2.2). The extent of cell 
fusion was quantified by counting nuclei in 100 polykaryocytes per assay by two 
independent observers (Fig. 2.3, Table 2.1). As shown previously, transient expression of 
full-length, wild-type gB, gD, gH, and gL genes under the human cytomegalovirus 
immediate early promoter (CMV-IE) caused limited polykaryocyte formation (Turner et 
al., 1998) (Fig. 2.2A). Similar numbers of polykaryocytes were formed when the CMV-
IE driven gB gene was substituted with plasmid p9-2080 expressing gB under the 
adenovirus major late promoter (Ad-MLP). (Fig. 2.2B). Transfection controls that did not
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Figure 2.1: Schematic diagram of the carboxyl terminus of HSV-1 gB. The predicted 
secondary structure of the gB carboxyl terminal 109 amino acids is shown as described 
previously (Baghian et al., 1993; Pellett et al., 1985). The location of the gB truncations 
and mutations specified by plasmids p9-1513, p9-1528, p9-1511, pCMV-gB(∆28), 
pCMV-gB(∆36), pCMV-gB(A874P), pCMV-gB(∆16), pCMV-gB(syn3) are shown. The 
symbol ∆ followed by a number indicates the number of amino acids deleted from the 
carboxyl terminus of gB. The location of the two predicted α−helices H17a and H17b are 
shown and marked by dashed lines.  
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Figure 2.2: Truncation of the carboxyl terminal 28 amino acid of gB causes 
extensive fusion of transfected Cos cells.  Cells were transfected with plasmids 
expressing gD, gH/gL, and  plasmid A: pCMV-gB, B: p9-2080, C: p9-1537, D: p9-1513, 
E: p9-1528, F: p9-1511. Transfected cells were visualized by IFA at 36 hours after 
transfection (65X magnification). 
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Figure 2.3:  Quantitation of the effect of gB truncation on fusion of transfected Cos 
Cells. Nuclei in 100 IFA positive cells per assay were counted by two observers and the 
average values and standard deviation were calculated.  
 
 
Table 2.1: Truncation of the carboxyl terminal 28 amino acid of gB causes extensivc 
fusion of transfected Cos cells. 
 
Plasmids Transfected
(all include gD, gHgL) gB 2080 1537 1528 1513 1511
Total nuclei counted 1838 1561 444 888 762 4460
Average nuclei 9.19 7.81 2.22 4.44 3.81 22.30
Standard Deviation 6.98 6.58 1.92 4.32 2.58 20.21
Standard Error 0.49 0.47 0.14 0.31 0.18 1.43
Median 8 6 2 3 3 16
Smallest # of nuclei 1 1 1 1 1 1
Largest # of nuclei 51 52 17 34 15 129
% change from gB - -15.1% -75.8% -51.7% -58.5% 142.7%
 104 
include gB failed to cause any cell fusion (data not shown). Similarly, inclusion of p9-
1537 in the transfection fusion assay failed to cause any cell fusion (Fig. 2.2C). Plasmid 
p9-1537 specifies gB containing an internal, in-frame truncation spanning amino acids 
130-697. This deletion causes rapid degradation of the gB product (Baghian et al., 1993). 
All gB mutants, which modified H17b used in these experiments expressed high levels of 
gB and similar amounts of gB were detected on cell surfaces by immunofluorescence 
against paraformaldehyde fixed transfected cells (Baghian et al., 1993; data not shown). 
Transfection with p9-1511 caused more than 2-fold increase in cell fusion in comparison 
to wild-type gB (Fig. 2.2F, Table 2.1). An identical truncation of 28 amino acids in gB 
specified by mutant virus amb1511 caused extensive cell fusion (Baghian et al., 1993). 
Interestingly, transfection of the 1511(gB∆28) plasmid mixture resulted in fusion of the 
entire cell monolayer (8 x 106 cells) within 48-72 hours after transfection (data not 
shown). 
 Transfections with p9-1513 or p9-1528 specifying gB truncations of 64 and 49 
amino acids, respectively, both of which disrupt the predicted α-helical region H17a, 
caused substantially less cell fusion (approximately 50% reduction) than that of the wild-
type gB gene (Fig. 2.2 D, E, Table 2.1). Previously, we showed that gB specified by p9-
1513 and p9-1528 was not as efficiently processed through the Golgi as the gB specified 
by p9-2080 (wild type) or p9-1511 (Baghian et al., 1993). Therefore, the inability of 
these two mutant forms of gB to cause cell fusion may be due to their altered processing 
and transport to cell surfaces.  
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The Role of α-helical Domain H17b in Cell Fusion  
 The 1511 gB truncation interrupted the predicted α−helical domain H17b, 
allowing only the first half of this domain to be expressed (Fig. 2.1) (Baghian et al., 
1993; Pellett et al., 1985). To further assess the role of this domain in the transient fusion 
assay, additional mutated gB genes were constructed and tested for their ability to cause 
cell fusion. Plasmid pCMV-gB(∆36) specifies a gB truncated immediately before the 
H17b domain, while plasmid pCMV-gB(∆16)  specifies gB truncated after the H17b 
domain (Fig. 2.1).  The gB(∆16) truncation produced fusion similar to wild-type gB (Fig. 
2.4A, C). In contrast, gB(∆36) caused similar levels of cell fusion to gB(∆28) (Fig. 2.4: 
D, E). To evaluate the role of the predicted α-helical structure of the H17b domain in cell 
fusion, a single amino acid replacement was engineered into the H17b domain by 
replacing alanine 874 with proline, causing disruption of the predicted α−helical structure 
(Fig. 2.1). Expression of gB(A874P)  produced cell fusion similar to gB(∆28) and 
gB(∆36) (Fig. 2.4: D, E, F). For comparative purposes, we tested the ability of gB 
specified by syncytial mutant HFEM(tsB5), referred to as gB(syn3), which contains a 
missense syncytial mutation within H17a, to cause cell fusion. Transient expression of 
the gB(syn3) gene did not increase cell fusion relative to the wild-type gB, in agreement 
with results obtained with other HSV-1 gB syncytial mutations (Turner et al., 1998)  
(Fig. 2.4: A, B). Polykaryocyte formation was quantified by counting propidium iodide 
stained nuclei as explained earlier. Results are summarized in Table 2.2A. 
The Effect of Heparin on gB-Mediated Cell Fusion 
 Heparin is a potent inhibitor of virus penetration as well as gB-mediated (syn3) 
virus induced cell fusion (Gruenheid et al., 1993; Herold et al., 1994; Herold et al., 1991; 
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Figure 2.4: gB-H17b-targeted mutations enhance fusion of transfected Cos cells. 
Cells transfected with plasmids expressing gD,  gH/gL, and A: gB, B: gB(syn3), C: 
gB(∆16), D: gB(∆28), E: gB (∆36), and F: gB (A874P). Transfected cells were visualized 
by IFA at 36 hours after transfection at 65X magnification. 
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Figure 2.5: gB-H17b-targeted mutations confer resistance to heparin inhibition of 
cell fusion. Cells transfected with plasmids expressing gD,  gH/gL, and A: gB, B: 
gB(syn3), C: gB(∆16), D: gB(∆28), E: gB (∆36), and F: gB (A874P). Cells were 
incubated in the presence of heparin. Transfected cells were visualized by IFA at 36 
hours after transfection at 65X magnification. 
 108 
 
 
 
 
gB gB (syn3) gB (∆16) gB (∆28) gB (∆36) gB (A874P)
Plasmids Transfected (all include gD, gHgL)
N
uc
le
i p
er
 T
ra
ns
fe
ct
ed
 C
el
l
 
 
 
 
 
 
Figure 2.6: Quantitative comparison of fusion of transfected cells in the presence 
and absence of heparin. Cell fusion represented in figure 4 (without heparin) and figure 
2.5 (with heparin) was quantitated as described in the legend of figure 3.  
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Table 2.2A: gB-H17b-targeted mutations enhance fusion of transfected Cos cells. 
 
 
Plasmids Transfected
(all include gD, gHgL) gB gB(syn3) gB(∆16) gB(∆28) gB(∆36) gB (A874P)
Total nuclei counted 2035 2340 2232 4146 4332 4000
Average nuclei 10.18 11.7 11.16 20.73 21.66 20
Standard Deviation 6.93 8.61 7.81 15.62 17.36 14.33
Standard Error 0.49 0.61 0.55 1.1 1.23 1.01
Median 9 11 10 17 18 18
Smallest # of nuclei 1 1 1 1 1 1
Largest # of nuclei 41 44 47 92 99 80
% Increase over wt gB - 14.9% 9.6% 103.6% 112.8% 96.5%  
 
 
 
Table 2.2B: gB-H17b-targeted mutations confer resistance to heparin inhibition of 
cell fusion.  
 
Plasmids Transfected
(all include gD, gHgL) gB gB(syn3) gB(∆16) gB(∆28) gB(∆36) gB (A874P)
Total nuclei counted 471 486 1059 3414 3397 2543
Average nuclei 2.36 2.43 5.3 17.07 16.99 12.72
Standard Deviation 1.93 2.14 5.07 10.95 14.04 9.31
Standard Error 0.13 0.15 1.1 0.77 0.99 0.66
Median 2 2 3 16 13 11
Smallest # of nuclei 1 1 1 1 1 1
Largest # of nuclei 10 14 26 55 91 50
% Inhibition by Heparin 85.2% 86.6% 57.7% 18.6% 22.6% 38.3%
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Shieh et al., 1992; WuDunn and Spear, 1989). Transfected cell monolayers were 
incubated either in the presence or absence of heparin (10 mg/ml). Cell fusion was 
visualized through fluorescence microscopy and the levels of observed cell fusion was 
quantified (Figs. 2.5, 2.6).  Incubation of transfected cell monolayers with heparin 
inhibited both wild-type gB and gB(syn3)-mediated cell fusion (~85% inhibition)  (Figs. 
2.4, 2.5: A, B; Table 2.2B) as previously reported for tsB5 virus-induced cell fusion 
(Seck et al., 1994). In contrast, fusion of cells expressing gB(∆28) or gB(∆36) was 
largely resistant to heparin inhibition (Figs. 2.4, 2.5: D, E). Cell fusion caused by 
gB(A874P)  was inhibited by approximately 40% in heparin treated versus untreated 
controls (Fig. 2.4, 2.5:F, Table 2.2B). Heparin inhibited fusion caused by gB(∆16) by 
approximately 58% (Figs. 2.4, 2.5: C; Table 2.2B). 
The Effect of Heparin on Virus-Induced Cell Fusion 
 Heparin was unable to fully inhibit cell fusion mediated by truncated or mutated 
gB in the transient fusion assay. Therefore, we assayed the effect of heparin on virus-
induced cell fusion caused by syncytial mutant viruses. Syncytial viruses mp(MP), 
HFEM(tsB5), and amb1511 were engineered to constitutively express EGFP as described 
previously for the construction of the KOS/EGFP virus (Foster, Chouljenko, and 
Kousoulas, 1999).  Expression of EGFP from this locus results in distinct nuclear and 
diffuse cytoplasmic fluorescence, facilitating visualization of polykaryocytes (Fig. 2.7).  
As previously reported (Seck et al., 1994), tsB5-induced cell fusion was inhibited by 
heparin (Fig. 2.7: C, D). In contrast fusion caused by mp(MP), which contains the syn1 
mutation in glycoprotein K (gK) was not inhibited by heparin (Fig. 2.7: G, H). Similar to 
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the results obtained in the transient fusion assay, cell fusion caused by mutant virus-
amb1511/EGFP was resistant to heparin inhibition (Fig. 2.7: E, F). 
DISCUSSION 
 Studies on the role of individual viral glycoproteins in virus entry as well as virus-
induced cell fusion are hampered by the fact that multiple glycoproteins and proteins are 
involved in both processes. In this regard, the established model system for virus-
associated membrane fusion phenomena via transient co-expression of gB, gD, and 
gH/gL represents a reasonable model system to investigate individual glycoprotein 
functions. However, it is important to compare virus-induced cell fusion and virus-free 
fusion systems to ensure that functional aspects of glycoproteins expressed in the 
transfection fusion system represent glycoprotein functions manifested in the context of 
the viral genome. Our investigations produced the following conclusions. First, we show 
that the predicted α−helical domain H17b within the carboxyl-terminus of gB is involved 
in both virus-induced and virus-free fusion systems. Second, heparin is a specific 
inhibitor of gB-mediated fusion in both systems. Third, resistance to heparin inhibition of 
gB-mediated cell fusion is associated with the predicted α−helical structure H17b. Thus, 
gB-mediated fusion is functionally similar for both fusion assays. 
 Previously, our laboratory showed that truncating gB by 28 amino acids produced 
wild type levels of mature gB and caused extensive virus-induced cell fusion (Baghian et 
al., 1993), while a truncation of 41 amino acids did not affect virus replication and failed 
to cause cell fusion (Huff et al., 1988). It was proposed that the α-helical domain H17b, 
which was interrupted by the 28 amino acid truncation, must be involved in virus-induced 
cell fusion (Baghian et al., 1993). Co-expression of the 28 amino acid truncated gB 
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Figure 2.7: Cell fusion caused by viruses specifying H17b mutated gB is resistant to 
heparin inhibition.  Vero cells were infected at an MOI of 0.1 with KOS/EGFP (A, B), 
tsb5/EGFP (C, D), amb1511/EGFP (E,F) and MP/EGFP (G, H) in the presence (B, D, F, 
H) or absence (A, C, E, G) of heparin. Infected cells were visualized by fluorescence 
microscopy (65X magnification). 
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specified by plasmid p9-1511 with gD, and gH/gL caused extensive cell fusion as 
evidenced by the formation of large-size polykaryocytes. The extent of the fusion 
occurring after cotransfection of glycoprotein genes containing the truncated gB was 
similar to virus-induced cell fusion caused by mutant viruses expressing the gB(syn3) or 
gB(∆28). Ultimately, transfection of Cos cells led to fusion of the entire cell monolayer 
of up to 5 x 106 cells into a single syncytium within 48 to 72 hours. Clearly, the 28 amino 
acid gB deletion functioned similarly in both the virus-induced cell fusion and virus-free 
transfection fusion assay.  Three conclusions can be made based on these results. First, 
the ability of truncated gB to cause extensive cell fusion in the transfection fusion assay 
provides further evidence that certain gB functions can be manifested in the absence of 
productive viral replication. Secondly, the truncated gB's ability to extensively fuse 
membranes requires only the presence of co-expressed gD and gH/gL glycoproteins. 
Thirdly, the domains of gB that are responsible for this extensive cell fusion phenotype, 
in both virus-induced and virus-free transfection systems, are located in the carboxyl-
terminus of gB. 
 In agreement with our previous results, which implicated the H17b α-helical 
domain in virus-induced cell fusion, we found that deletion of the entire H17b domain or 
substitution of a single proline within the H17b helical domain caused extensive cell 
fusion as evidenced by the formation of large-size polykaryocytes. The ability of the two 
gB truncations and the single proline residue substitution to cause extensive cell fusion 
indicates that the predicted α−helical structure H17b serves as a major determinant for 
membrane fusion. All gB mutants, which disrupted the predicted α-helical domain H17 b 
either by truncation or the proline substitution did not affect gB synthesis or transport to 
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cell surfaces as evidenced by immunofluorescence against transfected cells fixed with 4% 
paraformaldehyde (not shown). Therefore, the ability of these mutant gB forms to cause 
cell fusion is largely due to their specific gB mutations.  H17b is located immediately 
adjacent to the predicted 31 amino acid-long α-helix, H17a, within which multiple 
syncytial mutations have been mapped (Bzik et al., 1984a; Gage, Levine, and Glorioso, 
1993). However, syncytial mutations within H17a and H17b can be functionally 
differentiated with respect to their ability to cause membrane fusion in the transfection 
fusion system. The syn3 mutation within H17a failed to enhance fusion in the transfection 
fusion assay. In contrast, both the 36 and 28 amino acid truncations as well as the proline 
substitution affecting H17b readily caused extensive cell fusion. The most plausible 
explanation for these results is that H17b functions as an independent fusion domain 
regulator. Partial or full inactivation of this domain confers the ability on gB to cause 
extensive cell fusion. Furthermore, fusion associated with this domain requires the 
presence of only gD and gH/gL. In contrast, the H17a domain must require additional 
viral proteins expressed during viral infection. Truncations and mutations in the gH 
carboxyl terminus have been shown to inhibit cell fusion implying that the carboxyl-
terminus of gH is also involved in membrane fusion (Browne, Bruun, and Minson, 1996; 
Wilson, Davis-Poynter, and Minson, 1994). An alternative explanation of the role of the 
H17b domain in cell fusion is that the carboxyl-termini of gB and gH functionally 
interact and this interaction affects the fusogenic abilities of both gB and gH. It is worth 
noting that there is a discrepancy between trasfection fusion results obtained with HSV-1 
and HSV-2 glycoproteins, inasmuch as a syn mutation within HSV-2 gB was reported to 
enhance fusion in the transfection fusion system (Muggeridge, 2000). HSV-2 enters 
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faster into cells than HSV-1 implying the presence of an enhanced mechanism for virus-
to-cell fusion (DeLuca, 1981, Kousoulas, unpublished observations). Therefore, the 
different dynamics of HSV-1 and HSV-2 glycoprotein-mediated membrane fusion 
phenomena may account for the observed differences in fusion caused by syncytial 
mutations within HSV -1 and HSV-2 gB. Heparin is a specific inhibitor of gB-
mediated virus-induced cell fusion (Seck et al., 1994). In agreement to previous reports, 
we confirmed that heparin specifically inhibited fusion caused by syncytial mutant 
HFEM (tsB5), while it did not inhibit fusion caused by mutants with syncytial mutations 
in gK. Heparin is known to predominantly bind to gC and secondarily to gB (Herold et 
al., 1994; Herold et al., 1991; Laquerre et al., 1998; Spear et al., 1992). The binding sites 
of other proteins exhibiting heparin-binding activity have been mapped to dense regions 
of positively charged residues containing variable lengths of arginine-rich and/or lysine 
rich regions (Cardin et al., 1991a; Cardin et al., 1991b; Marino et al., 1999; Sendak and 
Bensadoun, 1998; Sendak et al., 2000; Wong et al., 1995). The primary sequence of gB 
contains a heparin binding site at amino acids 68 to 76 (KPKKNKKPK) in the amino 
terminus of gB. Deletion of this amino acid domain results in substantial reduction in 
heparin binding of gB (Laquerre et al., 1998).  There are additional potential heparin 
binding sites within gB at amino acid locations 158, 318, 494, 862 and 882 containing the 
consensus binding motif R/K-X-R/K. The simplest explanation for the inhibitory effect of 
heparin on gB-mediated cell fusion is that heparin physically blocks cell fusion. Heparin 
inhibited fusion in the transfection fusion system when full-copy gB, gD, and gH/gL 
were co-expressed or when transfections contained the gB(syn3)gene. However, heparin 
was unable to substantially inhibit fusion caused by truncations of gB that delete all or 
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part of the H17b α−helix. Heparin did partially inhibit fusion caused by the single Ala to 
Pro substitution, which inactivates the predicted α−helical structure of the H17b domain. 
These differences between the truncated gB and the proline substituted gB could be due 
to the more severe nature of the truncations versus the single amino acid replacement in 
that certain amino acids upstream or downstream of the proline substitution may confer 
partial susceptibility to heparin inhibition of membrane fusion.  
 We offer the following hypotheses to explain the effect of heparin on gB-
mediated cell fusion. First, truncation of gB may affect the conformation of the gB amino 
terminus resulting in the partial loss of heparin binding. Secondly, gB truncations may 
cause changes in the interaction of gB with cellular receptors, which render gB-mediated 
fusion resistant to heparin. In support of the latter hypothesis, it was shown that bovine 
herpesvirus gB interacted with two types of receptors on Madin Darby bovine kidney 
cells (MDBK), a heparan sulfate proteoglycan and an unknown high affinity receptor, 
respectively. Truncated gB retained the ability to bind heparin, but not the ability to block 
the interaction of gB with a high affinity binding receptor on MDBK cells (Li et al., 
1996). Furthermore, deletion of the carboxyl terminus of gB resulted in the loss of one 
monoclonal antibody epitope located in the amino terminal of gB, implying that the 
truncated gB had assumed an altered conformation, which was responsible for the loss of 
the binding to the high-affinity receptor (Li et al., 1996). Additional evidence that 
perturbations of the carboxyl terminus of gB may affect the conformation of the gB 
extracellular portion was provided by an Ala to Val change at position 851 within the 
syncytial region II of HSV-1 gB, which caused delayed viral entry kinetics (Gage, 
Levine, and Glorioso, 1993). 
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 Substantial differences between the virus-induced and transfection-induced fusion 
systems exist with respect to the role of heparan sulfate moieties on cell surfaces. 
Heparan sulfate enhanced virus-induced cell fusion, inasmuch as viruses with syncytial 
mutations failed to readily fuse heparan sulfate deficient cells. In contrast, fusion caused 
by transient transfection of viral glycoproteins did not require the presence of heparan 
sulfate, although it did require the presence of cell surface entry receptors specific for gD 
(Pertel et al., 2001; Shieh and Spear, 1994). Therefore, the ability of heparin to inhibit 
both virus-induced cell fusion and virus-free fusion in the transfection fusion assay must 
reflect direct inhibition of gB-associated functions and not heparin competitive inhibition 
of gB binding to heparan sulfate proteoglycans on apposed cell surfaces. Such 
interactions presumably, would strengthen interactions between plasma membranes and 
facilitate membrane fusion.  
 Heparin is known to bind to a variety of important proteins on cell surfaces and 
modulate the functions of these proteins predominantly through signal transduction 
effects to intracellular targets. However, heparin can also internalize into cells via 
specific or nonspecific receptors (Barzu et al., 1996; Heinzelmann et al., 1999; 
Letourneur, Caleb, and Castellot, 1995a; Letourneur, Caleb, and Castellot, 1995b; 
Watanabe, Haba, and Yuasa, 1995). Therefore, it is possible that endocytosed heparin 
may directly bind to the carboxyl terminus of gB at the predicted sites located at amino 
acids 862 and 882. In this scenario, resistance to heparin inhibition of cell fusion by 
truncated gB may be due to the lack of heparin binding sites, particularly the site at 
amino acid 882, which is deleted in both gB truncations. The reduced ability of heparin to 
inhibit cell fusion caused by gB(A874P) and gB(∆16) may be the result of local 
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conformational changes, which prevent binding of heparin to upstream binding sites.  
Additional experiments are needed to ascertain whether heparin readily enters into gB-
transfected cells and whether the carboxyl terminus of gB is able to bind heparin. 
 A carboxyl terminal truncation of the PRV gB enhanced both virus-induced and 
virus-free cell fusion (Klupp, Nixdorf, and Mettenleiter, 2000; Nixdorf et al., 2000).  
However, in the virus-free transfection assay cell fusion can occur in the absence of gD. 
Furthermore, a hybrid gD/gH protein composed of the extracellular portion of gD fused 
in-frame to a portion of gH, which contains the carboxyl terminus of gH including its 
membrane spanning region, functionally substituted the gH/gL heterodimer (Klupp and 
Mettenleiter, 1999; Klupp, Nixdorf, and Mettenleiter, 2000). We constructed and tested a 
similar HSV-1 gD/gH fusion protein and found that it failed to substitute for the presence 
of gD or gH/gL in the virus-free fusion system (not shown). Thus, it is clear that there are 
similarities between PRV and HSV-1 with respect to the role of the gB carboxyl terminus 
in cell fusion, but also substantial differences with respect to the functions of gD and 
gH/gL. In this regard, the apparent disparity between the two fusion systems may reflect 
fundamental differences in the functions of these proteins as well as differences in their 
interactions with cellular receptors (Nixdorf et al., 1999).  
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CHAPTER III 
 
HERPES SIMPLEX VIRUS TYPE 1 (HSV-1) GLYCOPROTEIN K 
(gK) IS REQUIRED FOR GLYCOPROTEIN B (gB)-MEDIATED 
VIRUS-INDUCED CELL FUSION, WHILE NEITHER gB AND gK 
NOR gB AND UL20p FUNCTION REDUNDANTLY IN VIRION DE-
ENVELOPMENT* 
 
 
 
INTRODUCTION 
Herpes simplex viruses specify at least eleven virally encoded glycoproteins, as 
well as several non-glycosylated membrane associated proteins that function in several 
important roles including virus entry via fusion of the viral envelope with cellular 
membranes, intracellular virion morphogenesis and egress, cell-to-cell spread, and virus-
induced cell fusion (Mettenleiter, 2002a; Mettenleiter, 2002b; Roizman and Sears, 2001; 
Spear, 2004; Spear and Longnecker, 2003).  Mutations that cause extensive virus-induced 
cell-to-cell fusion have been mapped to at least four regions of the viral genome: the 
UL20 gene (Baines et al., 1991; MacLean et al., 1991; Melancon, Foster, and Kousoulas, 
2004), the UL24 gene (Jacobson et al., 1998; Sanders, Wilkie, and Davison, 1982), the 
UL27 gene encoding glycoprotein B (gB) (Bzik et al., 1984; Pellett et al., 1985), and the 
UL53 gene coding for glycoprotein K (gK) (Bond and Person, 1984; Debroy, Pederson, 
and Person, 1985; Hutchinson et al., 1992; Pogue-Geile et al., 1984; Pogue-Geile and 
Spear, 1987; Ryechan et al., 1979).  
                                                 
* Accepted for publication in the Journal of Virology, MS # JVI01347-04 - Version 2, J. M. Melancon, R. 
E. Luna, T. P. Foster, and K. G. Kousoulas, Herpes Simplex Virus Type 1 (HSV-1) Glycoprotein K (gK) is 
Required for Glycoprotein B (gB)-mediated Virus-Induced Cell Fusion, while neither gB and gK nor gB 
and UL20p Function Redundantly in Virion De-Envelopment, with permission from the American Society 
for Microbiology. 
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The UL20 and UL53 (gK) genes encode multipass transmembrane proteins of 222 
and 338 amino acids, respectively, which are conserved in all alphaherpesviruses 
(Debroy, Pederson, and Person, 1985; MacLean et al., 1991; Ramaswamy and Holland, 
1992).  UL20p assumes a membrane topology that constitutes a mirror image of gK with 
both amino and carboxyl termini of UL20p located intracellularly, while both amino and 
carboxyl termini of gK are located extracellularly (Foster, Alvarez, and Kousoulas, 2003; 
Foster et al., 2004b; Melancon, Foster, and Kousoulas, 2004).  gK is known to be post-
translationally modified by N-linked carbohydrate addition, while UL20p is not 
glycosylated (Debroy, Pederson, and Person, 1985; Hutchinson et al., 1992; Ramaswamy 
and Holland, 1992).  UL20p and gK localize to TGN membranes after endocytosis from 
cell surfaces (Foster et al., 2004b). UL20p and gK are essential for cytoplasmic virion 
morphogenesis, since mutant viruses lacking either gK or UL20p accumulate capsids 
within the cytoplasm that are unable to acquire envelopes by budding into TGN-
associated membranes (Baines et al., 1991; Foster and Kousoulas, 1999; Foster et al., 
2004a; Fuchs et al., 1997; Hutchinson and Johnson, 1995; Jayachandra, Baghian, and 
Kousoulas, 1997; Melancon, Foster, and Kousoulas, 2004). Furthermore, UL20p is 
essential for virus-induced cell fusion caused by either gB or gK syncytial mutations 
(Foster et al., 2004a), and it is necessary for gK cell-surface expression (Foster, Alvarez, 
and Kousoulas, 2003; Foster et al., 2004a; Foster et al., 2004b), strongly suggesting that 
direct or indirect interactions between gK and UL20 are necessary for intracellular 
protein trafficking, virus egress, and virus mediated cell-to-cell fusion (Dietz et al., 2000; 
Foster, Alvarez, and Kousoulas, 2003; Foster et al., 2004a; Fuchs et al., 1997; Melancon, 
Foster, and Kousoulas, 2004).  
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Glycoprotein B (gB) is highly conserved across all subfamilies of herpesviruses. It 
exists within cells as a homodimeric type I integral membrane protein that is N-
glycosylated at multiple sites (Claesson-Welsh and Spear, 1986; Claesson-Welsh and 
Spear, 1987; Highlander et al., 1991; Laquerre, Person, and Glorioso, 1996; Roizman and 
Sears, 2001; Spear, 1993).  A variety of evidence indicates that gB plays important roles 
in membrane fusion phenomena during virus entry and virus-induced cell fusion: HSV-1 
mutant viruses lacking gB are not able to enter into cells (Cai et al., 1987) due to a post-
attachment defect that can be resolved by polyethelene glycol mediated fusion of viral 
envelopes with cellular membranes (Cai, Gu, and Person, 1988); Single amino acid 
substitutions and truncations of the carboxyl terminus of gB cause extensive virus-
induced cell fusion (Baghian et al., 1993; Bzik et al., 1984; Cai et al., 1988; Gage, 
Levine, and Glorioso, 1993); Transient co-expression of gB with gD, gH and gL causes 
cell-to-cell fusion, which is substantially increased by carboxyl terminal truncations of 
gB (Foster, Melancon, and Kousoulas, 2001; Haan, Lee, and Longnecker, 2001; Klupp, 
Nixdorf, and Mettenleiter, 2000; Pertel, 2002). These results suggest a direct role for gB 
in membrane fusion and suggest that perturbations of the carboxyl terminal domains of 
gB facilitate gB-mediated cell-to-cell fusion. 
It has been shown that syncytial mutations in gK failed to cause virus-induced cell 
fusion in the absence of gB indicating that gB was essential for gK-associated cell-to-cell 
fusion (Cai, Gu, and Person, 1988). In this paper, we utilized the HSV-1 (F) BAC system 
to generate multiple mutant viruses lacking either gK, UL20, or gB, or combinations of 
gK and gB, or UL20 and gB. Comparison of the BAC-generated insertion-deletion 
mutants in the HSV-1(F) genetic background revealed subtle but important differences in 
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individual virus phenotypes in comparison to the laboratory adapted virus strain KOS, 
most likely due to the limited passage of these viruses in cell culture. In addition, mutant 
viruses were generated carrying syncytial mutations in gB in the absence of either gK or 
UL20. Characterization of these viruses revealed that gK is necessary for gB-mediated 
virus-induced cell fusion. Concurrent deletion of either gB and gK or gB and UL20p did 
not prevent perinuclear virion de-envelopment indicating that gB and gK or gB and 
UL20p do not function redundantly in mediating fusion between the viral envelopes and 
the outer nuclear membrane.  
MATERIALS AND METHODS 
Cells and Viruses 
African green monkey kidney (Vero) cells, CV-1 cells and 293 cells were 
obtained from ATCC (Rockville, MD). Cells were maintained in Dulbecco’s modified 
Eagle medium (GIBCO-BRL; Grand Island, N.Y.), supplemented with 10% fetal calf 
serum (FCS) and antibiotics. Fd20-1 cells and D6 cells were maintained as described 
previously (Cai et al., 1987; Melancon, Foster, and Kousoulas, 2004). The UL19 and 
UL20 complementing cell line, G5, was a gift of P. Desai, (John Hopkins Medical 
Center) (Desai et al., 1993).  gKDIV5, gKsyn20DIV5, and tsB5 were as described 
previously (Foster, Alvarez, and Kousoulas, 2003; Foster, Rybachuk, and Kousoulas, 
2001).  Flp-In-CV-1 cells were maintained as directed by the manufacturer (Invitrogen; 
Carlsbad, CA). 
Plasmids 
Plasmid pcDNA5/FRT/gK was constructed by inserting the gK gene, PCR 
amplified from KOS viral DNA, into pcDNA5/FRT/V5-His-TOPO (Invitrogen).  
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Plasmid p20F2 contains a 7,185 bp HSV-1 (KOS) genomic fragment spanning the region 
comprising UL19, UL20, UL21, and UL22 and was described previously (Melancon, 
Foster, and Kousoulas, 2004).  Primers 5’CMVEGFP_20.5_BclI (5’TTCTTCTTCTTC 
TGATCATGCTGACGTAAGTAGTTATTAATAGTAATCAATTACGGGG3’) and 
3’CMVEGFP_BclI (5’CTCTTCCTCTCCTGATCAATGAGTTTGGACAAACCACA 
ACTAGA3’) were used to PCR amplify a CMV-EGFP gene cassette from pTF9200 
(Foster, Rybachuk, and Kousoulas, 1998).  The resultant PCR product was digested with 
BclI and ligated into p20F2 that was BamHI restricted and CIP treated. The resultant 
plasmid, designated p∆1920-EGFP, contained a CMV-EGFP gene cassette, which 
replaced the HSV-1 region in p20F2 contained within the BamHI sites at genomic 
positions 39234 and 41549 (Genbank accession number NC_001806), removing the 
entire UL20 ORF as well as the first 1293 bp of the UL19 ORF.  
Construction of Transformed Flp-In-CV-1 Cell Lines 
Generation of stable Flp-In-CV-1 expression cell lines was performed essentially 
as directed by the manufacturer (Invitrogen) and as described previously (Melancon, 
Foster, and Kousoulas, 2004). Confluent Flp-In-CV-1 monolayers in six well plates were 
transfected with 0.3 µg of pcDNA5/FRT/gK and 2.7 µg of pOG44 (Invitrogen), which 
expresses Flp recombinase, using Lipofectamine 2000.  After 2 weeks, hygromycin B 
(125µg/ml) resistant colonies were tested for the ability to complement the growth of 
YEbac∆gK virus.  All colonies tested complemented YEbac∆gK virus.  Isolate FcgK-1,  
derived from pcDNA5/FRT/gK transfected cells, was chosen for further use.  FcgK-1 
cells were used in generating YEbac∆gK virus stocks. 
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Construction of a Replication-Deficient Adenovirus Expressing gB 
pAd5-Blue is a replication-defective, E1/E3 deleted Ad5-containing plasmid 
(Moraes, Mayr, and Grubman, 2001).  gB was PCR amplified from HSV-1 KOS viral 
DNA using primers gB5’ClaI (5’-TCCTCCATCGATATGCGCCAGGGCGCCCCCG-
3’) and gB3’XbaI (5’-CTTCTTTCTAGATCACAGGTCGTCCTCGTCGGC-3’) and 
transferred into the unique ClaI and XbaI sites located in the E1-deleted region of pAd5-
Blue, immediately downstream of the CMV promoter, to generate pAd5-gB.  pAd5-gB 
was transfected into 293 cells in a T-25 flask with Lipofectamine 2000, according to the 
manufacturer’s directions (Invitrogen).  72 hours post-transfection, cell lysates were 
prepared by multiple freeze/thaw cycles.   A small portion of the cell lysate was then used 
to infect a subsequent flask of 293 cells.  After four passages, a high titer stock of Ad5-
gB was obtained, which was deficient for replication on Vero cells.  Ad5-gB virus at 
different MOIs was tested for its ability to complement YEbac∆gB on Vero cells, and an 
MOI of 10 was found to be optimal. 
Construction of HSV-1 Mutants with Deletions of the UL20, gB, and/or gK Genes 
Insertion-deletion mutagenesis of pYEbac102 DNA was accomplished in 
Escherichia coli using the λ gam, recE recT (GET) recombination system (Narayanan et 
al., 1999; Orford et al., 2000), as described previously for mutagenesis of the KSHV 
genome (Luna et al., 2004). Electrocompetent YEbac102 DH10B E. coli cells were 
transformed with the plasmid pGETrec, which contains the genes encoding recE, recT 
and bacteriophage λ gam, grown on plates containing chloramphenicol (12.5µg/ml) and 
ampicillin (100µg/ml). Individual colonies were picked and grown overnight in Luria-
Bertani (LB) medium containing chloramphenicol and ampicillin.  The next day, the 
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culture was inoculated into 250 ml of LB containing chloramphenicol and ampicillin until 
a 0.4 optical density was reached at 600 nm.  Addition of L-arabinose to a final 
concentration of 0.2% (w/v) and further incubation of 40 minutes induced the expression 
of the recE, recT and λ gam genes from the plasmid pGETrec.  The cells were then 
harvested and made electrocompetent.  For the ∆UL20-GFPZeo mutation, a PCR 
fragment containing a GFP-ZeocinR gene cassette flanked by ~50bp of viral sequences on 
both sides was used for recombination to construct pYEbac∆UL20, containing the GFP-
ZeocinR gene cassette within the targeted UL20 genomic region. For the ∆gB-Kan 
mutation, a PCR fragment containing a kanamycinR gene cassette flanked by ~50bp of 
viral sequences on both sides was used for recombination to construct pYEbac∆gB, 
which contained the kanamycinR gene cassette within the targeted UL27 genomic region. 
For the ∆gK-GFPZeo, a PCR fragment containing a GFP-ZeocinR gene cassette flanked 
by ~50bp of viral sequences on both sides was used for recombination to construct 
pYEbac∆gK, containing the GFP-ZeocinR gene cassette within the targeted UL53 
genomic region.  Briefly, 40µl of electrocompetent DH10B cells, harboring both 
pYEbac102 and pGETrec, were electroporated with 200ng of each PCR product to delete 
the target gene (gB, UL20, or gK) using standard electroporation parameters (1.8kV/cm, 
200Ω and 25µF).  Following electroporation, cells were grown in 1ml of LB for 60 min 
and subsequently streaked onto LB agar plates containing chloramphenicol (12.5 µg/ml) 
as well as either kanamycin (50µg/ml) or Zeocin (25µg/ml).  Mutant pYEbac102 DNA 
containing a deletion in the gB, UL20 or gK gene was isolated from bacterial colonies 
and a second round of electroporation was performed to remove the plasmid pGETrec. 
Following electroporation, cells were grown on agar plates containing chloramphenicol 
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as well as either kanamycin or Zeocin. Similar procedures were followed, starting with 
electrocompetent DH10B E. coli cells harboring pYEbac∆gB, in order to generate 
pYEbac∆gB∆gK and pYEbac∆gB∆UL20. 
Confirmation of the Targeted Mutations in pYEbac102 DNA 
HSV-1 BAC DNAs (pYEbac102, pYEbac∆gB, pYEbac∆UL20, pYEbac∆gK, 
pYEbac∆gB∆UL20, and pYEbac∆gB∆gK) were purified from 500 ml of BAC cultures 
using the Qiagen Large-Construct Kit (Qiagen; Valencia, CA).  BAC DNA was digested 
with KpnI, run on a 0.7% agarose gel, and transferred to charged nylon membranes 
(BioRAD; Richmond, CA).  Southern-blot hybridization was performed using either a 1.1 
kb kanamycin or 800 bp GFP-Zeocin PCR product labeled with biotin (New England 
Biolabs; Boston, MA). Chemiluminescence detection of the DNA was performed using 
the North2South Chemiluminescent Hybridization and Detection Kit as described by the 
manufacturer (Pierce Inc.; Rockford, IL). All mutations were sequenced to verify the 
presence of the desired mutations in the BACs.  To verify that no spurious mutations 
were introduced into the viral genome of the individual BAC mutants during mutagenesis 
or during the transfection procedure, each null mutation was rescued by homologous 
recombination with DNA fragments spanning each gene.  Each rescue virus was verified 
to have similar phenotypic and replication characteristics as the wild-type BAC, 
YEbac102. 
Transfection of HSV-1 BAC DNAs 
Transient transfection of cells with BAC DNAs was performed using 
Lipofectamine 2000 (Invitrogen). Complementing cell lines were grown to 95% 
confluency in 6 well plates.  Cells were transfected with BAC DNA mixed with 
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Lipofectamine 2000 in Opti-MEM media as recommended by the manufacturer 
(Invitrogen). After 6 hours of incubation at 37°C, the media was removed from the 
transfected cells, cells were washed with PBS, and fresh DMEM media with 10% fetal 
calf serum was added.  At 72 hours post-transfection, virus stocks were collected.   
Plaque Morphology of YEbac102 Mutants 
For plaque morphology, Vero, Fd20-1, FcgK-1 and D6 cells were infected at 
MOIs of 0.01 and 0.001 with the YEbac102, YEbac∆gB, YEbac∆UL20, YEbac∆gK, 
YEbac∆gB∆gK and YEbac∆gB∆UL20 viruses and visualized by immunohistochemistry 
at 48 hpi utilizing HRP conjugated anti-HSV antibodies (DAKO) and Novared 
(VectorLabs) substrate development.  For complementation of YEbac∆gB∆gK and 
YEbac∆gB∆UL20 viruses, Fd20-1 and FcgK-1 were infected with Ad5-gB at an MOI of 
10, 1 hour prior to HSV-1 infection.  Due to the constitutive expression of gB in all cells, 
plaques were visualized by immunohistochemistry at 48 hpi utilizing an anti-gD mAb 
(RG-1103; Rumbaugh-Goodwin Institute; Plantation, FL) with the Vectastain Elite ABC 
kit and Novared substrate development kit (VectorLabs; Burlingame, CA) according to 
the manufacturer’s directions and as described previously (Foster, Alvarez, and 
Kousoulas, 2003; Foster et al., 2004a).   
One-step Growth Kinetics of YEbac102 Mutants 
Analysis of one-step growth kinetics was as described previously (Foster, 
Alvarez, and Kousoulas, 2003; Foster, Rybachuk, and Kousoulas, 2001).  Briefly, each 
virus at an MOI of 5 was adsorbed to approximately 6x105 Vero cells at 4°C for 1 h.  
Thereafter, pre-warmed media was added and virus was allowed to penetrate for 2 hours 
at 37°C.  Any remaining extracellular virus was inactivated by low-pH treatment (0.1M 
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glycine, pH 3.0).  Cells and supernatants were harvested immediately thereafter (0 h) or 
after 4, 9, 16, 20 or 24 h incubations at 37° C. Virus titers were determined by end point 
titration of virus stocks on a complementing cell line. 
Generation of Recombinant UL20-null and gK-null Viruses Specifying Mutant gB 
In order to generate recombinant viruses specifying mutations in gB, PCR-
amplification of the UL27 region was performed from purified viral DNA of YEbac102 
(wt gB), tsb5 (gBsyn3), or amb1511 (gBamb1511).  Each PCR product was used for 
homologous recombination with both the Yebac∆gB∆UL20 and YEbac∆gB∆gK viruses. 
Virus plaques that formed on Fd20-1 (UL20 complementing) or FcgK-1 (gK 
complementing) cells were picked and sequentially plaque-purified at least five times.  
Replacement of the gB-null resident kanamycin cassette and the concomitant insertion of 
the specific mutant gB gene were confirmed by DNA sequencing. 
Generation of UL19 and UL20 Double-Null Viruses 
Viruses that contained a CMV-EGFP gene cassette in place of a UL19/ UL20 
gene deletion were generated by homologous recombination with plasmid p∆1920-EGFP 
and the parental viruses gKDIV5, gKsyn20DIV5, or tsB5 (gBsyn3).  G5 cells were 
transfected with p∆1920-EGFP and 6h post transfection (hpt) were infected at an MOI of 
0.1 with either gKDIV5, gKsyn20DIV5, or tsB5 (gBsyn3) to generate UL19 and UL20 
double-null viruses that were designated ∆1920, ∆1920-syn20 and ∆1920-syn3, 
respectively. Viruses were subsequently plaque isolated on G5 cells by fluorescence 
microscopy and sequentially plaque purified at least five times. Insertion of the CMV-
EGFP gene cassette and the concomitant deletion of the UL19 and UL20 genes were 
confirmed by diagnostic PCR and DNA sequencing. 
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Electron Microscopy 
Cell monolayers were infected with the indicated virus at an MOI of 3. All cells 
were prepared for TEM examination 24 hpi. Infected cells were fixed in a mixture of 2% 
paraformaldehyde and 1.5% glutaraldehyde in 0.1M NaCaC buffer, pH 7.3.  Following 
osmication (1% OsO4) and dehydration in an ethanol series, the samples were embedded 
in Epon-Araldyte resin and polymerized at 70ºC.  Thin sections were made on an MTXL 
Ultratone (RMC Products), stained with 5% uranyl acetate and CNA lead, and observed 
with a Zeiss 10 transmission electron microscope as described previously (Foster et al., 
2004a; Melancon, Foster, and Kousoulas, 2004). 
RESULTS 
Construction of the HSV-1 BACs pYEbac∆gB, pYEbac∆UL20, pYEbac∆gK, 
pYEbac∆gB∆UL20, and pYEbac∆gB∆gK 
 
The complete HSV-1(F) genome was recently cloned into a bacterial artificial 
chromosome (pYEbac102) enabling the genetic manipulation of the HSV-1 genome in E. 
coli. (Tanaka et al., 2003). The BAC-based GET homologous recombination system was 
utilized to construct deletions within the gB, UL20 and gK genes in E. coli.  Deletion of 
each gene was accomplished by targeting the gB, UL20 or gK open reading frames 
(ORFs) using specific primers as detailed in the Materials and Methods section.  For 
construction of the ∆UL20-GFPZeo mutation, primers A and B were used for 
homologous recombination and positioned to remove a 353 bp region of the UL20 gene 
upon insertion of a GFP-Zeocin gene cassette (Table 3.1; Fig. 3.1 B, C), extending from 
the UL20 ATG to a HpaI site inside the UL20 ORF.  Inactivation of the gB gene was 
achieved by insertion of a kanamycin gene cassette within gB (∆gB-Kan mutation). 
Specifically, primers C and D were designed to remove a 970 bp fragment starting with 
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gB ORF nucleotide 1655 upon homologous recombination with pYEbac102 (Table 3.1; 
Fig 3.1 B, C). This gB deletion does not disrupt the UL27.5 ORF overlapping the 5’ end 
of gB (Chang et al., 1998) and is similar to that of the K∆T gB-null virus (Cai et al., 
1987), with the exception that the ∆gB-Kan mutation was constructed to include a stop 
codon at the 5’ end of the kanamycin cassette ensuring that no aberrant proteins could be 
made via a translational read-through of the kanamycin gene cassette.  For construction 
of the ∆gK-GFPZeo mutation, primers E and F were positioned to delete almost the 
entire gK gene (941 bp) without affecting the proximal UL52 gene, which partially 
overlaps with the gK ORF (Table 3.1; Fig 3.1 B, C).  Each pYEbac102 mutant construct 
contains one or more of the insertion-deletion mutations mentioned above:  pYEbac∆gB 
contains the ∆gB-Kan mutation; pYEbac∆UL20 contains the ∆UL20-GFPZeo mutation; 
pYEbac∆gK contains the ∆gK-GFPZeo mutation; pYEbac∆gB∆UL20 contains both the 
∆gB-Kan and the ∆UL20-GFPZeo mutations; and pYEbac∆gB∆gK contains both the 
∆gB-Kan and the ∆gK-GFPZeo mutations. 
The YEbac102 viral constructs were tested for the presence of the engineered 
insertion-deletion mutation via diagnostic PCR. Primers a and b (Table 3.1; Fig 3.1A), 
located outside of the UL20 gene, amplified the predicted 909 bp diagnostic UL20 DNA 
fragments from BACs that contain wt UL20, while a predicted 2,469 bp product was 
produced from BACs that contain the ∆UL20-GFPZeo mutation (Fig. 3.2A, panel i). 
Primers c and d (Table 3.1; Fig 3.1A) located within gB but outside the deleted region 
amplified the predicted 2,127 bp diagnostic gB DNA fragment from BACs that contain 
wt gB, while a predicted 2,261 bp product was produced from BACs that contain the 
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 Table 3.1: Synthetic Oligonucleotide Primers 
 
Designation Name
A 3' UL20-GFPZeo 5'-CACGGACATCCCCCAAAACACGGGCGCCGACAACGGCA 
GACGATCCCTCTTGATGTTagacatgataagatacattgatgagtttgg-3'
B 5' UL20-GFPZeo 5'-CTGACGTAAGCGACCCTTTGCGGTTTCGGTCTCCCCACCT 
CCACCGCACACCCCgtccgttacataacttacggtaaatgg-3'
C 3' gB-Kan 5'-GTTGGGAACTTGGGTGTAGTTGGTGTTGCGGCGCTTGCGC 
ATGACCATGTCcggttgatgagagctttgttgtaggtggac-3'
D 5' gB-Kan 5'-CTGACCCTGTGGAACGAGGCCCGCAAGCTGAACCCCAAC 
GCCATCGCCTCGTGAccacgttgtgtctcaaaatctctgatgtta-3'
E 5' gK-GFPZeo 5'-AGCACCTCTCAACCGTCGTCTTGATAACGGCGTACGGCCT 
CGTGCTCGTGTGGTGAgtccgttacataacttacggtaaatgg-3'
F 3' gK-GFPZeo 5'-CAGTTTCCAATTTGCATATGCCGTTACGGTTTCCGCCGGCC 
TGGATGTGACGagacatgataagatacattgatgagtttgg-3'
a UL20-Rev 5'-GAAGGCTGCGGCCTCGTTCCAG-3'
b UL20-For 5'-ACGGCCTTATCAAAACACTCGCCTC-3'
c gB-Rev 5'-TCACAGGTCGTCCTCGTCGGC-3'
d gB-For 5'-GTGATCGACAAGATCAACGCCAAGG-3'
e gK-For 5'-GGCACGCCATGGTCGCCGTCCGTTCCCTGC-3'
f gK-Rev 5'-ATCACATACCCCGTTCCGCTTCCG-3'
* For GET recombination primers, the region homologous to HSV-1 DNA is upper case, and the region which binds to the marker gene is lower case
Diagnostic PCR for wt gB (2127 bp)        
or ∆gB-Kan (2261 bp)
Diagnostic PCR for wt gK (1265 bp)        
or ∆gK-GFPZeo (2238 bp)
UL20 GET recombination   (2025 bp)
gB GET recombination       (1209 bp)
gK GET recombination       (2022 bp)
Diagnostic PCR for wt UL20 (909 bp)     
or ∆UL20-GFPZeo (2469 bp)
Primer
Primer sequence* Purpose and product size
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Figure 3.1: Schematic of the strategy for the construction of pYEbac102 mutant 
BACs. (A) The top line represents the prototypic arrangement of the HSV-1 genome with 
the unique long (UL) and unique short (US) regions flanked by the terminal repeat (TR) 
and internal repeat (IR) regions. (B) Shown below are the expanded genomic regions of 
the UL20, UL27, and UL53 ORFs as well as the approximate locations of the sites where 
insertion of the marker genes was targeted and the primers used in diagnostic PCR to 
confirm the presence of each mutation. (C) PCR fragments containing the kanamycin or 
GFP-Zeocin gene cassette flanked by ~50 bp of viral sequences on both sides were used 
for targeted GET recombination in E.coli to construct pYEbac102 mutant BACs with 
insertion-deletion mutations in the UL20, UL27, and/or UL53 ORFs.  The approximate 
location of the primers used in amplification of each PCR fragment are also shown. 
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∆gB-Kan mutation (Fig. 3.2A, panel iii).  Primers e and f (Table 3.1; Fig 3.1A) located 
outside of the gK deletion region amplified a 1,265 bp diagnostic gK DNA fragment 
from BACs that contain wt UL20, while a predicted 2,238 bp product was produced from 
BACs that contain the ∆gK-GFPZeo mutation (Fig. 3.2A, panel ii). 
Further confirmation of the genetic content of the pYEbac102 mutant constructs 
was obtained via restriction endonuclease fragment analysis (Fig. 3.2B) and Southern-
blotting (Fig. 3.2C, D). Restriction enzyme analysis of pYebac102, pYEbac∆gB, 
pYEbac∆UL20, pYEbac∆gK, pYEbac∆gB∆UL20 and pYEbac∆gB∆gK DNA with KpnI 
produced a similar genomic DNA restriction pattern with a few exceptions caused by the 
specified alterations of gB, UL20 and gK containing KpnI DNA fragments. First, the 
4,701 bp band containing the UL27 (gB) ORF increased in size by 134 bp to 4,835 bp for 
pYEbac∆gB, pYEbac∆gB∆UL20 and pYEbac∆gB∆gK as a result of the ∆gB-Kan 
mutation.  This 4,835 bp KpnI DNA fragment (demarcated by a black arrow) was visible 
in the lanes labeled with the above mentioned constructs appearing between the predicted 
4,680 bp and 4959 bp KpnI DNA fragments (Fig. 3.2B).  In addition, Southern blot 
analysis revealed that a kanamycin gene cassette probe hybridized to a single 4,835 bp 
KpnI DNA fragment contained only in pYEbac∆gB, pYEbac∆gB∆UL20 and 
pYEbac∆gB∆gK restriction digests (indicated by a black arrow) (Fig. 3.2C), indicating 
that the ∆gB-Kan mutation had been successfully transferred into a single genomic site. 
Second, the wild-type 9,432 bp KpnI DNA fragment containing the UL20 ORF increased 
in size by 1,560 bp to 10,992 bp for pYEbac∆UL20 and pYEbac∆gB∆UL20. It is 
apparent that the 9,432 bp band is missing in pYEbac∆UL20 and pYEbac∆gB∆UL20, as 
indicated by a gray arrow (Fig. 3.2B). However, the 10,992 bp KpnI DNA fragment is
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Figure 3.2: Genomic analysis of pYEbac102 mutants. (A) Diagnostic PCR to confirm 
the insertion of the relevant gene cassettes in place of the deleted genomic regions in 
UL20 (A, panel i) UL27 (gB) (A, panel ii), and UL53 (gK) (A, panel iii).  (B) KpnI 
restriction fragment analysis of pYEbac102 mutant BACs in comparison to the wild-type 
pYEbac102. The black arrow demarcates the position of the KpnI DNA fragment altered 
by the ∆gB-Kan mutation, while the gray arrow points to the missing 9,432 bp fragment 
resulting from the ∆UL20-GFPZeo mutation. (C, D) Southern-blot analysis of 
pYEbac102 mutant BACs. The KpnI restricted BACs from Figure 2B were hybridized 
with either a kanamycin (C) or GFP-Zeocin (D) biotinylated probe.  The biotinylated 
kanamycin probe hybridized to an estimated 4,835 bp DNA fragment in pYEbac∆gB, 
pYEbac∆gB∆gUL20 and pYEbac∆gB∆gK DNA, which was absent in the wild-type 
pYEbac102 DNA (indicated by a black arrow in panel C).  The biotinylated GFP-Zeocin 
probe identified a predicted 10,992 bp DNA fragment (gray arrow) in pYEbac∆UL20 and 
pYEbac∆gB∆gUL20 DNA corresponding to the ∆UL20-GFPZeo mutation, and a 
predicted 8,956 bp fragment (white arrow) in pYEbac∆gK and pYEbac∆gB∆gK DNA 
corresponding to the ∆gK-GFPZeo mutation (D). 
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not easily identifiable due to the presence of a KpnI genomic fragments with predicted 
sizes of 10,837 and 11,024 bp. The 10,992 bp DNA fragment contains the ∆UL20-
GFPZeo mutation, which was confirmed by probing the corresponding blot with a GFP-
Zeocin probe (Fig. 3.2D, gray arrow). The GFP-Zeocin  probe hybridized to unique DNA 
fragments of the predicted sizes for both pYEbac∆UL20 and pYEbac∆gB∆UL20. 
Finally, the ∆gK-GFPZeo mutation is predicted to increase in size of the wild-type 7,983 
bp DNA fragment containing the UL53 (gK) ORF by 973 bp to 8,956 bp. These DNA 
fragments were not readily discernible in the ethidium bromide stained restriction profile 
(Fig. 3.2A). However, the GFP-Zeocin probe hybridized to the 8,956 bp DNA fragment 
(white arrow) in pYEbac∆gK and pYEbac∆gB∆gK confirming the creation of the ∆gK-
GFPZeo mutation (Fig. 3.2C). Again, the presence of a single DNA fragment detected by 
the GFP-Zeocin probe indicates the absence of any spurious insertions. 
Generation of Infectious Virus from pYEbac102-Based Constructs  
 To generate virus stocks from the mutant pYEbac102 constructs, transient 
transfection of individual BAC DNAs was performed into specific cell lines transformed 
with either the gB, UL20 or gK gene and capable of complementing the resultant viruses.  
Specifically, pYEbac102 was transfected into Vero cells, pYEbac∆gB into gB 
complementing D6 cells (Cai et al., 1987), pYEbac∆UL20 into UL20 complementing 
Fd20-1 cells (Melancon, Foster, and Kousoulas, 2004), and pYEbac∆gK into FcgK-1 
cells. The FcgK-1 cell line constitutively expresses gK gene under the CMV IE promoter 
and was constructed to efficiently complement the ∆gK-GFPZeo mutation and minimize 
the chance for generation of wild-type viruses via recombination with the endogenous gK 
gene (see Materials and Methods).  For all transfection experiments, virus plaques 
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became visible 72 hours post transfection and virus stocks were collected at appropriate 
points exhibiting maximum cytopathic effects. 
 For complementation of the double-null viruses produced by transfection of 
pYEbac∆gB∆UL20 and pYEbac∆gB∆gK, the replication-deficient adenovirus Ad5-gB 
was constructed, which constitutively expresses gB under the CMV-IE promoter (see 
Materials and Methods).  A series of experiments were performed to assess the optimum 
MOI of this virus that could maximize complementation of gB-null viruses. These 
experiments showed that Ad5-gB at an MOI of 10 efficiently complemented gB-deficient 
viruses (not shown). To complement double-null viruses having the gB gene deletion, the 
UL20 or gK complementing cell lines were infected with Ad5-gB one hour prior to 
transfection with pYEbac∆gB∆UL20 or pYEbac∆gB∆gK.  The same strategy was used 
to amplify virus stocks of the double-null viruses.   
Plaque Morphology and Growth Kinetics of HSV-1 YEbac102 Mutants 
HSV-1 viruses containing deletions in UL20, gB, and gK have been described 
previously (Baines et al., 1991; Cai et al., 1987; Foster et al., 2004a; Hutchinson et al., 
1993; Jayachandra, Baghian, and Kousoulas, 1997).  These viruses were produced by 
homologous recombination of plasmid constructs with viral DNA in cell culture 
experiments. Typically, isolation of these viruses required multiple plaque purifications 
to ensure that the mutant virus stocks did not contain contaminating wild-type virus. In 
contrast, the YEbac102 UL20, gB and gK null viruses were constructed in E. coli using 
the GET recombination system (Narayanan et al., 1999; Orford et al., 2000). In this case, 
production of mutant viruses did not require any plaque purification, since the progeny 
viruses did not contain any contaminating wild-type genomes. 
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Figure 3.3:  Plaque phenotypes of gB, gK and UL20-null viruses. Plaque phenotypes 
of YEbac102, YEbac∆UL20, YEbac∆gB and YEbac∆gK were observed on Vero (A1, 
B1, C1, D1), Fd20-1 (A2, B2, C2, D2), D6 (A3, B3, C3, D3) and FcgK-1 (A4, B4, C4, 
D4) cells.  Confluent cell monolayers were infected with the wild-type YEbac102 (A1, 
A2, A3, A4), YEbac∆UL20 (B1, B2, B3, B4), YEbac∆gB (C1, C2, C3, C4) or 
YEbac∆gK (D1, D2, D3, D4) at an MOI of 0.001, and viral plaques were visualized at 48 
hpi by immunohistochemistry. 
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To assess the effect of the deletion of the various genes on cell-to-cell spread, the 
plaque morphologies of the YEbac102, YEbac∆gB, YEbac∆UL20 and YEbac∆gK 
viruses were examined in Vero, Fd20-1, D6 and FcgK-1 cells at 48 hpi (Fig 3.3).  The 
wild-type YEbac102 produced large plaques of a similar size on all infected cells (Fig 
3.3: A).  Infection of non-complementing cells with either YEbac∆UL20 or YEbac∆gK 
resulted in small plaques containing on average 3 to 5 cells (Fig 3: B1, B3, B4 and D1, 
D3, D3, respectively), while complementation of the UL20 and gK gene deletions 
resulted in large plaques comparable in size to the YEbac102 plaques (Fig 3.3: B2, D4, 
respectively).  Similarly, infection of non-complementing cells with the YEbac∆gB virus 
produced only single infected cells (Fig. 3.3: C1, C2, C4), indicating that the virus was 
unable to spread beyond the primary infected cell, while infection of complementing D6 
cells resulted in large plaques (Fig. 3.3: C3). 
  The YEbac∆gB∆UL20 and YEbac∆gB∆gK double-null viruses formed large 
plaques when plated onto Ad5-gB infected Fd20-1 or FcgK-1 cells, respectively (Fig. 
3.4: A5, B6), single infected cells on Vero cells or cells able to complement for only gK 
or UL20 (Fig. 3.4: A1, A2, A4, B1, B2, B4), or very small plaques in cells able to 
complement gB (Fig. 3.4: A3, A6, B3, B5). 
Rescue of the individual mutations from each BAC-derived virus was performed 
by homologous recombination with wild-type DNA fragments spanning each gene. 
Double-null mutations were rescued sequentially with the gB-null mutation rescued first 
followed by rescue of either the gK-null or UL20-null mutations. Importantly, all rescued 
viruses formed large plaques similar to the wild type YEbac102 virus when plated on 
non-complementing Vero cells, indicating that there were no spurious mutations in the  
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Figure 3.4:  Plaque phenotypes of double-null viruses and rescued viruses. Plaque 
phenotypes of YEbac∆gB∆gUL20 and YEbac∆gB∆gK on Vero (A1, B1), Fd20-1 (A2, 
B2), D6 (A3, B3), and FcgK-1 (A4, B4) cells, or Ad5-gB infected Fd20-1 (A5, B5) and 
FcgK-1 (A6, B6) cells are shown.  Confluent cell monolayers were infected with 
YEbac∆gB∆gUL20 (A1, A2, A3, A4, A5, A6) or YEbac∆gB∆gK (B1, B2, B3, B4, B5, 
B6) at an MOI of 0.001.  The plaque phenotypes of the rescued gB, gK and UL20-null 
(D, E, F) and double-null (G, H) viruses in comparison to the wild-type YEbac102 (C) 
are shown on Vero cells. Viral plaques were visualized at 48 hpi by 
immunohistochemistry. 
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Figure 3.5:  Viral replication kinetics. Comparison of virus replication characteristics 
of YEbac102 (●),YEbac∆UL20 (■),YEbac∆gK (▲),YEbac∆gB (○),YEbac∆gB∆UL20 
(□), and YEbac∆gB∆gK (∆) on Vero cells. One step kinetics of infectious virus 
production were calculated after infection at an MOI of 5 followed by incubation at 37°C. 
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parental mutant BAC viruses affecting virus replication and egress (Fig. 3.4: C, D, E, F, 
G, H). 
 To examine the effect of the various mutations on virus replication, Vero cells 
were infected at an MOI of 5 with either the wild-type or each mutant virus. Virus stocks 
were prepared at 0, 4, 9, 16, 20, or 24 hpi and titrated in triplicate onto complementing 
cells (Fig. 3.5).  The kinetics of both YEbac∆UL20 and YEbac∆gK viral replication was 
substantially slower than that of the YEbac102 virus. Maximum titers for the 
YEbac∆UL20 and YEbac∆gK mutants viruses were 105 pfu/ml in comparison to 108 
pfu/ml for the YEbac102 virus at 24 hpi (Fig. 3.5).  In contrast, the YEbac∆gB, 
YEbac∆gB∆UL20 and YEbac∆gB∆gK viruses failed to produce infectious virus in Vero 
cells (Fig. 3.5). 
Ultrastructural Characterization of the YEbac∆gB∆UL20 and YEbac∆gB∆gK 
Double-Null Mutant Viruses 
 
 Previous reports indicated that gB was not essential for virion egress (Cai et al., 
1987; Cai, Gu, and Person, 1988), while both gK and UL20p were found to be essential 
for cytoplasmic virion morphogenesis and egress (Foster et al., 2004a; Jayachandra, 
Baghian, and Kousoulas, 1997). To ascertain whether gB functioned redundantly with 
either gK or UL20p in virion de-envelopment from perinuclear spaces, the ultrastructural 
phenotypes of each YEbac102-based mutant virus carrying UL20, gB, or gK deletions 
relative to the wild-type YEbac102 virus were determined by transmission electron 
microscopy at 24 hpi. As expected, the YEbac102 and YEbac∆gB viruses exhibited no 
apparent defects in virion egress exemplified by the presence of fully enveloped virions 
extracellularly (Fig 3.6 A, B), as well as the presence of fully enveloped virions 
intracellularly (not shown).  Unlike the wild-type virus, ultrastructural visualization 
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Figure 3.6:  Ultrastructural morphology of gB, gK and UL20-null viruses. Electron 
micrographs of Vero cells infected with YEbac102 (A), YEbac∆gB (B), YEbac∆UL20 
(C) or YEbac∆gK (D). Confluent cell monolayers were infected at an MOI of 5, 
incubated at 37°C for 24 hours, and prepared for transmission electron microscopy. 
Nuclear (n), cytoplasmic (c) and extracellular (e) spaces are marked. 
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Figure 3.7:  Ultrastructural morphology of gB/gK and gB/UL20 double-null viruses. 
Electron micrographs of Vero cells infected with YEbac∆gB∆gUL20 (A1, A2, A3, A4, 
A5) or YEbac∆gB∆gK (B1, B2, B3, B4). Confluent cell monolayers were infected at an 
MOI of 5, incubated at 37°C for 24 hours, and prepared for transmission electron 
microscopy. Panels A4 and B3 show partially-enveloped capsids. Panels A5 and B4 show 
a tegument-like accumulation on membranes that are folded irregularly.  Nuclear (n), 
cytoplasmic (c) and extracellular (e) spaces are marked.  
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of YEbac∆UL20 and YEbac∆gK infected Vero cells revealed a cytoplasmic defect in 
virion egress, characterized by the presence of unenveloped capsids in the cytoplasm as 
well as aberrantly enveloped virions (Fig. 3.6 C, D).  These results are consistent with 
previous findings (Foster et al., 2004a; Jayachandra, Baghian, and Kousoulas, 1997).  In 
general, ultrastructural examination of Vero cells infected with the YEbac∆gB∆gK (Fig. 
3.7A) and YEbac∆gB∆UL20 (Fig. 3.7B) double-null viruses revealed similar virion 
morphogenetic defects to those of the gK and UL20-null viruses exhibiting high numbers 
of unenveloped capsids in the cytoplasm.  In addition, the observed ultrastructural 
phenotypes revealed specific defects in cytoplasmic envelopment: i) multiple capsids 
appeared proximal to membranes apparently unable to complete the budding process into 
cytoplasmic vesicles (Fig. 3.7: A4, B3); ii) cytoplasmic vesicular membranes appeared to 
contain electron dense material consistent with the accumulation of tegument proteins in 
the presence or absence of proximal capsids (Fig. 3.7: A5, B4).  
Generation and Characterization of Recombinant gK-null and UL20-null viruses 
Containing the gBsyn3 or gBamb1511 Mutation 
 
 It was previously determined that gB was required for the expression of the syn20 
(gK) syncytial phenotype (Cai, Gu, and Person, 1988).  To determine whether gK was 
required for virus-induced cell fusion due to syncytial mutations in gB, YEbac102-based 
recombinant viruses were constructed carrying either the gBsyn3 or the gBamb1511 
syncytial mutations in the absence of the gK gene. These viruses were constructed by 
rescuing the YEbac∆gB∆gK virus with either wild-type gB, gBsyn3 or gBamb1511 (see 
Materials and Methods). The same strategy was used to isolate recombinant viruses 
carrying the gBsyn3 or gBamb1511 mutations in the absence of the UL20 gene by 
rescuing the gB deletion in the YEbac∆gB∆UL20 virus.
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Figure 3.8:  Plaque morphology of gK and UL20-null viruses carrying syncytial 
mutations in gB. Plaque phenotypes of gK-null (A, B, C, D, E, F) and UL20-null (G, H, 
I, J, K, L) recombinant viruses containing specific gB mutations on Vero (A, C, E, G, I, 
K) and FcgK-1 (B, D, F) or Fd20-1 (H, J, L) cells.  Confluent cell monolayers were 
infected with the gK-null viruses containing: wild-type gB (A, B), gBsyn3 (C, D), or 
gBamb1511 (E, F); or UL20-null viruses containing wild-type gB (G, H), gBsyn3 (I, J), 
or gBamb1511 (K, L) at an MOI of 0.001, and viral plaques were visualized at 48 hpi by 
immunohistochemistry.  Insets are shown at 2.4x magnification to facilitate visualization 
of the non-syncytial phenotype of the small plaques. 
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 To assess the effect of each gB mutation on virus-induced cell fusion, Vero cells, 
as well as either gK or UL20 complementing cells, were infected with each mutant virus 
at an MOI of 0.001.  Virus plaques were visualized at 48 hpi by immunohistochemistry 
as described previously (Foster et al., 2004a; Melancon, Foster, and Kousoulas, 2004).  
Viruses specifying the wild type, syn3, or amb1511 gB in the gK-null background 
formed small, non-syncytial plaques on Vero cells (Fig. 3.8: A, C, E).  As expected, the 
virus containing the wild-type gB formed large, non-syncytial plaques on FcgK-1 cells 
(Fig. 3.8: B), while gK-null viruses specifying either the gBsyn3 or gBamb1511 mutation 
formed large, syncytial plaques on FcgK-1 cells (Fig 3.8: D, F).  Similarly, UL20-null 
viruses specifying the wild-type, syn3, or amb1511 gB formed small, non-syncytial 
plaques on Vero cells (Fig. 3.8: G, I, K).  The UL20-null virus containing the wild-type 
gB formed large, non-syncytial plaques on Fd20-1 cells (Fig. 3.8: H), and the UL20-null 
viruses specifying either the gBsyn3 or gBamb1511 mutation formed large, syncytial 
plaques on Fd20-1 cells (Fig. 3.8: J, L).   
Virion Assembly and Egress Is Not Required for Either gB or gK-Mediated Virus-
Induced Cell-to-Cell Fusion 
 
 To investigate the potential requirement for virion egress in virus-induced cell 
fusion, recombinant viruses were constructed carrying a UL19 and UL20 deletion in an 
otherwise wild-type, syn20, or tsB5 genetic background.  UL19 encodes the major capsid 
protein (VP5), and capsid formation can not occur in its absence (Desai et al., 1993).  
Briefly, a CMV-EGFP gene cassette was inserted into the viral genome effectively 
deleting a sizeable portion of the UL19 ORF and all of the UL20 ORF. Recombinant 
viruses were isolated via fluorescence microscopy and plaque purified on G5 cells, which 
complement the UL19/UL20-null defect (Desai et al., 1993), and characterized as 
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Figure 3.9:  Plaque phenotypes of ∆1920, ∆1920-syn20 and ∆1920-syn3 viruses on 
Vero (A, C, E) and FcgK-1 (B, D, F) cells.  Confluent cell monolayers were infected 
with the ∆1920 (A, B), ∆1920-syn20 (C, D) or ∆1920-syn3 (E, F) at an MOI of 0.001, 
and viral plaques were visualized at 48 hpi by immunohistochemistry. 
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described in Materials and Methods. CV-1 or Fd20-1 cells were infected with ∆1920, 
∆1920-syn20 and ∆1920-syn3 viruses at an MOI of 0.005.  As expected, these infections 
did not cause virus-induced cell fusion in non-complementing CV-1 cells (Fig. 3.9: A, C, 
E).  However, the ∆1920-syn20 and ∆1920-syn3 viruses formed syncytial plaques 
containing a range of 3 to 100 nuclei per syncytium in Fd20-1 cells, which complement 
only UL20 (Fig. 3.9: D, F), while the ∆1920 virus failed to cause virus-induced cell 
fusion (Fig. 3.9: B). 
DISCUSSION 
HSV-1 BAC Generated Recombinant Viruses 
Investigations of the structure and function of individual viral proteins has been 
greatly facilitated through the use of recombinant viruses specifying mutated proteins. 
Typically, recombinant viruses have been produced by homologous recombination 
between a mutated DNA fragment and viral genomes. In most instances, the resultant 
recombinant viruses have to be extensively purified due to the presence of a large amount 
of contaminating wild-type viruses. Recently, the HSV-1 (F) genome was cloned into a 
bacterial artificial chromosome (BAC) by inserting the BAC into the intergenic region 
between UL3 and UL4 without deletion of any viral genes (Tanaka et al., 2003), unlike 
previously constructed HSV-1 BACs that contained deletions of one or more viral genes 
(Horsburgh et al., 1999; Saeki et al., 1998; Stavropoulos and Strathdee, 1998). 
Transfection of the resultant pYEbac102 plasmid into cells resulted in production of the 
YK304 infectious virus, which was indistinguishable from wild-type HSV-1 in vitro and 
in vivo, exhibiting wild-type virulence in mice after intracerebral inoculation (Tanaka et 
al., 2003).  
157 
 Taking advantage of the HSV-1 pYEbac102 system, we generated recombinant 
viruses lacking either the gK, gB or UL20 genes as well as viruses having deletions in 
both gK and gB, or gB and UL20.  As expected, the gB/gK and gB/UL20 double-null 
viruses failed to produce infectious virus or spread beyond the primary infected Vero 
cells. Generally, the gK, gB or UL20-null viruses exhibited similar defects in virus 
replication and plaque morphologies to corresponding viruses constructed in the KOS 
genetic background. However, it was noted that the HSV-1(F) gK and UL20-null viruses 
exhibited up to 10-fold greater defect in virus replication, while virus plaques were 
typically smaller than those produced by the KOS mutant viruses.  These results may be 
attributed to genetic differences between the F and KOS virus strains, although no 
apparent differences were noted between the wild-type viruses with regard to their 
replication kinetics and plaque morphology. Alternatively, it is possible that the 
requirement for extensive passage of mutant viruses in the KOS background during 
plaque purification may have resulted in improved adaptation of these viruses for growth 
in Vero cells. In this regard, generation of mutant viruses via the pYEbac102 system 
provides a unique advantage in assessment of the structure and function of individual 
viral proteins without the potential complications arising from extensive cell culture 
passage of virus stocks. 
gB, UL20p and gK are not Required for Virion De-Envelopment 
 HSV-1 is thought to acquire an initial envelope when capsids formed in the 
nucleus of cells bud into the perinuclear space. Subsequently, a putative fusion event 
between viral envelopes and the outer nuclear membranes results in capsid release into 
the cytoplasm. Final envelopment is thought to occur by budding into cytoplasmic 
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vesicles derived from the TGN or endosomes that facilitate egress of enveloped virions to 
extracellular spaces (Fig. 3.10). Currently, it is not known whether viral glycoproteins 
involved in virus entry, or virus-induced cell fusion also function in this de-envelopment 
step. Results obtained in this study clearly show that gK, UL20 or gB are not essential for 
virion de-envelopment. In the case of gB, previous studies suggested that lack of gB did 
not adversely influence egress of virion particles to supernates of infected cells, although 
these virions lacked gB and were rendered non-infectious (Cai et al., 1987; Cai, Gu, and 
Person, 1988). Similar results have been reported for gH, gL and gD, which are thought 
to be required for virus-induced and virus-free (transient expression) membrane fusion 
(Forrester et al., 1992; Ligas and Johnson, 1988; Roop, Hutchinson, and Johnson, 1993).  
Ultrastructural examination of the gB-null virus confirmed initial findings and clearly 
showed that lack of gB did not adversely affect the production of enveloped virions in 
extracellular spaces. Investigations with recombinant viruses specifying single gene 
deletions in either gB, gK or UL20p did not exclude the possibility that gB and gK may 
function in a redundant manner to facilitate virion de-envelopment. This possibility can 
be discounted on the basis that the gB/gK double null virus efficiently produced 
unenveloped capsids into the cytoplasm of infected cells. Similar results were obtained 
for the gB/UL20 double null virus. Furthermore, it is improbable that UL20p or gK alone 
could mediate virion de-envelopment due to the fact that these two proteins act in a 
cooperative manner for intracellular transport and virus-induced cell fusion. Construction 
of a triple-null virus lacking gB, gK and UL20p could resolve this possibility. 
Alternatively, other viral glycoproteins such as gH/gL may function redundantly with gK, 
UL20p or gB in the de-envelopment process. Virions found in perinuclear spaces are 
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Figure 3.10:  Schematic of HSV-1 virion morphogenesis and egress. (I) Mature 
capsids budding through the inner nuclear membrane into the perinuclear space; (II) De-
envelopment of perinuclear virions at the outer nuclear membrane; (III) Re-envelopment 
of cytoplasmic capsids by budding into cytoplasmic vesicles; (IV) Final egress to the 
extracellular space. 
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known to contain the UL34 and UL31 tegument proteins, which are absent from 
extracellular enveloped virions (Reynolds et al., 2002). Thus, it is possible that the de-
envelopment process involves different tegument-membrane protein interactions from 
those occurring during virus entry. In this regard, virion de-envelopment from perinuclear 
spaces seems to bear little similarity to either virus entry or virus-induced cell fusion 
suggesting that this membrane fusion event may be regulated by a fundamentally 
different mechanism. 
Role of gK on gB-Mediated Cell-to-Cell Fusion 
Previous reports showed that gK syncytial mutations could not cause virus-
induced cell fusion in the absence of gB, indicating that gB served essential functions for 
cell-to-cell fusion (Cai, Gu, and Person, 1988). Both gBsyn3 and gBamb1511 mutations 
cause extensive virus-induced cell fusion (Baghian et al., 1993; Bzik et al., 1984). 
However, unlike the gBsyn3 single amino acid mutation, which does not enhance gB-
mediated fusion in the transient coexpression system, the gBamb1511 truncation causes 
greatly enhanced fusion in the transient expression system (Foster, Melancon, and 
Kousoulas, 2001). These findings suggest that the gBamb1511 truncation may disengage 
gB from other viral or cellular functions responsible for down-regulation of the fusogenic 
potential of gB. However, recombinant viruses containing the gB syncytial mutations 
gBsyn3 or gBamb1511, but lacking the gK or the UL20 gene, failed to cause virus-
induced cell fusion indicating that expression of both gK and UL20p is required for gB-
mediated membrane fusion. In addition, deletion of the carboxyl terminal 28 amino acids 
of gB specified by the amb1511 mutation does not abrogate the requirement for 
expression of both gK and UL20p in gB-mediated virus-induced cell fusion, suggesting 
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that gB amino acid sequences other than the carboxyl terminal 28 amino acids are 
required for gK or UL20p regulatory interactions with gB. Recently, gK expression was 
reported to inhibit membrane fusion caused by coexpression of gB, gD, gH and gL 
(Avitabile, Lombardi, and Campadelli-Fiume, 2003). These findings seem to contradict 
results obtained herein with the recombinant viruses lacking gK. However, a similar 
result was reported for gM, which inhibited membrane fusion in the transient 
coexpression system (Klupp, Nixdorf, and Mettenleiter, 2000; Koyano et al., 2003), but 
was required for virus-induced cell fusion caused by syncytial mutations in gB (Davis-
Poynter et al., 1994). These results suggest that gM and gK may regulate virus-induced 
cell fusion both positively as well as negatively depending on the presence of different 
sets of viral proteins. 
Virion Egress is not Required in Virus-Induced Cell Fusion 
 Virus-induced cell fusion starts at approximately 5 hpi at 37° C at which time 
infectious virions are produced and egress out of infected cells. Therefore, it is possible 
that egressing virions may contribute directly or indirectly to the virus-induced 
membrane fusion phenomena mediated by cell-surface expressed gB and gK carrying 
syncytial mutations. It has been shown that cell surface expression of gB is not affected 
in a gK-null or UL20-null virus (Foster et al., 2004a; Jayachandra, Baghian, and 
Kousoulas, 1997).  Therefore, the requirement for the presence of UL20p and gK for gB-
mediated virus-induced cell fusion may be due to defects in virion egress. Earlier reports 
indicated that production of virion particles may not be necessary for virus-induced cell 
fusion, inasmuch as, syncytial mutants caused fusion in the presence of the replication 
inhibitor phosphonoacetic acid (Kousoulas, Person, and Holland, 1978). These early 
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findings were confirmed herein by the phenotype of the UL19/UL20 double-null viruses 
containing either the gBsyn3 or gBamb1511 mutation. These viruses are unable to form 
capsids because of the deletion in the UL19 gene, coding for the major capsid protein 
VP5. Both viruses caused virus-induced cell fusion in the UL20 complementing cell line 
indicating that virion formation and egress are not necessary for virus-induced cell 
fusion. 
The rapid generation of recombinant viruses using the YEbac102 system greatly 
facilitates the characterization of the function of individual viral proteins, while helping 
to discern potentially complex interactions among multiple proteins through the 
introduction of multiple mutations into an identical genetic background. In this report, we 
have demonstrated the utility of this system in investigating the role of gB, gK and 
UL20p in virus induced cell fusion and morphogenesis. The existence of an intimate 
relationship between gK/UL20p and gB in virus-induced cell fusion suggests that both 
gK and UL20p act to regulate the fusogenic properties of gB. Future studies will be 
targeted to investigate direct physical interactions among gB, gK and UL20p and their 
role in the regulation of membrane fusion phenomena in the HSV-1 life cycle. 
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CHAPTER IV 
GENETIC ANALYSIS OF THE HERPES SIMPLEX VIRUS TYPE 1   
(HSV-1) UL20 PROTEIN DOMAINS INVOLVED IN CYTOPLASMIC 
VIRION ENVELOPMENT AND VIRUS-INDUCED CELL FUSION* 
 
 
 
INTRODUCTION 
Herpes simplex viruses (HSV) specify at least eleven virally encoded 
glycoproteins, as well as several non-glycosylated membrane associated proteins, most of 
which play important roles in multiple membrane fusion events during virus entry and 
intracellular virion morphogenesis and egress (Roizman and Sears, 1996; Spear, 1993a; 
Spear, 1993b; Spear, Eisenberg, and Cohen, 2000). Spread of infectious virus occurs 
either by release of virions to extracellular spaces or through virus-induced cell-to-cell 
fusion. Mutations that cause extensive virus-induced cell fusion predominantly arise in 
four genes of the HSV genome: the UL20 gene (Baines et al., 1991; MacLean et al., 
1991), the UL24 gene (Jacobson et al., 1998; Sanders, Wilkie, and Davison, 1982), the 
UL27 gene encoding glycoprotein B (gB) (Bzik et al., 1984; Pellett et al., 1985), and the 
UL53 gene coding for glycoprotein K (gK) (Bond and Person, 1984; Debroy, Pederson, 
and Person, 1985; Hutchinson et al., 1992; Pogue-Geile et al., 1984; Ryechan et al., 
1979). Of these four membrane associated proteins, only UL20 and gK are essential for 
the intracellular transport of virions to extracellular spaces in all cell types (Baines et al., 
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Genetic analysis of the herpes simplex virus type 1 UL20 protein domains involved in cytoplasmic virion 
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1991; Foster and Kousoulas, 1999; Fuchs et al., 1997; Hutchinson and Johnson, 1995; 
Jayachandra, Baghian, and Kousoulas, 1997).  
Virus morphogenesis and egress of infectious herpes virions is thought to involve 
sequential de-envelopment and re-envelopment steps in transit to extracellular spaces: a) 
primary envelopment by budding of capsids assembled in the nuclei through the inner 
nuclear leaflet leading to the production of enveloped virions within perinuclear spaces; b) 
de-envelopment by fusion of viral envelopes with the outer nuclear leaflet leading to the 
accumulation of unenveloped capsids in the cytoplasm; c) re-envelopment of cytoplasmic 
capsids into TGN-derived vesicles. This final event in cytoplasmic virion envelopment is 
thought to be mediated by interactions between tegument proteins and cytoplasmic 
portions of viral glycoproteins embedded within the TGN-derived membranes. 
Cytoplasmically enveloped viruses  are thought to be transported to extracellular spaces 
within Golgi or TGN-derived vesicles (reviewed in: Johnson and Huber, 2002; 
Mettenleiter, 2002; Tomishima, Smith, and Enquist, 2001).  
The UL20 gene encodes a 222 amino acid non-glycosylated transmembrane 
protein that is conserved in all alphaherpesviruses. The UL20p is a structural component 
of extracellular enveloped virions and it is expressed in infected cells assuming a 
predominantly perinuclear and cytoplasmic distribution (Ward et al., 1994). A partial 
deletion of the UL20 gene was reported to form weakly syncytial viral plaques in certain 
cell types and severe defects in cytoplasmic virion envelopment implying that UL20 
functioned in virus-induced cell fusion and virion morphogenesis. Furthermore, 
replication of the UL20-null virus could be partially complemented in certain cell types 
indicating a cellular specificity of UL20 functions (Baines et al., 1991). This UL20p 
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cellular specificity was phenomenologically associated with disruption of the Golgi 
apparatus during viral infections, inasmuch as, cells that complemented the UL20-null 
virus retained intact Golgi, while the Golgi of cells failing to complement the UL20-null 
virus were disrupted and dispersed throughout the cytoplasm (Avitabile et al., 1995; 
Avitabile et al., 1994). 
Recently, we showed that a precise deletion of the UL20 gene caused 
accumulation of unenveloped capsids into the cytoplasm indicating that the HSV-1 
UL20p functioned in cytoplasmic stages of virion envelopment and that the previously 
reported partial deletion of the UL20 gene caused a predicted fusion of the UL20 gene to 
the adjacent UL20.5 gene. In addition, syncytial mutations in either gB or gK failed to 
cause fusion in the absence of the UL20 gene, suggesting that the UL20 protein was 
essential for virus-induced cell fusion (Foster et al., 2004). Furthermore, we showed that 
UL20 is required for cell-surface expression of gK, suggesting a functional 
interdependence between gK and UL20 for virus egress and cell-to-cell fusion (Dietz et 
al., 2000; Foster, Alvarez, and Kousoulas, 2003). In this manuscript we have delineated 
via site-directed mutagenesis the functional domains of UL20p involved in infectious 
virus production and virus-induced cell fusion. Importantly, we show that both amino and 
carboxyl terminal portions of UL20p, which are predicted to lie within the cytoplasmic 
side of cellular membranes, function both in cytoplasmic virion envelopment and virus-
induced cell fusion. Overall, the data suggest that UL20p’s role in virus-induced cell 
fusion can be functionally separated from its role in cytoplasmic virion morphogenesis, 
and that UL20p domains that function in gB-syn3 virus-induced cell fusion are distinct 
from those functioning in gKsyn1 virus-induced cell fusion. 
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MATERIALS AND METHODS 
Cells and Viruses 
African green monkey kidney (Vero) cells were obtained from ATCC (Rockville, 
MD). The Vero-based UL20 complementing cell line, G5, was a gift of Dr. P. Desai, 
(John Hopkins Medical Center) (Desai et al., 1993). Cells were maintained as previously 
described (Desai et al., 1993; Foster, Alvarez, and Kousoulas, 2003; Foster and 
Kousoulas, 1999). The parental wild-type strain used in this study HSV-1 (KOS) was 
originally obtained from P. A. Schaffer (Harvard Medical School). Flp-In-CV-1 cells 
were maintained as directed by the manufacturer (Invitrogen, Inc.).  ∆20DIV5, 
∆20gBsyn3 and ∆20syn20DIV5 viruses were as described previously (Foster et al., 2004), 
and virus stocks were grown on Fd20-1 cells, described below. In this paper, for 
simplification purposes, the ∆20DIV5 virus is referred to as ∆20 virus and the 
∆20syn20DIV5 virus is referred to as ∆20gKsyn1 virus (the syn20 and syn1 mutation are 
the same, Ala-to-Val at gK amino acid 40). 
Construction of Transformed Flp-In-CV-1 Cell Lines 
Generation of stable Flp-In-CV-1 expression cell lines was performed essentially 
as directed by the manufacturer (Invitrogen).  Briefly, confluent Flp-In-CV-1 monolayers 
in six well plates were transfected using Lipofectamine 2000 with 0.3 µg of either 
pcDNA5/FRT/UL20 or pFRT/gDpro/UL20 and 2.7 µg of pOG44 (Invitrogen), which 
expresses Flp recombinase. After 2 weeks, hygromycin B (125 µg/ml) resistant colonies 
were tested for the ability to complement the growth of ∆20, ∆20gBsyn3 and ∆20gKsyn1 
viruses. All colonies derived from each plasmid complemented UL20 null virus.  Isolates 
Fc20-1 and Fd20-1, derived from pcDNA5/FRT/UL20 and pFRT/gDpro/UL20 
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transfected cells, respectively, were chosen for further use.  Fd20-1 cells were used in 
generating UL20-null virus stocks. 
Plasmids 
pCR2.1-UL20, which was used as the parental vector for UL20 mutagenesis, was 
generated by cloning a 773bp DNA fragment containing the UL20 gene, obtained by PCR 
amplification of HSV-1(KOS) viral DNA, into pCR2.1/TOPO (Invitrogen). A 7,185bp 
fragment spanning the region comprising UL19, UL20, UL21, and UL22 was PCR 
amplified from KOS viral DNA using primers p20F2 5’ (TTTCTTGAATTCACGACGG 
CGGTGTAGCCCACG) and p20F2 3’ (CTTCTTGAATTCCCCATCACCCACAACGC 
CAGC), EcoRI restricted, and ligated into puc19BX (Foster et al., 2004) to generate 
p20F2.  p20F2 was modified by silencing the BamHI site at genomic nucleotide position 
39235 (Genbank accession number  NC_001806), conserving the UL19 amino acid 
sequence, and removing a 767 bp BamHI DNA fragment containing the UL20 gene, 
resulting in plasmid p20F2BX (see Fig 4.2: D).  
 UL20 cluster to alanine mutants, single point mutants, and truncation mutants 
were generated by two methods. Mutants CL11, CL23 , CL34, CL38, CL121, CL209, 66t, 
and 149t were generated using the GeneTailor™ Site-Directed Mutagenesis Kit as 
directed by the manufacturer (Invitrogen). Mutants CL5, CL16, CL30, CL41, CL46, 
CL49, CL153, CL173, CL177, 181t, 204t, 211t, 216t, Y49A, S50A, R51A, D123A, 
R209A, T212A, and R213A were generated by splice-overlap extension (SOE) PCR 
(Aiyar, Xiang, and Leis, 1996). Mutant UL20 genes were transferred into the BamHI site 
of the vector p20F2BX. All p20F2BX mutant constructs were sequenced to verify error 
free mutagenesis. Plasmid p20R contains a wild type UL20 gene cloned into p20F2BX. 
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An additional plasmid was constructed from p20F2BX, designated p∆20NE, to include 
the same UL20 deletion as p∆20-EGFP (Foster et al., 2004) without the EGFP gene 
cassette. Plasmid pcDNA5/FRT/UL20 was constructed by inserting the UL20 gene, PCR 
amplified from KOS viral DNA, into pcDNA5/FRT/V5-His-TOPO (Invitrogen). An 
additional plasmid, pFRT/gDpro/UL20, was constructed by replacing the CMV promoter 
in pcDNA5/FRT/UL20 with the HSV-1 KOS gD promoter region. 
UL20 Complementation Assay for Infectious Virion Production 
The complementation assay was modified from a similar assay described 
previously (Bjerke et al., 2003). Confluent Vero monolayers in six well plates were 
transfected with 1.5 µg of pcDNA3.1/V5-His-TOPO/lacZ (Invitrogen), expressing β-
galactosidase under control of the CMV promoter, and 1.5 µg of wild-type or mutant 
UL20 plasmid with Lipofectamine 2000 as described by the manufacturer (Invitrogen).  
Six hours post-transfection, the monolayers were infected with a UL20-null virus at an 
MOI of 1. Infections were placed on a rocker for 1 hour at 4°C, and then transferred to 
37°C for 2 hours. Residual virus was inactivated using an acid wash (PBS containing .5M 
glycine, pH3) for 2 min, and monolayers were subsequently washed 3 times with DMEM 
to restore the pH to a normal level. Infections were incubated at 37°C for 24 hours.  After 
repeated freeze/thaw cycles, virus stocks were titered in triplicate on G5 cells, which 
effectively complement the UL20-null defect (Foster et al., 2004). An aliquot of each 
virus stock was saved to assay for β-galactosidase expression as described below.  
β-galactosidase expression levels were quantified essentially as described 
previously (Bjerke et al., 2003). 100 µl of Z buffer containing 0.27% β−mercaptoethanol 
and 0.2% Triton X-100 was added to 100 µl of virus stock and vortexed for 30 s.  Cell 
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debris was pelleted by centrifugation at 16,100 g in a microcentrifuge for 30 s. 160 µl of 
the supernatant was transferred to a 96-well plate and reacted with 40 ul of 4 mg/ml ο-
nitrophenyl-β−D-galactopyranoside (ONPG) at room temperature.  The reactions were 
allowed to proceed for 90 minutes before determining absorbance at 405 nm. 
Calculation of Complementation Ratios 
The complementation ratio for each mutant was calculated with the formula [(virus 
titer of mutant / virus titer of negative control)*(experimental β-galactosidase value / β-
galactosidase value of negative control)].  Using this formula, values obtained from the β-
galactosidase assay were used to correct for minor differences in transfection efficiency; 
and the complementation ratio for the negative control (plasmid p∆20NE) was set at 1.  
UL20 Complementation Assay for Virus-Induced Cell-to-Cell  Fusion 
Confluent Vero monolayers in six-well plates were transfected with 3 µg of wild-
type or mutant UL20 plasmid with Lipofectamine 2000 as described by the manufacturer 
(Invitrogen).  18 hours post transfection, the monolayers were infected at an MOI of 0.1 
with either ∆20gKsyn1 or ∆20gBsyn3 viruses.  Infections were placed on a rocker at room 
temperature for 1 hour, then transferred to 37° C for 30 minutes. Cells were overlaid with 
DMEM containing 1% methylcellulose.  24 hours post-infection, cell fusion was 
determined by visualization of syncytia formation by fluorescence microscopy. Cell 
fusion was blindly scored by two independent observers and scores were linked to 
individual mutants after the cell fusion scoring was completed. Cell fusion was scored as 
completely absent (--), or present at very low (+), moderate (++), near (+++) or at levels 
equivalent (++++) to those observed when the wild-type UL20 gene was used. The score 
of (-) indicates no syncytial formation as determined by the absence of cells having more 
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than one nucleus. The score of (+) indicates the presence of syncytia containing on the 
average 5 nuclei or less.  The score of (++) reflects syncytia containing 6-10 nuclei per 
cell. The score of (+++) is assigned to 11-20 nuclei per cell. The score of (++++) is for 
syncytia having greater than 20 nuclei per cell. 
Electron Microscopy 
 Cell monolayers were infected with the indicated virus at an MOI of 5. All cells 
were prepared for TEM examination 24 hpi. Infected cells were fixed in a mixture of 2 % 
paraformaldehyde and 1.5% glutaraldehyde in 0.1M NaCaC buffer, pH 7.3.  Following 
osmication (1% OsO4) and dehydration in an ethanol series, the samples were embedded 
in Epon-Araldyte resin and polymerized at 70º C.  Thin sections were made on an MTXL 
Ultratone (RMC Products), stained with 5% uranyl acetate and CNA lead, and observed 
with a Zeiss 10 transmission electron microscope as described previously (Foster, 
Alvarez, and Kousoulas, 2003). 
Generation of Recombinant Viruses Specifying Mutant UL20p 
Viruses that contained the UL20 mutations were generated by rescuing the UL20-
null viruses (∆20, ∆20gBsyn3, ∆20gKsyn1) with plasmids containing the desired UL20 
mutant genes bracketed by adjacent viral sequences to facilitate homologous 
recombination with the viral genome (Fig. 4.3). Briefly, confluent Vero cell monolayers 
were transfected with each plasmid and transfected cells were infected with the ∆20 virus 
six hours after transfection. Virus stocks were prepared at 48 hpi and recombinant viruses 
were plaque isolated on Vero cells and sequentially plaque-purified at least five times.  
Replacement of the UL20-null resident CMV-EGFP gene cassette and the concomitant 
insertion of the mutated UL20 gene were confirmed by DNA sequencing. Visualization of 
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viral plaques was achieved by either phase contrast microscopy or immunohistochemistry 
essentially as described previously (Foster et al., 2004). 
RESULTS 
Mutagenesis of HSV-1 UL20 
To delineate the functional domains of UL20p required for infectious virus 
production, virus egress and virus-induced cell fusion, we constructed a panel of 31 
mutations within the UL20 gene by site-directed mutagenesis. These mutations included: 
1) cluster-to-alanine mutants in which a cluster of proximal amino acids were changed to 
alanine residues; 2) single amino acid replacement mutants within alanine cluster regions; 
3) carboxyl terminal truncations of UL20p. The mutated amino acids for each type of 
mutation are shown in Table 4.1. The carboxyl terminal truncations are identified with the 
number of the last remaining amino acid (i.e. 66t retains UL20p amino acids 1-66). To 
facilitate placement of each mutation on the predicted luminar or cytoplasmic portions of 
UL20p, the hydrophobic and membrane-spanning domains of UL20p were calculated 
using the TMPred and SOSUI computer algorithms (Hirokawa, Boon-Chieng, and 
Mitaku, 1998; Hofmann and Stoffel, 1993), and used to derive a predicted membrane 
spanning model of UL20p (Fig. 4.1). This UL20p model features four membrane 
spanning regions placing both amino and carboxyl termini of UL20p within the cytoplasm 
(Domains I and V).  In addition, a third small domain is located intracellularly (domain 
III), while the two other domains are located extracellularly (domains II and IV). The 
predicted membrane topology of UL20p was used as the guide for selecting alanine 
scanning mutations within predicted intracellular and extracellular domains of UL20p.  
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Table 4.1:  Amino acid sequences of mutations 
 
I CL5 DD AA
I CL11 DRD AAA
I CL16 DE AA
I CL23 EEGE AAGA
I CL30 EE AA
I CL34 SLSS ALAA
I CL38 YGT AGA
I CL41 SD AA
I CL46 SS AA
I CL49 YSR AAA
I         Y49A       ASR
I         S50A YAR
I         R51A YSA
III CL121 KRDR AADA
IV CL153 ETFSPD AAFAPA
IV         E153A ATFSPD
IV         T154A EAFSPD
IV         S156A ETFAPD
IV         D158A ETFSPA
IV CL173 TD AA
IV CL177 RTR AAA
V CL209 RFWTR AFWAA
V         R209A AFWTR
V         T212A RFWAR
V         R213A RFWTA
66t VILFL VILG*
149t LFAAA LFAG*
181t RALGI RALG*
204t SANFF SANG*
211t RFWTR RFWG*
216t AILNA AILG*
Truncations
* indicates stop codon
Mutant aa sequenceDomain Mutation Name Wildtype aa sequence
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Figure 4.1:  Predicted membrane topology of UL20p and location of the 15 cluster-
to-alanine mutations.  Membrane topology was predicted using the TMPred and SOSUI 
algorithms (19, 20). UL20p domains where cluster-to-alanine mutations are located are 
indicated by a shaded oval.  Naming of cluster mutations is based on the first amino acid 
mutated in each cluster. Transmembrane region (TM), Cluster mutant (CL). 
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Regions containing clusters of charged amino acids as well as potential phosphorylation 
sites were specifically targeted. The location of each cluster mutation is marked on the 
UL20p model starting with the first mutated amino acid of the cluster (Fig. 4.1, Table 
4.1). 
Complementation Assay for Infectious Virus Production 
Previous studies showed that deletion of the HSV-1 UL20 and PRV UL20 genes 
resulted in up to two logs reduction in infectious virus production relative to their parental 
wild type strains (Baines et al., 1991; Foster et al., 2004; Fuchs et al., 1997).  To delineate 
functional domains of the UL20 protein involved in infectious virus production, each of 
the 31 mutated UL20 genes was tested for its ability to complement the HSV-1(KOS) 
UL20-null virus. The mutated genes were cloned into plasmids under their own promoter 
control bracketed by upstream and downstream DNA sequences to facilitate 
complementation experiments as well as isolation of recombinant viruses (Fig. 4.2: D, E; 
see Materials and Methods). Complementation experiments involved transfection of Vero 
cells with plasmids encoding wild-type or mutant UL20 genes, followed by infection with 
the UL20-null virus (Foster et al., 2004). A complementation ratio was calculated for each 
mutant UL20 plasmid, p20R (wild-type UL20, positive control), and p∆20NE (UL20-null 
mutation, negative control). The complementation ratio of p∆20NE was set to 1 for each 
experiment. The complementation ratios for the UL20 cluster mutants and truncation 
mutants are shown in Figure 3A.  Mutants CL5, CL11, CL16, CL23, CL30, CL34, CL38, 
CL41 CL46, CL121, CL173, CL177, and CL209 complemented the UL20-null virus to a 
variable extent in comparison to the positive plasmid control p20R and the negative 
plasmid control p∆20NE (Fig. 4.3A). Mutants CL49, CL153, 66t, 149t, 181t, 204t, 211t,  
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Figure 4.2: Schematic of the strategy for the construction of UL20-mutant genes 
used for complementation and isolation of recombinant viruses. (A) The top line 
represents the prototypic arrangement of the HSV-1 genome with the unique long (UL) 
and unique short (US) regions flanked by the terminal repeat (TR) and internal repeat (IR) 
regions. (B) Shown below is and expanded genomic region of the UL20-null virus 
between map units 0.239 and 0.305 containing the UL19, CMV-EGFP, UL20.5, UL21, 
and UL22 genes. (C) The p20F2BX-UL20mut plasmid denotes the expression and 
recombination plasmids used for complementation assays and construction of the 
recombinant viruses carrying each UL20 mutation. (D, E) Mutated UL20 genes were 
inserted into the BamHI restriction site of p20F2BX. 
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Figure 4.3: Complementation ratios of mutant UL20p genes.  Vero cells were 
transfected with plasmids encoding wild-type or mutant UL20 genes under the UL20 
promoter and then infected with the HSV-1(KOS) UL20-null (∆20) virus. (A) Bar 
graph showing complementation ratios for UL20 cluster-to-alanine mutants and carboxyl 
terminal truncations. (B) Complementation ratios of the CL49, Y49A, S50A, and R51A 
mutants. (C) Complementation ratios of the CL153, E153A, T154A, S156A, and D158A 
mutants. (D) Complementation ratios of the CL209, R209A, T212A, and R213A mutants.  
The error bars shown represent the maximum and minimum complementation ratios 
obtained from three independent experiments, and the bar height represents the average 
complementation ratio.  
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and 216t failed to efficiently complement the UL20-null defect in infectious virion 
production producing complementation ratios similar to those of plasmid p∆20NE 
(negative control) indicating that the mutated UL20 protein was not able to function 
properly in virus egress (Fig. 4.3A). To delineate the specific amino acids responsible for 
the UL20-associated defects identified by the cluster mutations, we examined the 
complementation ratios of several point mutants within cluster regions. The CL49 (YSR-
to-AAA; Table 4.1) mutant UL20 gene failed to efficiently complement the ∆20 virus. 
The Y49A mutant gene, which involves the Y residue within the CL49 target sequence, 
produced a complementation ratio similar to CL49, while the adjacent S50A and R51A 
mutant genes complemented infectious virus production to nearly wild-type levels (Fig. 
4.3B). These results indicate that the mutation of the Y residue is responsible for 
complementation defect exhibited by the UL20 gene carrying the CL49 mutation. In 
contrast, the UL20 genes carrying the E153A, T154A, S156A, and D158A mutations 
complemented the UL20-null virus at a greater level than the CL153 mutation indicating 
that these amino acids were not individually responsible for the lack of complementation 
by the UL20 gene carrying the CL153 mutation (Fig. 4.3C). The CL209 UL20 mutant 
gene as well as mutant genes carrying individual amino acid changes within the CL209 
target sequence efficiently complemented ∆20 infectious virus production (Fig. 4.3D). 
Complementation for Virus-Induced Cell-to-Cell Fusion 
 Recently, we showed that syncytial mutations in either gB or gK failed to cause 
virus-induced cell fusion in the absence of the UL20 gene (Foster et al., 2004). Therefore, 
the panel of 31 UL20 mutants was tested for the ability to complement UL20-null viruses 
containing syncytial mutations in either gB (syn3) or gK (syn1) for virus-induced cell 
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fusion. Confluent Vero monolayers were transfected with plasmids encoding either wild 
type or mutant UL20p, and subsequently infected with either ∆20gKsyn1 or ∆20gBsyn3 
viruses. These viruses contain a CMV-EGFP gene cassette in place of the UL20 gene, 
which facilitates visualization of syncytia formation by fluorescence microscopy (17). 
Cell fusion was scored by two observers as completely absent (--), or present at very low 
(+), moderate (++), near (+++) or at levels equivalent (++++) to those observed when the 
wild-type UL20 gene was used.  Complementation results are summarized in Table 4.2, 
and select mutant phenotypes are displayed in Figure 4.4. 
UL20 genes carrying the CL5, CL11, CL16, CL23, CL30, CL34, CL173, CL177, 
and CL209 mutations produced syncytia at levels similar to those produced by the 
positive control plasmid p20R containing the wild-type UL20 gene. Syncytia formation 
was completely absent in complementation assays with UL20 genes specifying the CL153 
mutation and all UL20p carboxyl terminal truncations (66t, 149t, 181t, 204t, and 211t) 
except the 216t truncation, which complemented virus-induced cell fusion (Fig. 4.4: 
panels E, G, I; Table 4.2). Other UL20 mutations had varying phenotypes with regard to 
the extent of syncytia formation (Table 4.2). As with the infectious virion production 
assay, the phenotype produced by the CL49 mutation was similar to that of Y49A, but not 
S50A or R51A (Table 4.2, Fig. 4.4: panels D, F, H, J).  Most mutant UL20 genes were 
either able or unable to complement both ∆20gBsyn3 and ∆20gKsyn1 viruses, although 
the level of complementation varied among the different UL20 mutant genes. However, 
the CL41 and CL46 mutant UL20 genes efficiently complemented gBsyn3, but not 
gKsyn1 virus-induced cell fusion indicating that these mutations had a differential effect  
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Table 4.2: Complementation results for cell fusion. 
gK (syn1) gB (syn3)
I CL5 ++++ ++++
I CL11 ++++ ++++
I CL16 ++++ ++++
I CL23 ++++ ++++
I CL30 +++ ++++
I CL34 +++ +++
I CL38 + +
I CL41 ++ ++++
I CL46 ++ ++++
I CL49 ++ ++
I         Y49A       ++ ++
I         S50A ++++ ++++
I         R51A ++++ ++++
III CL121 ++ ++
IV CL153 -- --
IV         E153A +++ ++++
IV         T154A ++++ ++++
IV         S156A ++++ ++++
IV         D158A ++++ ++++
IV CL173 +++ ++++
IV CL177 ++++ ++++
V CL209 +++ ++++
V         R209A ++++ ++++
V         T212A ++++ ++++
V         R213A +++ ++++
66t -- --
149t -- --
181t -- --
204t -- --
211t -- --
216t + +++
Truncations 
UL20-null complementation for cell fusion
Domain Mutation Name
 
 
The extent of cell fusion was scored by two observers as completely absent (--), or 
present at very low levels (+), moderate levels (++), near (+++) or at (++++) levels 
similar to those obtained with the wild-type UL20 gene.    
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Figure 4.4:  Complementation for virus-induced cell-to-cell fusion of UL20-null 
viruses containing syncytial mutations in gK(syn1) or gB(syn3). Vero cells were 
transfected with plasmids encoding wild-type or mutant UL20 genes and then infected 
with either the ∆20gKsyn1 or ∆20gBsyn3 viruses. Twenty-four hpi, cell fusion was 
determined by visualization of syncytia formation by fluorescence microscopy. The extent 
of syncytial formation (complementation) obtained with the negative control plasmid, 
p∆20NE (A) and positive control plasmid, p20R (B) are shown for reference purposes. 
Representative images for the CL38, 204t, 211t, and 216t mutants (C, E, G, I, 
respectively), and for the CL49, Y49A, S50A, and R51A (D, H, F, J, respectively) are 
shown. 
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of gBsyn3 versus gKsyn1-induced cell fusion (Table 4.2). The CL38 mutation, which is 
immediately proximal to the CL41 mutation, had an obvious defect in complementation 
for both gBsyn3 and gKsyn1-induced cell fusion (Table 4.2, Figure 4C). 
Plaque Phenotypes of ∆20gBsyn3 and ∆20gKsyn1 Recombinants Containing Selected 
UL20 Mutations 
 
 To further investigate the ability of UL20 mutant genes to complement for virus-
induced cell fusion caused by the gBsyn3 or gKsyn1 virally encoded mutations, specific 
recombinant viruses expressing UL20p mutant genes were isolated by rescue of the UL20 
gene deletion of the ∆20gBsyn3 and ∆20gKsyn1 viruses. Recombinant viruses were 
identified by a lack of EGFP expression on Vero cells. Viral plaques produced by each 
recombinant virus were characterized as small plaques, if they contained on the average 
no more than 75 cells, or large plaques, if they contained more than 250 cells per plaque. 
As expected, we were unable to isolate recombinants expressing the CL153, 66t, 149t, 
181t, 204t, or 211t mutations on Vero cells, while rescue with the wild-type UL20 gene 
resulted in viruses that formed large syncytial plaques similar to the viruses carrying the 
gBsyn3 or gKsyn1 mutations alone (Fig. 4.5: panels A, G). Recombinant viruses carrying 
the gKsyn1 mutation and either the CL41 or CL46 UL20 mutation produced small 
syncytial plaques on Vero cells (Fig. 4.5: panels C, D), while the recombinant viruses 
carrying the gBsyn3 mutation and either the CL41 or CL46 mutation produced large 
syncytial plaques on Vero cells (Fig. 4.5: panels I, J).  Recombinant viruses containing the 
CL38 mutation (Fig. 4.5, panels B, H), or the CL49 mutation (Fig. 4.5, panels E, K) in the 
gBsyn3 or gKsyn1 genetic background produced significantly smaller syncytial plaques 
than the gBsyn3 or gKsyn1 viruses specifying the wild-type UL20 gene. The gBsyn3 or 
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Figure 4.5:  Plaque phenotypes of ∆20gKsyn1 (A, B, C, D, E, F) and ∆20gBsyn3 (G, 
H, I, J, K, L) derived recombinant viruses containing selected UL20 mutations on 
Vero cells. Confluent cell monolayers were infected with the recombinant viruses 
containing wild-type UL20 (A, G), or the UL20 mutants CL38 (B, H), CL41 (C, I), CL46 
(D, J), CL49 (E, K), or 216t (F, L), and viral plaques were visualized by 
immunohistochemistry at 24 hpi. 
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gKsyn1 recombinant viruses specifying the 216t mutation produced syncytial plaques 
similar in size to the gBsyn3 or gKsyn1 viruses (Fig. 4.5: panels F, L).   
Plaque Phenotypes of Selected UL20 Mutations in the Context of Wild-Type gB and 
gK Genes  
 
 Attempts were made to isolate recombinant viruses specifying each of the 31 
engineered UL20 mutation in the ∆20 genetic background specifying wild-type gB and 
gK genes. As expected, the CL153 mutation and all of the UL20p truncations except 216t 
failed to yield recombinant viruses on Vero cells. Most other UL20 mutations produced 
non-syncytial virus plaques on Vero cells of similar size to recombinant viruses produced 
by rescuing the ∆20 virus with the wild-type UL20 allele in agreement with initial 
complementation results. Interestingly, recombinant viruses were isolated containing the 
CL49, Y49A, and 216t mutations, which allowed complementation for virus-induced cell 
fusion, but exhibited deficiencies in infectious virus production (Fig. 4.3: panels A, B; 
Table 4.2;  Fig. 4.4: panels D, F, I). Recombinant viruses containing the CL49, Y49A, 
216t, CL209, and R209A mutations produced partially syncytial plaques on Vero cells 
(Fig. 4.6: panels B1, C1, F1, G1, H1) suggesting that specific UL20 domains were 
involved in virus-induced cell fusion. In contrast, these viruses produced non-syncytial 
plaques when plated on the G5 cells (Fig. 4.6: panels B2, C2, F2, G2, H2) indicating that 
the wild-type UL20 gene expressed by G5 cells was dominant over UL20 syncytial 
mutations. In the amino terminus of UL20p, recombinants expressing the S50A and R51A 
mutations, which are immediately proximal to the Y49A and contained within the CL49 
mutation, did not cause syncytial plaque formation suggesting that mutation of the Y  
residue is responsible for the resultant syncytial phenotype (Fig. 4.6: compare panels B1, 
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Figure 4.6:  Domains of UL20p associated with UL20p-induced cell fusion. Plaque 
phenotypes of recombinant viruses containing selected UL20 mutations are shown 
on Vero (A1, B1, C1, D1, E1, F1, G1, H1, I1, J1) and G5 (A2, B2, C2, D2, E2, F2, G2, 
H2, I2, J2) cells.  Confluent cell monolayers were infected with recombinant viruses 
containing wild-type UL20 (A1, A2), or the UL20 mutants CL49 (B1, B2), Y49A (C1, 
C2), S50A (D1, D2), R51A (E1, E2), 216t (F1, F2), CL209 (G1, G2), R209A (H1, H2), 
T212A (I1, I2), or R213A (J1, J2) at an MOI of 0.001, and viral plaques were visualized 
at 30 hpi.  White arrows indicate syncytia formation. 
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 C1 with D1, E1). In the carboxyl terminus of UL20p, recombinant viruses expressing the 
CL209 and R209A mutations produced partially syncytial plaques on Vero cells, while 
those expressing the T212A and R213A did not (Fig. 4.5: compare panels G1, H1 with I1, 
J1), suggesting that the R residue at position 209 is responsible for the CL209 syncytial 
phenotype. On average, syncytia produced by recombinant viruses expressing the 
carboxyl terminal syncytial mutations 216t, CL209, and R209A were larger than those 
produced by the amino terminal syncytial mutations CL49 and Y49A. 
Ultrastructural Characterization of Recombinant Viruses Carrying Mutations 
Within the Amino and Carboxyl Termini of UL20p 
 
 To evaluate the intracellular virion distribution of the recombinant viruses 
specifying the 216t, CL49 and Y49 UL20 mutations, Vero cells infected with UL20p 
wild-type and mutant viruses at an MOI of 5 were examined via electron microscopy at 24 
hours post infection. As previously shown (Foster et al., 2004), the ∆20 (UL20-null) virus 
caused accumulation of unenveloped capsids into the cytoplasm in infected Vero cells 
(Fig. 4.7: panel A). In contrast, the ∆20-rescued virions were transported to extracellular 
spaces and exhibited no apparent cytoplasmic defects (Fig. 4.7: panel B). Importantly, 
infection with the 216t mutant virus resulted in an accumulation of capsids in the 
cytoplasm (Figure 7: panels C, D, E, F), similar to the UL20-null phenotype. Similarly, 
infection with the CL49 mutant resulted in the accumulation of capsids as well as small 
percentage of enveloped particles within the cytoplasm (Figure 8: panels A, B). The 
Y49A mutant virus produced the same ultrastructural phenotype as the CL49 mutant (Fig. 
8: panel C). The S50A and R51A mutants exhibited no apparent defects in intracellular 
morphogenesis, appearing to have an intracellular distribution similar to wild type KOS 
virus (Fig. 8: panels D and E).  
192 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7:  Electron micrographs of Vero cells infected with ∆20DIV5 (A), ∆20-
rescue (B) or 216t (C, D, E, F) viruses. Confluent cell monolayers were infected at an 
MOI of 5, incubated at 37°C for 24 hours, and prepared for transmission electron 
microscopy. Panel D shows a higher magnification of panel C. Panel F shows a partially-
enveloped capsid often seen in UL20-null infected cells. Nuclear (n), cytoplasmic (c) and 
extracellular (e) spaces are marked.  
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Figure 4.8: Electron micrographs of Vero cells infected with the CL49 (A, B), Y49Α 
(C), S50A (D) or R51A (E) viruses. Confluent cell monolayers were infected at an MOI 
of 5, incubated at 37°C for 24 hours, and prepared for transmission electron microscopy. 
Nuclear (n), cytoplasmic (c) and extracellular (e) spaces are marked. 
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DISCUSSION 
 The UL20 gene has been implicated in virion egress, virus-induced cell fusion, 
Golgi fragmentation, and Golgi-dependent glycosylation of HSV-1 viral glycoproteins 
(Avitabile et al., 1995; Avitabile et al., 1994; Baines et al., 1991; Fuchs et al., 1997). 
Recently, we showed that a precise deletion of the UL20 gene caused accumulation of 
capsids into the cytoplasm indicating that UL20 functioned in cytoplasmic events of 
virion morphogenesis. Moreover, lack of UL20p prevented virus-induced cell fusion 
caused by syncytial mutations in either gB or gK suggesting that UL20p plays important 
regulatory roles in membrane fusion phenomena associated with virion morphogenesis 
and virus-induced cell fusion (Foster et al., 2004). In this report, we constructed and 
characterized a panel of 31 different mutations within UL20p to delineate domains of 
UL20p functioning in virion morphogenesis and virus-induced cell fusion. Analysis of the 
various mutant phenotypes reveals that UL20p contains at least three domains involved in 
virion morphogenesis and virus-induced cell fusion: The amino and carboxyl termini of 
UL20 (domains I and V), which are predicted to lie on the cytoplasmic side of 
membranes, and UL20p domain IV, which is predicted to lie extracellularly. Overall, the 
data suggest that the UL20p’s role in virus-induced cell fusion can be functionally 
separated from its role in cytoplasmic virion morphogenesis, and that certain UL20p 
domains that function in gB-syn3-mediated virus-induced cell fusion are distinct from 
those functioning in gKsyn1-mediated virus-induced cell fusion. 
The Predicted Membrane Topology of UL20p 
 Computer assisted prediction of the membrane spanning domains of UL20p 
indicated that UL20p spanned membranes four times placing both the amino (domain I) 
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and carboxyl terminal (domain V) portions within the cytoplasm of cellular membranes 
and internal to the virion envelope. This predicted structure includes two domains, a very 
small domain of 5 amino acids (domain II) and a second domain of 25 amino acids 
(domain IV), predicted to be localized in the lumen (extracellular) and external to the 
virion envelope. Initial epitope tagging results indicate that domain I is located 
intracellularly, while domain IV is located extracellularly in support of this model (data 
not shown). However, additional work is required to fully confirm this UL20p topology 
model. Domain I is the largest domain (63 aa) and it includes stretches of acidic amino 
acid (D, E) clusters, which could form electrostatic interactions with other proteins. These 
acidic clusters as well as the amino acid motif YXXΦ (YSRL) have been shown to 
function in endocytosis of alphaherpesvirus envelope proteins from plasma membranes to 
the TGN (Alconada, Bauer, and Hoflack, 1996; Alconada et al., 1999; Brideau et al., 
1999; Tirabassi and Enquist, 1999; Zhu et al., 1996). The acidic cluster motifs appear to 
direct TGN localization by binding to a cellular connector protein, PACS-1, which 
connects the glycoproteins to the AP-1 complex (Wan et al., 1998), while the YXXΦ 
motif binds adaptor proteins directly (2, 3, 40).  
UL20p Domains that Function in Infectious Virus Production and Virus-Induced 
Cell Fusion 
 
 To delineate the functional domains of UL20p, we constructed a panel of 
mutations within the UL20 gene coding for cluster-to-alanine replacements, single amino 
acid substitutions and carboxyl terminal truncations. Complementation experiments of the  
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Table 4.3:  Differential effects of mutations on infectious virion production and cell 
fusion. 
 
 
 
 
 
 
gKsyn1 gBsyn3
I CL5, CL11, CL16, CL23, CL30, 
CL34, CL121, CL173, CL177, 
CL209
Yes High High
II CL153, 66t, 149t, 181t, 204t, 
211t
No No No
III CL49, 216t No Low Low (CL49)
High (216t)
IV CL38, CL41, CL46 Yes Low Low (CL38)
High (CL41, CL46)
Complementation for Virus-Induced Cell 
FusionMutants Group
Complementation for 
Infectious Virion 
Production
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HSV-1 (KOS) UL20-null virus, in the presence or absence of either the gBsyn3 or 
gKsyn1 mutations, using each mutant UL20 gene revealed that most mutations could be 
broadly categorized into four major groups based on their differential effect on infectious 
virus production and virus-induced cell fusion (Table 4.3). Group I mutations 
complemented infectious virus production and virus-induced cell fusion. These mutations 
included: the CL5, CL11, CL16, CL23, CL30 in the amino terminus of UL20p (domain 
I); CL121 (domain III); CL173, CL177 (domain IV); CL209 (domain V). Considering 
that these cluster mutations involved replacement of multiple amino acids to alanine 
residues, these results indicate that UL20p regions spanned by these mutations were not 
crucial for the structure and functions of UL20p.  
Group II mutations were unable to complement infectious virus production and 
virus-induced cell fusion. These mutations included the CL153, 66t, 149t, 181t, 204t, and 
211t mutations. The 66t, 149t and 181t mutations specify large carboxyl terminal UL20p 
truncations, which are expected to drastically affect the synthesis, transport and membrane 
topology of UL20p. Therefore, it is not surprising that these mutations failed to 
complement both infectious virus production and virus-induced cell fusion. The 204t and 
211t mutations encode carboxyl terminal truncations of 18 and 11 aa, respectively, 
encompassing UL20p domain V. Although, these deletions are rather small and not 
predicted to affect the membrane incorporation and topology of UL20p (not shown), they 
may still affect the structure and function of UL20p. Alternatively, this UL20p carboxyl 
terminal domain may be involved in protein-protein interactions necessary for UL20p-
associated viral functions. The UL20p domain IV is predicted to lie in the lumen or 
extracellular side of membranes. Based on the fact that the CL173 and CL177 mutations 
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complemented the UL20-null virus, but the CL153 did not, the data suggests that amino 
acids 150-156 are important in infectious virus production. However, none of the single 
amino acid changes, E153A, T154A, S156A and D158A significantly altered UL20p’s 
ability to complement the UL20-null virus suggesting that the combined effect of the 
CL153 mutations may affect the conformation of this domain. Alternatively, this domain 
may interact with lumenal portions of other viral glycoproteins, such as gB or gK, to 
facilitate infectious virus production and virus-induced cell fusion.  
Group III mutations included the CL49 and 216t mutations, located at the amino 
and carboxyl termini of UL20p, respectively, which complemented for virus-induced cell 
fusion at a reduced level, but failed to efficiently complement infectious virus production. 
The carboxyl terminus of UL20p (Domain V) is composed of 18 amino acids and 
predicted to localize intracellularly. The 216t complementation results suggest that the 
terminal six amino acids of UL20p are crucial for infectious virus production. This result 
was further corroborated by the recombinant virus expressing the 216t mutation, which 
produced an ultrastructural phenotype similar to the UL20-null virus characterized by the 
accumulation of unenveloped capsids into the cytoplasm. The 216t mutation was able to 
complement both gBsyn3 and gKsyn1-induced cell fusion, albeit at lower levels than the 
wild-type UL20 gene. However, the recombinant virus carrying the 216t mutation in the 
∆20syn1 and ∆20syn3 genetic backgrounds revealed no apparent differences in the size 
and extent of syncytial plaque formation in comparison to the corresponding ∆20syn1 and 
∆20syn3 viruses expressing the wild-type UL20 allele indicating that the UL20 216t 
mutation did not adversely affect virus-induced cell fusion.  
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The CL49 mutant phenotype in the amino terminus of UL20p is of particular 
interest because alignment of the predicted amino acid sequences of multiple UL20 
homologues encoded by alphaherpesviruses revealed conservation of certain amino acid 
motifs within the UL20p amino terminus (not shown). One such motif is the YXXΦ 
(YSRL) amino acid sequence overlapping the CL49 mutated sequence, which is 
conserved in HSV-1, HSV-2, and cercopithecine herpesvirus 1 and 2, but not in varicella 
zoster (VZV) or pseurodabies virus (PRV) (not shown). This motif is known to function 
in the retrieval of cell-surface expressed proteins to the TGN compartment (Canfield et 
al., 1991; Johnson and Kornfeld, 1992; Kirchhausen, Bonifacino, and Riezman, 1997; 
Marks et al., 1996; Mellman, 1996; Trowbridge, Collawn, and Hopkins, 1993). 
Mutagenesis of the Y residue of a YXXΦ (YTKI) motif within gK domain IV, shown to 
lie in the cytoplasmic side of membranes, produced a gK-null phenotype (Foster and 
Kousoulas, 1999). Similarly, site directed mutagenesis of the Y49, S50 and R51 residues 
within this motif revealed that only the Y49A mutation caused failure to complement the 
UL20-null virus indicating that this tyrosine residue played an important role in infectious 
virus production. Tyrosine residues within YXXΦ motifs are known to be potentially 
phosphorylated. Therefore, it is possible that the Y(49) residue of UL20p is 
phosphorylated, and that this phosphorylation may be required for proper intracellular 
localization and function of  UL20p. This result was further supported by the 
ultrastructural phenotype of the recombinant viruses expressing the CL49 and Y49A 
mutations, both of which showed an accumulation of unenveloped capsids into the 
cytoplasm similar to that of the UL20-null virus. However, the CL49 and the Y49A 
mutations complemented, albeit at reduced levels, both gBsyn3 and gKsyn1 induced cell 
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fusion suggesting that these mutations only partially inactivated UL20p functions required 
for virus-induced cell fusion. This result was further supported by the small size, but 
syncytial plaque phenotype of the recombinant viruses expressing the CL49 mutation in 
either the gKsyn1 or gBsyn3 genetic background. 
Group IV mutations exhibited a variable effect on virus-induced cell fusion, but 
did not drastically reduce infectious virus production. Specifically, the CL38 UL20 
mutant gene complemented virus-induced cell fusion caused by the ∆20gBsyn3 and 
∆20gKsyn1 viruses at low levels, while the CL41 and  CL46 mutant genes complemented 
∆20gKsyn1 at low levels but ∆20gBsyn3 at high levels and equivalent to 
complementation levels produced with the wild-type UL20 gene. The initial 
complementation results were further supported by the recombinant viruses carrying 
either the CL41 or CL46 mutation in the gKsyn1 or gBsyn3 genetic background. 
Specifically, the gKsyn1 recombinants carrying either the CL41 or CL46 mutations 
produced small syncytial plaques, while the gBsyn3 recombinants carrying either the 
CL41 or CL46 mutations  produced large syncytial virus plaques indistinguishable to the 
gBsyn3 recombinant virus carrying the wild-type UL20 allele. These results suggest that 
the UL20p amino terminus domain demarcated by the CL38-CL46 mutations is important 
in virus-induced cell fusion; however, the specific amino acid requirements within this 
domain may be different for gBsyn3 versus gKsyn1-induced cell fusion. 
UL20p Mutations that Cause Virus-Induced Cell Fusion 
Characteristically, recombinant viruses expressing the CL49, Y49A, CL209, 
R209A and 216t UL20p mutations in a wild-type genetic background formed small 
syncytial plaques on Vero cells. Recombinant viruses specifying the T212A and R213A 
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mutations did not produce syncytial plaques on Vero cells indicating that the R209A 
mutation was responsible for the syncytial phenotype of the CL209 mutation. Thus, it is 
evident that the amino and carboxyl termini of UL20p are directly associated with virus-
induced cell fusion in the context of wild-type gB or gK expression. Therefore, the ability 
of these mutations to complement either gBsyn3 or gKsyn1 virus-induced cell fusion 
discussed earlier may be in part due to the inherent fusogenic character of the mutated 
UL20p. Most likely, this is not the case because recombinant viruses carrying the UL20 
R209A syncytial mutation as well as either the gBsyn3 or gKsyn1 mutation did not 
exhibit increased virus-induced cell fusion in comparison to viruses specifying either the 
gBsyn3 or gKsyn1 mutations and the wild-type UL20 gene (not shown). Alternatively, 
UL20p may function as a regulator of virus-induced cell fusion through interactions with 
other viral proteins such as gB and gK and disruption of these interactions by specific 
UL20p mutations may result in syncytia formation. 
Deletion of the gK gene or lethal gK mutations cause entrapment of enveloped 
virions within cytoplasmic vesicles presumably originating from the TGN compartment 
and the accumulation of unenveloped capsids in the cytoplasm (Foster and Kousoulas, 
1999; Jayachandra, Baghian, and Kousoulas, 1997). Similarly, deletion of the UL20 gene, 
or lethal UL20p mutations cause accumulation of unenveloped capsids into the cytoplasm 
and a small portion of enveloped capsids within cytoplasmic vesicles (Foster et al., 2004; 
Fuchs et al., 1997). These results suggest that UL20p and gK may have interrelated 
functions with regard to cytoplasmic virion envelopment. The fact that the Y49A, CL49 
and 216t mutant viruses produced syncytial plaques, although their ultrastructural 
phenotypes seemed to be similar to that of the UL20-null virus suggests that UL20 
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functions for virus-induced cell fusion may be distinct from those functioning in 
cytoplasmic virion envelopment. Alternatively, the same domains may function in both 
cytoplasmic virion envelopment and virus-induced cell fusion; however, virion 
envelopment may be more susceptible to the negative effects of these mutations in 
comparison to virus-induced cell fusion.   
Overall, our previous findings and the results presented in this paper suggest the 
existence of functional interactions between gK and UL20p as well as between UL20p 
and gB. In this regard, it is interesting to note that syncytial mutations in gB lie in the 
intracellular carboxyl terminus of gB allowing the possibility that intracellular domains of 
UL20p (domains I and V) directly or indirectly interact with the carboxyl terminus of gB 
altering gB’s fusogenic properties. 
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CHAPTER V 
CONCLUDING REMARKS  
 
SUMMARY 
 The Herpes Simplex Virus life cycle contains a number of membrane fusion 
events that must function properly to ensure a productive infection, including:  virus 
attachment and entry into susceptible cells, de-envelopment at the outer nuclear 
membrane, and virus-induced cell-to-cell fusion. Virus-induced cell-to-cell fusion is 
mediated by viral glycoproteins expressed on cellular membranes and has been 
extensively studied for several reasons:  as a probe of the structure and function of 
cellular membranes during infection reflected in their behavior, as a tool for analysis of 
the functions of viral membrane proteins, and as a model of the initial interaction 
between HSV and susceptible cells that results in fusion of the viral envelope with the 
cellular plasma membrane (Campadelli-Fiume and Serafini-Cessi, 1985; Roizman, 1962; 
Spear, 1985; Spear, 1993).   
  A virus-free cell fusion assay was recently developed in order to attempt to 
understand the underlying mechanisms that are responsible for viral fusion events.  In this 
system, transiently expressed gB, gD, gH, and gL are necessary and sufficient to induce 
syncytia formation in certain cell types (Turner et al., 1998).  The transient fusion assay 
was utilized in Chapter II to investigate the effect of mutations targeted to the carboxyl 
terminus of gB.  First, it was demonstrated that the predicted α−helical domain H17b 
within the carboxyl-terminus of gB is involved in both virus-induced and virus-free 
fusion systems. Second, heparin was shown to be a specific inhibitor of gB-mediated 
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fusion in both systems. Third, resistance to heparin inhibition of gB-mediated cell fusion 
was associated with the predicted α−helical structure H17b. Thus, gB-mediated fusion is 
functionally similar for both fusion assays.  The observed enhancement of cell fusion 
resulting from the disruption of H17b raises the question of how H17b regulates 
membrane fusion.  In this regard, it is possible that during a productive infection other 
viral proteins interact with this region in the carboxyl terminus of gB to inhibit aberrant 
membrane fusion from occurring.  Alteration of the conformation of the gB carboxyl 
terminus may cause an activation of the fusogenic potential of gB, disengaging gB from 
other viral or cellular controls and resulting in unregulated membrane fusion. 
 The sole requirement for gB, gD, gH, and gL in the transient membrane fusion 
system is similar to the requirement for virus entry. An important difference between the 
virus-free and virus-induced membrane fusion systems is that virus-expressed gB-
mediated low amounts of cell-to-cell fusion, while transient expression of gB causes 
significant amounts of cell-to-cell fusion. This observation has prompted the hypothesis 
that additional viral proteins exert negative control on gB-mediated cell fusion, with the 
primary candidates being viral proteins and glycoproteins such as UL20p and gK that 
themselves contain syncytial mutations. In this regard, syncytial mutations in gK and 
UL20p could be thought to inactivate the negative regulatory control of these molecules 
on gB function, thus releasing the natural fusogenic properties of gB.  In support of this 
hypothesis, gK was shown to inhibit cell fusion resulting from transiently expressed gB, 
gD, gH and gL, while a syncytial gK variant showed a decreased ability to inhibit cell 
fusion (Avitabile, Lombardi, and Campadelli-Fiume, 2003).  In addition, it was 
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previously shown that gB is absolutely required for virus-induced cell fusion to occur 
resulting from syncytial mutations in UL53 (gK) (Cai, Gu, and Person, 1988).  
 However, in herpesviruses, complexity seems to prevail over simplicity; and we 
showed in Chapter III that gK can not solely act as a negative regulator of gB-mediated 
membrane fusion, since gK is absolutely required for virus-induced cell fusion to occur 
resulting from the gBsyn3 syncytial mutation.  Moreover, the gBamb1511 mutation that 
disrupts H17b could not cause virus-induced cell fusion in the absence of gK.  These 
findings definitively abolish the hypothesis that gK is an inhibitor of virus-induced cell 
fusion and suggests a more complicated relationship between gK and gB. Interestingly, a 
similar result was reported for gM, which inhibited membrane fusion in the transient 
coexpression system (Klupp, Nixdorf, and Mettenleiter, 2000; Koyano et al., 2003), but 
was required for virus-induced cell fusion caused by syncytial mutations in gB (Davis-
Poynter et al., 1994).  In addition, gE, gI, and UL20 were all shown to be required for the 
virus-induced fusion of cellular membranes (Davis-Poynter et al., 1994; Foster et al., 
2004a), while these proteins were not required for fusion to occur in the transient system.  
Consequently, these results indicate that regulation and activation of the herpesvirus 
membrane fusion machinery during virus-induced cell fusion is mediated by a complex 
of many different viral proteins. Alternatively, additional functions of other glycoproteins 
may be required prior to gB-mediated membrane fusion. These functions may involve 
tighter binding to additional cellular co-receptors on opposed membranes that may  
render a more favorable environment for enabling gB’s fusogenic properties.  
 HSV-1 is thought to acquire an initial envelope when capsids formed in the 
nucleus of cells bud into the perinuclear space. Subsequently, a putative fusion event 
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between viral envelopes and the outer nuclear membrane, termed de-envelopment, results 
in capsid release into the cytoplasm. Final envelopment is thought to occur when 
cytoplasmic capsids bud into vesicles derived from the TGN or endosomes that facilitate 
egress of enveloped virions to extracellular spaces. Previously, it was not known whether 
viral glycoproteins involved in virus entry or virus-induced cell fusion also function in 
the de-envelopment step. The results presented in Chapter III clearly show that gK, UL20 
and gB are not essential for virion de-envelopment. In the case of gB, previous studies 
suggested that lack of gB did not adversely influence egress of virion particles to 
supernates of infected cells, although these virions lacked gB and were rendered non-
infectious (Cai et al., 1987; Cai, Gu, and Person, 1988). Ultrastructural examination of 
the gB-null virus confirmed initial findings and clearly showed that gB is not required for 
efficient production of enveloped virions in extracellular spaces. Examination of 
recombinant viruses specifying single gene deletions in either gB, gK or UL20p did not 
exclude the possibility that gB and gK could function in a redundant manner to facilitate 
virion de-envelopment. This possibility can be discounted on the basis that both the 
gB/gK double null virus and the gB/UL20 double null virus efficiently produced 
unenveloped capsids into the cytoplasm of infected cells.   However, the possibility still 
exists that gH/gL could mediate de-envelopment in the absence of either gB and gK or 
gB and UL20.   
 Recently, we showed that a precise deletion of the UL20 gene caused 
accumulation of unenveloped capsids into the cytoplasm indicating that the HSV-1 
UL20p functioned in cytoplasmic stages of virion envelopment and that the previously 
reported partial deletion of the UL20 gene caused a predicted fusion of the UL20p to the 
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adjacent UL20.5 gene. In addition, syncytial mutations in either gB or gK failed to cause 
fusion in the absence of the UL20 gene, suggesting that the UL20 protein was essential 
for virus-induced cell fusion (Foster et al., 2004a).  In Chapter IV, we delineated via site-
directed mutagenesis the functional domains of UL20p involved in infectious virus 
production and virus-induced cell fusion. The data suggest that UL20p’s role in virus-
induced cell fusion can be functionally separated from its role in cytoplasmic virion 
morphogenesis, and that UL20p domains that function in gB-syn3 virus-induced cell 
fusion are distinct from those functioning in gKsyn1 virus-induced cell fusion. 
 As a result of the research presented here, several hypotheses concerning the 
herpesvirus fusion machinery were successfully addressed.  We found that syncytial 
mutations in gB can act differently in a virus-induced versus a virus-free fusion system, 
while identifying a region of gB involved in the regulation of membrane fusion. In 
addition, we found that gK is required for virus-induced cell fusion to occur, despite its 
apparent inhibitory effect in virus-free systems.  We eliminated the proposed hypothesis 
of redundant functions for gB and gK in the fusion event occurring during virion de-
envelopment.  Furthermore, we identified the specific regions of UL20 required for virion 
egress and virus-induced cell fusion and demonstrated separation of the two functions.  
The results presented here represent significant progress into the understanding of 
herpesvirus membrane fusion, but there is still a great deal of knowledge that must be 
obtained to fully decipher the mechanisms involved. 
CURRENT AND FUTURE RESEARCH CHALLENGES 
 The work completed on mutagenesis of the UL20 protein has left several open 
questions regarding the functional interrelationship between gK and UL20p. Recently, 
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our laboratory showed that UL20 and gK are interdependent for transport out of the 
endoplasmic reticulum, transport to the plasma membrane, and internalization to the 
trans-Golgi network (Foster et al., 2004b); however, the domains of either protein 
required for proper localization have not been examined.   The data presented in Chapter 
IV revealed several mutant forms of UL20p that showed defects in function for virus-
induced cell fusion and/or final envelopment.  As a result, we sought to identify whether 
or not the deficiencies could be attributed to a malfunction in protein transport and 
localization.  If a mutant UL20p was unable to transport gK, this would indicate that the 
mutation potentially affects either an interacting domain or the ability of the UL20 
protein to fold correctly; whereas if the mutant UL20p transports gK correctly, then the 
mutation would be thought to affect a UL20 domain involved in interactions with other 
viral or cellular components critical for proper function.   
To investigate the ability of each UL20p mutant to transport gK, Vero cells were 
co-transfected with a plasmid coding for gK as well as with plasmids encoding wild-type 
or mutant UL20p.  The transport and localization of both UL20p and gK was determined 
by confocal microscopy.  An αTGN46 pAb was used to determine colocalization with 
the TGN.  As expected, wt UL20 and 216t, which complemented the UL20-null fusion 
defect, are able to mediate gK and UL20 colocalization at the TGN (Fig. 5.1: A, F). 
CL153 and 204t, which were not able to complement the UL20-null defect, are not able  
to mediate gK translocation from the endoplasmic reticulum (ER), and both retain an ER 
like distribution (Fig. 5.1: C, D).  In contrast, both CL61 and 211t, which were both 
unable to complement the UL20-null defect, are able to mediate colocalization with gK at 
the TGN (Fig. 5.1: B, E).   
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Figure 5.1:  gK localization at the TGN mediated by selected UL20p mutants.  Vero 
cells were co-transfected with gKD1V5 as well as with plasmids encoding wild-type or 
mutant UL20p.  36 hours post-transfection, cells were washed thoroughly, fixed, and 
processed for confocal microscopy.  After permeabilization, rabbit αFLAG pAb was used 
to identify UL20, and sheep αTGN46 pAb was used to identify the TGN.   
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Figure 5.2:  gK cell surface expression and endocytosis to the TGN mediated by 
selected UL20p mutants.  Vero cells were co-transfected with gKD1V5 as well as with 
plasmids encoding wild-type or mutant UL20p.  24 hours post-transfection, cells were 
incubated under live conditions with aV5 (gK) mAb for 6 hours.  Cells were washed 
thoroughly, fixed, and processed for confocal microscopy.  After permeabilization, rabbit 
αFLAG pAb was used to identify UL20, and sheep αTGN46 pAb was used to identify 
the TGN.   
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 An internalization assay was also performed to determine whether gK was 
expressed on cell surfaces and subsequently internalized to the TGN.  Results obtained 
were similar as those in the colocalization experiments.  As expected, wt UL20 and 216t 
are able to mediate gK surface expression and subsequent endocytosis to the TGN (Fig. 
5.2: A, F).  CL153 and 204t are not able to mediate gK internalization, and the mutant 
UL20 retains an endoplasmic reticulum (ER)-like distribution (Fig. 5.2: C, D).  Again, 
both CL61 and 211t, which were both unable to complement the UL20-null defect, are 
able to mediate gK surface expression and internalization to the TGN (Fig. 5.2: B, E).  
The CL61 mutation is located adjacent to a predicted transmembrane region and may 
affect the correct folding of domains that are not required for proper localization.   
Taken together, these results indicate that UL20-mediated transport of gK to the 
cell surface and subsequent internalization ot the TGN is not sufficient for UL20/gK to 
function properly in virion egress or virus induced cell-to-cell fusion. Specific domains of 
UL20 must be involved in interactions with viral or cellular proteins.  The differing 
results of the carboxyl-terminal truncations of UL20 indicate that further work must be 
done to understand the function of the carboxyl terminus of UL20 in virion egress and 
virus-induced cell fusion.  
 In the amino terminus of UL20, the mutations CL38 and CL49 previously showed 
interesting but opposing phenotypes, whereby CL38 was virtually non-functional in cell 
fusion and CL49 showed a severe defect in virion egress (see Chapter IV). Interestingly, 
both CL38 and CL49 are able to mediate gK localization at the TGN (data not shown).  
Our hypothesis was that a double mutation containing both CL38 and CL49 should 
eliminate both aspects of UL20 function, and the ability of the CL38-49 mutant to 
219 
transport gK would be tested as well to evaluate the nature of the defect in function.  
Preliminary complementation experiments indicate that the CL38-49 mutation does 
indeed eliminate the function of UL20 in both virus-induced cell fusion and infectious 
virus production.  In addition, recombinant viruses containing the CL38-49 mutation 
were not readily isolated on non-complementing cells, indicating that the mutation is 
probably lethal to virus infectivity.  Analysis of CL38-49 and gK transport revealed that 
there is no apparent defect in cellular localization (data not shown).  As a result, further 
analysis must be done to characterize the nature of the CL38-49 defect.  Hopefully, 
deciphering the basis of function of the tyrosine residues at positions 38 and 49 in UL20 
will provide a clearer picture of the role that UL20 plays in the virus life cycle.   
 The UL20 gene encodes a protein of 222 amino acids with a predicted mass of 
24kDa. However, as depicted below, UL20p is visualized as a 30-32 kDa protein 
consisting of multiple protein species (Fig. 5.3: A).  Cluster-to-alanine mutagenesis 
revealed that mutations within the UL20p amino terminus altered the apparent molecular 
mass of UL20p-related proteins, indicating that the UL20p amino terminus is potentially  
post-translationally modified (data not shown).  The amino terminus of UL20p contains 
multiple potential phosphorylation sites as predicted by NetPhos 2.0 (Blom, Gammeltoft, 
and Brunak, 1999).  Interestingly, the tyrosine residues at position 38 and 49 have the 
potential for phosphorylation.  Current and future experiments are targeted to determine 
the nature of these UL20p modifications. 
 In order to ascertain whether or not UL20p is phosphorylated, infections of UL20-
null or wild type virus were performed with the presence of 32P (orthophosphate) in 
phospahate-free media at late times post infection.  A portion of extracted protein was 
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Figure 5.3:  Western analysis and potential phosphorylation of UL20p.  (A) Vero 
cells were either untransfected or transfected with a plasmid specifying UL20p with an 
amino terminal 3xFLAG epitope tag prior to infection with a UL20-null virus.  Western 
analysis of UL20p was performed utilizing a FLAG mAb. (B, C) Vero cells were infected 
with either a UL20-null or a wild-type virus that encodes UL20p with an amino terminal 
3xFLAG epitope tag at an MOI of 10.  11 hours post infection, the media was replaced 
and cells were incubated with phosphate-free media for 1 hour.  Phosphate-free media 
containing 32P (orthophosphate, 250 µCi/mL) was then added for 6 hours before cell 
lysates were prepared and immunoprecipitation of UL20 was performed.  The 32P profiles 
of the total lysate (B) and the UL20 immunoprecipitations (C) are shown above.  
Asterisks are provided to show corresponding bands representing UL20p. 
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used for immunoprecipitation of UL20, and both the total cellular extracts and the 
immunoprecipitated UL20 were analyzed after SDS-PAGE utilizing the Perkin Elmer 
Cyclone Storage Phosphor Imaging System (Fig 5.3: B, C).  While the 32P total viral 
protein profile did not reveal any significant differences between the UL20-null and the 
wild-type virus, the 32P profile resulting from the UL20 immunoprecipitation clearly 
shows two bands present in only the wild-type sample around 30 kDa, which seem to 
correspond with the profile of UL20 seen through western blot analysis (Fig 5.3).  A 
group of higher molecular weight bands are also present between 60 and 90 kDa that may 
or may not be non specific background.  Further experiments must be performed to 
confirm the presence of phosphorylation on UL20p.  One approach to identifying the 
location of UL20p phosphorylation would be to screen the library of mutant UL20 genes 
that delete consensus phosphorylation sites.  The confirmation of phosphorylation on 
UL20p would imply that UL20 functions, including those during virion egress and virus-
induced cell fusion, could be regulated by cellular or viral kinases, whereby only one 
form of UL20p could properly function in gK transport to cell surfaces or final 
envelopment at the TGN.   Alternatively, UL20p phosphorylation could be required for 
interactions with gB that serve to regulate virus-induced cell fusion. 
 While genetic analysis has been successful in revealing the components involved 
in fusion processes, one of the biggest obstacles to truly understanding membrane fusion 
in herpesviruses is the complete lack of knowledge regarding the mechanism that triggers 
fusion between opposing membranes.  It would be of great interest to determine whether 
or not there is a conformational change in gB that results from the regulated activation of 
the membrane fusion machinery following the binding of gD to an entry receptor.  The 
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syncytial forms of gB provide a unique opportunity to study conformation changes in the 
ectodomain of gB, as syncytial mutations in gB reside almost exclusively in the 
cytoplasmic carboxyl terminus.  Therefore, changes from syncytial mutations resulting in 
a loss of regulation of the membrane fusion machinery could be thought to occur through 
“activation” of gB due to a conformational change in its extracellular N-terminus.  In 
Chapter II we found that heparin inhibition of membrane fusion could be circumvented 
through generation of specific mutations in the predicted alpha helical region, H17b, in 
the carboxyl terminus of gB.  Since the heparin binding sites of gB reside exclusively in 
its ectodomain, it is reasonable to suggest that resistance to heparin inhibition resulted 
from an alteration of gB’s conformation causing inability of gB to bind to heparin.  
Consequently, the ability of gB to bind to labeled soluble heparin could be used to map 
the potential activation of gB due to an altered conformation.  By eliminating potential 
heparin binding sites in the extracellular portion of gB through site directed mutagenesis, 
it would also be possible to study gB and its syncytial forms by comparison of the regions 
that are required for heparin inhibition of cell fusion with the regions that are modified 
due to syncytial mutations in H17b.    
 Since UL20p and gK are required for gB-mediated virus-induced cell fusion to 
occur, it would also be very important to examine whether or not the conformation of gB 
is altered in the presence or absence of UL20p and/or gK, implying a direct functional 
interaction between gB and UL20p or gK.  A similar method to that described above 
could be utilized to study the effect of additional viral proteins on the conformation of gB 
through its ability to bind to soluble heparin.  Such an understanding of the role of gB in 
membrane fusion could provide leads into the way that gB, gD, and gH/gL interact with 
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gK, UL20p and other viral or cellular proteins to regulate the potential of the herpesvirus 
membrane fusion machinery. 
Perhaps the least understood aspect of the herpesvirus life cycle is virion 
morphogenesis and egress.  After mature capsids envelope and de-envelope at the 
perinuclear space, they transit through an unknown mechanism to cytoplasmic vesicles 
where they obtain a final envelope.  The mechanism and components required for final 
envelopment are not clear; however, genetic analysis has identified gK and UL20p as 
potential candidates to mediate the final envelopment step.  Deletion of either UL20p or 
gK results in a cytoplasmic block in virion egress consisting of an accumulation of 
unenveloped and partially enveloped capsids in the cytoplasm of infected cells.  Through 
extensive targeted mutagenesis of UL20p, we sought to identify domains that were 
functional in protein localization and cell fusion, but not virion egress.  The available 
evidence seems to indicate that the carboxyl terminus of UL20 may interact with viral 
tegument proteins to assist in the final envelopment step.  Several candidate tegument 
proteins have been identified through careful examination of their ultrastructural 
phenotypes. One approach to identifying components of the egress pathway is to generate 
multiple deletions of viral tegument and membrane proteins.  We are currently generating 
double-null viruses containing deletions in UL20 and specific tegument proteins in an 
attempt to reveal redundant or sequential steps in the virion egress pathway.   
FINAL COMMENTS 
 Membrane fusion events occur regularly as necessary biological processes in the 
cell.  The fusion process itself is as an energetically unfavorable event necessitating the 
use of fusogenic proteins acting alone or as part of a complex to assist in overcoming the 
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forces that discourage fusion from occurring (Rand et al., 1988).  Endocytosis, 
exocytosis, and other intracellular membrane trafficking events are all mediated by fusion 
processes that occur continuously in the cell.  It is known that membrane fusion of 
transport vesicles to targeted intracellular membranes are carried out by complex “fusion 
machines” that consist of a core of integral proteins and also a number of peripheral 
regulatory proteins.   
 All enveloped viruses utilize membrane fusion between their viral envelopes and 
cellular membranes to facilitate entry into the cytoplasm of cells. Most enveloped viruses 
make use of a single fusogenic protein to mediate entry, and that fusion protein is also 
necessary and sufficient to confer fusion activity when expressed in tissue culture cells.  
Such is the case for the influenza virus hemagglutinin (HA) (Wiley and Skehel, 1987), 
human immunodeficiency virus type 1 (HIV-1) gp41 (Lifson et al., 1986; Sodroski et al., 
1986), Ebola virus GP2 (Takada et al., 1997), vesicular stomatitis virus glycoprotein 
(VSV-G) (Florkiewicz and Rose, 1984), and the coronavirus Spike protein (corona) 
(Xiao et al., 2003). Viral fusion proteins often combine into homotrimers that project 
from the viral envelope. Fusion proteins are usually are synthesized in an inactive form, 
and a conformational activation is required before optimal fusion activity is acquired 
under physiological conditions.   
The Herpes Simplex Virus life cycle contains a number of membrane fusion 
events, including:  virus attachment and entry into susceptible cells, de-envelopment at 
the outer nuclear membrane, and virus-induced cell-to-cell fusion.  In contrast to other 
enveloped viruses, the entry process of HSV-1 requires the presence of at least four 
glycoproteins: gB, gD, gH and gL.  These four membrane proteins are also necessary and 
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sufficient to mediate cell-to-cell fusion when expressed in tissue culture cells.  The 
mutations that cause extensive virus-induced cell-to-cell fusion in HSV-1 map 
predominantly to the genes that encode gB and gK.  The differential effects of UL20p 
mutations on the regulation of gB- and gK- mediated syncytia formation imply that 
functional intreractions occur between UL20p, gB, and gK.  The requirement for gK and 
UL20p in gB-induced syncytia formation provides further evidence for a functional 
protein complex.  In addition, preliminary results from our laboratory indicate that 
UL20p directly interacts with both gK and gB (personal communication, Dr. Timothy 
Foster).  Based on these results, we have proposed that the presence of a core complex of 
proteins involved in regulation of HSV-1 virus-induced cell fusion that we have termed 
the “Alphaherpesvirus Fuseosome” consisting of UL20p, gK, gB, gD, and the gH/gL 
heterodimer (Fig. 5.4). 
 It is important to note that the proposed complex appears to function only at cell 
surfaces during virus-induced cell fusion. As discussed earlier, gB is not essential for 
either de-envelopment or cytoplasmic envelopment during virion egress. In this regard, 
the UL20p/gK complex must carry out fundamentally distinct functions during 
cytoplasmic envelopment relative to those carried out at cell surfaces.  One potential 
explanation for the distinct functions of UL20p/gK may be differential processing of 
UL20p via phosphorylation or other means.  In this regard, it is known that viral proteins 
that are structural components of the virion are predominantly underphosphorylated 
relative to infected cells. Thus, it is possible that gK/UL20p underphosphorylation 
promotes interactions required for cytoplasmic envelopment, while phosphorylation of 
UL20p promotes interactions of the UL20p/gK complex with gB at cell surfaces. 
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Figure 5.4:  The proposed Alphaherpesvirus Fuseosome.   A schematic representation 
of interactions between the core integral membrane proteins responsible for regulation of 
HSV-1 virus-induced cell-to-cell fusion is shown.  UL20p is thought to interact directly 
with both gB and gK (blue arrows).  There are also thought to be functional interactions 
that must take place between gB and gD or gH/gL (green arrow) in order to activate the 
fusogenic potential of gB. 
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